
<html lang="en"     class="pb-page"  data-request-id="367ec2de-7886-4c97-bc28-637cac9a4974"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00554;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor" /></meta><meta name="dc.Creator" content="Rareş-Petru  Moldovan" /></meta><meta name="dc.Creator" content="Rodrigo  Teodoro" /></meta><meta name="dc.Creator" content="Yongjun  Gao" /></meta><meta name="dc.Creator" content="Winnie  Deuther-Conrad" /></meta><meta name="dc.Creator" content="Mathias  Kranz" /></meta><meta name="dc.Creator" content="Yuchuan  Wang" /></meta><meta name="dc.Creator" content="Hiroto  Kuwabara" /></meta><meta name="dc.Creator" content="Masayoshi  Nakano" /></meta><meta name="dc.Creator" content="Heather  Valentine" /></meta><meta name="dc.Creator" content="Steffen  Fischer" /></meta><meta name="dc.Creator" content="Martin G.  Pomper" /></meta><meta name="dc.Creator" content="Dean F.  Wong" /></meta><meta name="dc.Creator" content="Robert F.  Dannals" /></meta><meta name="dc.Creator" content="Peter  Brust" /></meta><meta name="dc.Creator" content="Andrew G.  Horti" /></meta><meta name="dc.Description" content="Cannabinoid receptors type 2 (CB2) represent a target with increasing importance for neuroimaging due to its upregulation under various pathological conditions. Encouraged by preliminary results ob..." /></meta><meta name="Description" content="Cannabinoid receptors type 2 (CB2) represent a target with increasing importance for neuroimaging due to its upregulation under various pathological conditions. Encouraged by preliminary results ob..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 23, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00554" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00554" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00554" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00554" /></link>
        
    
    

<title>Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00554" /></meta><meta property="og:title" content="Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0016.jpeg" /></meta><meta property="og:description" content="Cannabinoid receptors type 2 (CB2) represent a target with increasing importance for neuroimaging due to its upregulation under various pathological conditions. Encouraged by preliminary results obtained with [11C](Z)-N-(3-(2-methoxyethyl)-4,5-dimethylthiazol-2(3H)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide ([11C]A-836339, [11C]1) in a mouse model of acute neuroinflammation (induced by lipopolysaccharide, LPS), we designed a library of fluorinated analogues aiming for an [18F]-labeled radiotracer with improved CB2 binding affinity and selectivity. Compound (Z)-N-(3-(4-fluorobutyl)-4,5-dimethylthiazol-2(3H)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (29) was selected as the ligand with the highest CB2 affinity (Ki = 0.39 nM) and selectivity over those of CB1 (factor of 1000). [18F]29 was prepared starting from the bromo precursor (53). Specific binding was shown in vitro, whereas fast metabolism was observed in vivo in CD-1 mice. Animal PET revealed a brain uptake comparable to that of [11C]1. In the LPS-treated mice, a 20–30% higher uptake in brain was found in comparison to that in nontreated mice (n = 3, P &lt; 0.05)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00554"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00554">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00554&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00554&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00554&amp;href=/doi/10.1021/acs.jmedchem.6b00554" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7840-7855</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00425" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00594" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rare%C5%9F-Petru++Moldovan">Rareş-Petru Moldovan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rodrigo++Teodoro">Rodrigo Teodoro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongjun++Gao">Yongjun Gao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Winnie++Deuther-Conrad">Winnie Deuther-Conrad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mathias++Kranz">Mathias Kranz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuchuan++Wang">Yuchuan Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroto++Kuwabara">Hiroto Kuwabara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masayoshi++Nakano">Masayoshi Nakano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Valentine">Heather Valentine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steffen++Fischer">Steffen Fischer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+G.++Pomper">Martin G. Pomper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dean+F.++Wong">Dean F. Wong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+F.++Dannals">Robert F. Dannals</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Brust">Peter Brust</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+G.++Horti">Andrew G. Horti</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Helmholtz-Zentrum Dresden-Rossendorf e.V., Institute of Radiopharmaceutical Cancer Research, Leipzig, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Johns Hopkins School of Medicine, Department of Radiology, Baltimore, 21287 United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 0049 341 234179 4634; e-mail: <a href="/cdn-cgi/l/email-protection#c3b1edaeacafa7acb5a2ad83abb9a7b1eda7a6"><span class="__cf_email__" data-cfemail="285a064547444c475e49466840524c5a064c4d">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Phone: 410 614 5130; e-mail: <a href="/cdn-cgi/l/email-protection#096861667b7d60384963616460276c6d7c"><span class="__cf_email__" data-cfemail="aecfc6c1dcdac79feec4c6c3c780cbcadb">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00554&amp;href=/doi/10.1021%2Facs.jmedchem.6b00554" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7840–7855</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 8, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 April 2016</li><li><span class="item_label"><b>Published</b> online</span>23 August 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 September 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00554" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00554</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7840%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRare%25C5%259F-Petru%2BMoldovan%252C%2BRodrigo%2BTeodoro%252C%2BYongjun%2BGao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D17%26contentID%3Dacs.jmedchem.6b00554%26title%3DDevelopment%2Bof%2Ba%2BHigh-Affinity%2BPET%2BRadioligand%2Bfor%2BImaging%2BCannabinoid%2BSubtype%2B2%2BReceptor%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7855%26publicationDate%3DSeptember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00554"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2477</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00554" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rareş-Petru&quot;,&quot;last_name&quot;:&quot;Moldovan&quot;},{&quot;first_name&quot;:&quot;Rodrigo&quot;,&quot;last_name&quot;:&quot;Teodoro&quot;},{&quot;first_name&quot;:&quot;Yongjun&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Winnie&quot;,&quot;last_name&quot;:&quot;Deuther-Conrad&quot;},{&quot;first_name&quot;:&quot;Mathias&quot;,&quot;last_name&quot;:&quot;Kranz&quot;},{&quot;first_name&quot;:&quot;Yuchuan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Hiroto&quot;,&quot;last_name&quot;:&quot;Kuwabara&quot;},{&quot;first_name&quot;:&quot;Masayoshi&quot;,&quot;last_name&quot;:&quot;Nakano&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Valentine&quot;},{&quot;first_name&quot;:&quot;Steffen&quot;,&quot;last_name&quot;:&quot;Fischer&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;G. Pomper&quot;},{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;F. Wong&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;F. Dannals&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Brust&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;G. Horti&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7840-7855&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00554&quot;},&quot;abstract&quot;:&quot;Cannabinoid receptors type 2 (CB2) represent a target with increasing importance for neuroimaging due to its upregulation under various pathological conditions. Encouraged by preliminary results obtained with [11C](Z)-N-(3-(2-methoxyethyl)-4,5-dimethylthiazol-2(3H)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide ([11C]A-836339, [11C]1) in a mouse model of acute neuroinflammation (induced by lipopolysaccharide, LPS), we designed a library of fluorinated analogues aiming for an [18F]-labeled radiotracer with improved CB2 binding affinity and selectivity. Compound (Z)-N-(3-(4-fluorobutyl)-4,5-dimethylthiazol-2(3H)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (29) was selected as the ligand with the highest CB2 affinity (Ki = 0.39 nM) and selectivity over those of CB1 (factor of 1000). [18F]29 was prepared starting from the bromo precursor (53). Specific binding was shown in vitro, whereas fast metabolism was observed in vivo in CD-1 mice. Animal PET revealed a brain uptake comparable to that of [11C&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00554&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00554" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00554&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00554" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00554&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00554" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00554&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00554&amp;href=/doi/10.1021/acs.jmedchem.6b00554" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00554" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00554" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00554%26sid%3Dliteratum%253Aachs%26pmid%3D27500461%26genre%3Darticle%26aulast%3DMoldovan%26date%3D2016%26atitle%3DDevelopment%2Bof%2Ba%2BHigh-Affinity%2BPET%2BRadioligand%2Bfor%2BImaging%2BCannabinoid%2BSubtype%2B2%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D17%26spage%3D7840%26epage%3D7855%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/jmcmar.2016.59.issue-17/20160908/jmcmar.2016.59.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cannabinoid receptors type 2 (CB<sub>2</sub>) represent a target with increasing importance for neuroimaging due to its upregulation under various pathological conditions. Encouraged by preliminary results obtained with [<sup>11</sup>C](<i>Z</i>)-<i>N</i>-(3-(2-methoxyethyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide ([<sup>11</sup>C]A-836339, [<sup>11</sup>C]<b>1</b>) in a mouse model of acute neuroinflammation (induced by lipopolysaccharide, LPS), we designed a library of fluorinated analogues aiming for an [<sup>18</sup>F]-labeled radiotracer with improved CB<sub>2</sub> binding affinity and selectivity. Compound (<i>Z</i>)-<i>N</i>-(3-(4-fluorobutyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>29</b>) was selected as the ligand with the highest CB<sub>2</sub> affinity (<i>K</i><sub>i</sub> = 0.39 nM) and selectivity over those of CB<sub>1</sub> (factor of 1000). [<sup>18</sup>F]<b>29</b> was prepared starting from the bromo precursor (<b>53</b>). Specific binding was shown in vitro, whereas fast metabolism was observed in vivo in CD-1 mice. Animal PET revealed a brain uptake comparable to that of [<sup>11</sup>C]<b>1</b>. In the LPS-treated mice, a 20–30% higher uptake in brain was found in comparison to that in nontreated mice (<i>n</i> = 3, <i>P</i> < 0.05).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since its isolation and elucidation of the structure in 1964 by Mechoulam and co-workers,<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> (−)-<i>trans</i>-Δ<sup>9</sup>-tetrahydrocannabinol (THC) has been the subject of many scientific investigations due to its intriguing biological properties.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> This led to the discovery of the endogenous cannabinoid system, which comprises a class of transmembrane proteins that belongs to the superfamily of G-protein-coupled receptors and their modulatory lipids.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Etymologically, cannabinoid receptors are proteins that are activated by THC, the principal psychoactive constituent of the cannabis plant.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Two types of cannabinoid receptors have been cloned so far, cannabinoid receptor type 1 (CB<sub>1</sub>)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and cannabinoid receptor type 2 (CB<sub>2</sub>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> There is evidence for further cannabinoid receptors with unclear molecular identity, collectively known as non-CB<sub>1</sub>/CB<sub>2</sub> receptors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The most prominent candidates are GPR55<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and GPR119.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> CB<sub>1</sub> receptors are mainly located at the terminals of central and peripheral neurons and are the most abundantly expressed G-protein-coupled receptors in the brain.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Their activation is responsible for the psychotropic effect of THC.<a onclick="showRef(event, 'ref5 ref12'); return false;" href="javascript:void(0);" class="ref ref5 ref12">(5, 12)</a> On the other hand, the CB<sub>2</sub> receptor has been categorized as the peripheral cannabinoid receptor due to its presence on cells and tissues of the immune, reproductive, cardiovascular, gastrointestinal, and respiratory systems.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Although numerous reports were unable to detect the CB<sub>2</sub> receptor in normal healthy brain, recent evidence suggests that CB<sub>2</sub> receptors are present in the brain under normal and in particular under pathological conditions, although to a much lesser extent than the ubiquitously expressed CB<sub>1</sub> receptors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The role and distribution of CB<sub>1</sub> receptors in the living human brain have already been investigated intensively.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Much less is known about the role and distribution of the CB<sub>2</sub> receptors in the human brain.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Low levels of CB<sub>2</sub> receptors are found in microglial cells,<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> human fetal astrocytes,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and human cerebral microvascular endothelial cells.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Overexpression of the CB<sub>2</sub> receptor has been found on microglia associated with neuritic plaques in Alzheimer’s disease.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Enhanced CB<sub>2</sub> receptor expression, primarily on activated microglia, has been demonstrated in several other neurodegenerative disorders such as multiple sclerosis,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Down’s syndrome,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and Huntington’s disease.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> CB<sub>2</sub> expression pathologies also include traumatic brain injury,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> neuropathic pain,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and HIV-induced encephalitis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Significant alterations of a balance in the cannabinoid system between the levels of endogenous ligands and their receptors occur during malignant transformation in various types of cancer including brain tumors, as previously reviewed.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a></div><div class="NLM_p">CB<sub>2</sub>-selective ligands have gained increasing importance as therapeutic drugs for the diseases mentioned above, especially for the prevention of psychoactive side effects.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38">(30-38)</a> Molecular imaging with positron emission tomography (PET) of disease-specific expression of CB<sub>2</sub> receptors in various disorders of the central nervous system like neuroinflammation, neurodegeneration, and glioma offers the potential of individualized diagnosis and therapeutic monitoring.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Recently, a substantial effort has been put into the development of radioligands for PET imaging of CB<sub>2</sub> receptors (for reviews, see refs <a onclick="showRef(event, 'ref31 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref31 ref40 ref41">31, 40, and 41</a>). Several radiolabeled CB<sub>2</sub> molecules have been developed with the most representative ones depicted in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative radiolabeled CB<sub>2</sub> ligands.<a onclick="showRef(event, 'ref42 ref44 ref47 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref42 ref44 ref47 ref49 ref50">(42, 44, 47, 49, 50)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The principle of CB<sub>2</sub> imaging under neuroinflammatory circumstances was proven by our previous work using [<sup>11</sup>C]<b>1</b>.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Recent PET studies revealed a significant increase in the binding of [<sup>11</sup>C]<b>1</b> in a mouse model of Alzheimer’s disease that was consistent with increased CB<sub>2</sub> immunoreactivity in astrocytes and microglia.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Compound [<sup>11</sup>C]<b>2</b> ([<sup>11</sup>C]NE40) was developed by Evens and co-workers,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and a first-in-man study in healthy subjects was reported.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> However, PET studies with [<sup>11</sup>C]<b>2</b> did not show the expected increase of binding in subjects with Alzheimer’s disease as compared to healthy controls, perhaps due to the insufficient binding affinity of the radiotracer.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The usefulness of CB<sub>2</sub> PET radiotracers in models of neuroinflammation was also demonstrated in dynamic PET studies in primates using radiolabeled triazine scaffolds ([<sup>18</sup>F]<b>3</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref34 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref34 ref47 ref48">(34, 47, 48)</a> The most recently developed PET radioligands for CB<sub>2</sub> receptors are [<sup>11</sup>C]<b>4</b> ([<sup>11</sup>C]RS-016)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and [<sup>11</sup>C]<b>5</b> ([<sup>11</sup>C]RSR-056),<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> which demonstrated moderately specific binding in the mouse LPS mouse model of neuroinflammation.</div><div class="NLM_p">Altogether, the importance of targeting CB<sub>2</sub> receptors has been shown by several groups worldwide and has been characterized in several pathological conditions in animals. However, the development of a radioligand suitable for the noninvasive investigation of the CB<sub>2</sub> receptor in healthy and diseased brains remains challenging.</div><div class="NLM_p">Our aim was to develop an <sup>18</sup>F-labeled PET radiotracer based on the scaffold of compound <b>1</b><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The newly synthesized derivatives contain the basic structural features of lead compound <b>1</b> with modifications to increase CB<sub>2</sub> binding affinity and selectivity relative to those of CB<sub>1</sub> combined with a facile incorporation of the fluorine-18 ([<sup>18</sup>F]) via nucleophilic substitution at the aliphatic position. As part of our efforts, modifications at the thiazole <i>N</i>-alkyl chain, thiazole position 5, and at the cyclopropyl subunit were performed (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> and <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), and their impact on CB<sub>2</sub> binding affinity and selectivity toward CB<sub>1</sub> were investigated. On the basis of the structure–activity relationship findings, radiofluorination and biological investigation in a murine model of neuroinflammation were performed for the most promising derivative.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead compound <b>1</b><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and proposed fluoro-derivatization. For details on the Alk(ox)yl, see Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities of <b>1</b> and the New Derivatives Determined by (A) CEREP (France) and (B) HZDR (Leipzig)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0015.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">N/A = not available.</p></div></div><div></div></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Lead Compound <b>1</b> and <i>N</i>-Alkyl Derivatives <b>17</b>–<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) RX, neat, 90 °C, 16 h; (b) 2,2,3,3-tetramethylcyclopropane-1-carboxylic acid, BOP, Et<sub>3</sub>N, DCM, rt, 24 h, 30–50% over two steps;<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (c) NaH, alkyl bromide, DMF, 0 °C to rt, 80–85%; BOP = (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">The synthesis of the new derivatives has been performed as described earlier for <b>1</b><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> with minor modifications. Generally, the synthesis started with commercially available thiazole <b>6</b> as free base, which is <i>N</i>-alkylated in solvent-free, thermal reaction conditions followed by the BOP reagent-mediated coupling with 2,2,3,3-tetramethyl-cyclopropylcarboxylic acid to give compounds <b>17</b>–<b>29</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">For the synthesis of the fluoro-triethylene and fluoro-tetraethylene glycols <b>20</b> and <b>21</b> (see <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), tosylates <b>34</b> and <b>35</b> were synthesized as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Triethylene and tetraethylene glycol (<b>30</b> and <b>31</b>, respectively) were bitosylated then monofluorinated using TBAF, resulting in a 42% yield over two steps (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>A).<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a> Commercially available 2-amine-4,5-dimethylthiazol (<b>6</b>) was reacted with the two corresponding tosylates <b>34</b> and <b>35</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) in a minimum amount of DMF (for solubilization) to provide compounds <b>7</b> and <b>8</b>, respectively, as -OTs salts as observed by <sup>1</sup>H NMR spectroscopy (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Reagents <b>34</b>, <b>35</b>, <b>37</b>, and <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TsCl, KOH, DCM, 0 °C, 3 h, quantitative;<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (b) TBAF, THF, rt, 16 h, 42%; (c) MsCl, Et<sub>3</sub>N, DCM, 0 °C to rt, 1 h, quantitative;<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> (d) BBr<sub>3</sub>, LiAlH<sub>4</sub>, DCM, 0 °C to rt, 1 h, 90%.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></p></p></figure><div class="NLM_p">For the synthesis of the compounds <b>25</b> and <b>26</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), mesylates <b>37</b> and <b>40,</b> respectively, were synthesized as racemates from the corresponding alcohols (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>B and C).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> All other <i>N</i>-alkylating agents used for the synthesis of compounds <b>7</b>–<b>16</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) were commercially available. The coupling of derivatives <b>7</b>–<b>16</b> with 2,2,3,3-tetramethyl-cyclopropylcarboxylic acid was performed according to the general procedure previously described<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> by employing BOP as coupling reagent and triethylamine (Et<sub>3</sub>N) in DCM. Yields between 20 and 45% were obtained. Compounds <b>18</b> and <b>19</b> were synthesized from the alcohol <b>17</b> by Williamson ether synthesis. Analogously, compounds <b>23</b> and <b>24</b> were synthesized from alcohol <b>22</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">In an effort to further investigate the pharmacology of lead compound <b>1</b>, we introduced a hydroxyl group and its corresponding methyl ether by substituting the 2,2,3,3-tetramethylcyclopropyl partial structure with a 3-(hydroxymethyl)-2,2-dimethylcyclopropyl subunit (compounds <b>44</b> and <b>45</b>, respectively; <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the hydrophilic derivatives <b>44</b> and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KMnO<sub>4</sub>, Na<sub>2</sub>SO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 4 h, 30%;<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (b) <b>2</b>, BOP, Et<sub>3</sub>N, DCM, rt, 24 h, 42%; (c) LiAlH<sub>4</sub>, THF, rt, 4 h, quantitative; (d) NaH, MeI, DMF, 0 °C to rt, 4 h, 95%.</p></p></figure><div class="NLM_p">The synthesis of <b>45</b> started from the commercially available <i>rac</i>-ethyl-chrysanthemate (<b>41</b>), which was first oxidized with KMnO<sub>4</sub>, and the resulting carboxylic acid (<b>42</b>, mixture of <i>cis</i>/<i>trans</i> isomers)<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> was coupled with 2-aminothiazole derivative <b>9</b> in the presence of BOP and Et<sub>3</sub>N to give ester <b>43</b>. At this step, epimerization took place presumably via Et<sub>3</sub>N-mediated deprotonation-protonation at the cyclopropyl subunit. Compound <b>43</b> was obtained as a racemic mixture of <i>trans</i> isomers as determined by 2D-NOESY NMR (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00554/suppl_file/jm6b00554_si_001.pdf" class="ext-link">Supporting Information</a>). Reduction of ester <b>43</b> to alcohol <b>44</b> was performed with LiAlH<sub>4</sub> in quantitative yield, which was further etherified with MeI under deprotonation via Williamson ether synthesis to give <b>45</b> in 95% yield over two steps.</div><div class="NLM_p">The structure of <b>1</b> was also modified at the thiazole 5-position starting from ethyl 3-oxobutanoate, which was brominated in the first step<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and then cyclized with thiourea (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). 2-Aminothiazole <b>48</b> was <i>N</i>-alkylated with 2-bromoethyl methyl ether and then coupled with 2,2,3,3-tetramethylcyclopropane-1-carboxylic to give compound <b>49</b>. Double methylation of <b>49</b> with the Grignard reagent MeLi gave the 2-isopropanol derivative <b>50</b>. Methoxylation of <b>50</b> was performed via Williamson ether synthesis to form <b>51</b> in 79% yield.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of compounds <b>50</b> and <b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KBr, H<sub>2</sub>O<sub>2</sub>, 1 h, quantitative;<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> (b) thiourea, EtOH, reflux, 1 h, quantitative; (c) (i) 2-bromoethyl methyl ether, 95 °C, 16 h, (ii) 2,2,3,3-tetramethylcyclopropane-1-carboxylic acid, BOP, Et<sub>3</sub>N, DCM, rt, 24 h, 36% over two steps; (d) MeLi, −78 °C, 30 min, 72%; (e) NaH, MeI, overnight, rt, 79%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Structure–Activity Relationship</h3><div class="NLM_p">The main purpose of the study was to develop an [<sup>18</sup>F]fluoro analogue of <b>1</b> with greater CB<sub>2</sub> binding affinity. The new fluorinated derivative had to be highly selective for CB<sub>2</sub> versus CB<sub>1</sub> (CB<sub>2</sub>/CB<sub>1</sub> > 100) because of the high CB<sub>1</sub> receptor density in the healthy human brain. We mainly focused on compound <b>1</b><i>N</i>-alkyl chain modifications. The binding affinities of the new derivatives were determined by CEREP (France) and HZDR (Leipzig).</div><div class="NLM_p">The first <i>N</i>-alkyl chain analogue of <b>1</b> is the fluoro-ethoxyethane derivative <b>18</b> that exhibits greater CB<sub>2</sub> binding affinity than that of <b>1</b>, but its CB<sub>2</sub>/CB<sub>1</sub> selectivity was reduced (<100 fold) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The increase in the number of ethoxyethane groups (<b>20</b> and <b>21</b>) led to a dramatic reduction in the CB<sub>2</sub> affinity (19 and 1100 nM, respectively) compared to those of <b>18</b> and <b>1</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">The propoxyethane analogues of <b>1</b> and <b>18</b> (compounds <b>22</b>–<b>24</b>) exhibited comparable CB<sub>2</sub> and CB<sub>1</sub> binding affinities, but they were slightly more lipophilic. Two derivatives were synthesized by branching a methyl group at the <i>N</i>-alkyl chain (compounds <b>25</b> and <b>26</b>), which led to a significant decrease in the CB<sub>2</sub> binding affinity.</div><div class="NLM_p">Three further derivatives have been synthesized, <b>27</b>–<b>29</b>, all of which lack the oxygen atom at the thiazole <i>N</i>-alkyl chain subunit and clearly show a correlation between the thiazole-<i>N</i>-alkyl chain length and binding affinity toward CB<sub>2</sub>. Furthermore, derivatization at both the cyclopropyl and thiazole 5-position led to decreased CB<sub>2</sub> binding affinity (compounds <b>44</b>, <b>45</b>, and <b>50</b>; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p last">Of this new series of compounds (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), <b>29</b> manifests the best combination of high CB<sub>2</sub> binding affinity (<i>K</i><sub>i</sub> = 0.39 nM) and excellent CB<sub>2</sub>/CB<sub>1</sub> selectivity. It was selected for radiolabeling and animal experiments.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Radiochemistry</h3><div class="NLM_p">The synthesis of the precursor for the <sup>18</sup>F radiosynthesis (<b>53</b>) was performed starting from 4,5-dimethylthiazol-2-amine (<b>6</b>) by coupling with 2,2,3,3-tetramethylcyclopropane-1-carboxylic acid in the presence of BOP reagent with an 18% yield. Alkylation of thiazole <b>52</b> was performed using a large excess of 1,4-dibromobutane (10 equiv) and deprotonation with NaH (2 equiv).</div><div class="NLM_p">Radiosynthesis of [<sup>18</sup>F]<b>29</b> was achieved by aliphatic nucleophilic substitution of the corresponding bromo precursor (<b>53</b>). Manual optimization of the radiosynthesis was performed to select the best radiolabeling conditions prior to the transfer to an automated module (e.g., solvent, temperature, heating method, and amount of precursor for radiolabeling).</div><div class="NLM_p">Low labeling yields (≤10%) were obtained when using DMF and DMSO (120–150 °C) as solvents under conventional and microwave-assisted radiofluorination (power cycling mode, 100 W, 120–150 °C) heating methods in the presence of the reactive anhydrous K<sub>2</sub>CO<sub>3</sub>/K2.2.2. complex, which is probably due to the observed decomposition of bromo precursor <b>53</b> at short reaction times (≤5 min). No significant increases in labeling efficiencies were noticed when a 2-fold increase of precursor amount was used with DMF and DMSO as solvents. The best bromo-to-fluoro displacement was obtained when acetonitrile (CH<sub>3</sub>CN) was used as the solvent at 80 °C for 15 min (labeling yields ∼30%) in the presence of the K<sub>2</sub>CO<sub>3</sub>/K2.2.2. complex (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). It is worth mentioning that under these conditions the maximum [<sup>18</sup>F]F<sup>–</sup> incorporation yield was reached with 3.5 mg of <b>53</b>. The radio-thin-layer chromatography (radio-TLC) and the radio-HPLC findings pointed out that, besides the desired radiotracer, only unreacted radiofluoride was present in the reaction mixture.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Precursor for Radiolabeling <b>53</b> and Radiosynthesis of [<sup>18</sup>F]<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 2,2,3,3-Tetramethylcyclopropane-1-carboxylic acid, BOP, Et<sub>3</sub>N, DCM, rt, 24 h, 18%; (b) NaH, Br(CH<sub>2</sub>)<sub>4</sub>Br, DMF, rt, overnight, 56%; (c) [<sup>18</sup>F]F–K2.2.2., CH<sub>3</sub>CN, 80 °C.</p></p></figure><div class="NLM_p">For animal experiments, the radiosynthesis of [<sup>18</sup>F]<b>29</b> was translated to the automated module Tracerlab FX<sub>FN</sub>, and the total synthesis time was approximately 70 min (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). For isolation of the product, the reaction mixture was transferred onto a semipreparative HPLC column (entry 7, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) followed by purification on a preconditioned Sep-Pack C18 light cartridge (entry 11) using EtOH as eluent. An injectable solution was obtained by evaporation of the solvent under a gentle stream of nitrogen at 70 °C with the subsequent addition of a saline-alcohol mixture (0.9%:10% NaCl:EtOH). [<sup>18</sup>F]<b>29</b> was obtained with a 16 ± 8.7% radiochemical yield, high radiochemical purity (≥98%), and a specific activity of 169.7 ± 11.7 GBq/μmol at the end of the synthesis. The identity of [<sup>18</sup>F]<b>29</b> was confirmed by coinjection of the corresponding reference compound as depicted in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B. In vitro evaluation of stability proved that [<sup>18</sup>F]<b>29</b> was stable in saline and EtOH with more than 98% intact radiotracer remaining up to 90 min. An experimental logD<sub>7,4</sub> of 3.22 ± 0.03 was found for [<sup>18</sup>F]<b>29</b>, which is within the desired range for compounds that will penetrate the blood-brain barrier.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Scheme of the synthesis module Tracer Lab FX-FN for the automated radiosynthesis of [<sup>18</sup>F]<b>29</b>. (1) Chromafix 30 PS-HCO<sub>3</sub><sup>–</sup>, (2) K<sub>2</sub>CO<sub>3</sub> (1.78 mg in 0.4 mL H<sub>2</sub>O), (3) K2.2.2. (11.2 mg in 1 mL of CH<sub>3</sub>CN), (4) 3.5 mg <b>53</b> in 1 mL of CH<sub>3</sub>CN, (5) 3 mL of H<sub>2</sub>O/CH<sub>3</sub>CN (1:1), (6) reactor, (7) Reprosil-Pur C18-AQ (65% CH<sub>3</sub>CN/20 mM NH<sub>4</sub>OAc; flow rate of 4.2 mL/min), (8) 40 mL of H<sub>2</sub>O, (9) 2 mL of H<sub>2</sub>O, (10) 1.25 mL of EtOH, (11) Sep Pak C18 light cartridge, (12) product in 0.9% NaCl containing 10% EtOH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Representative semipreparative radio-HPLC profile of [<sup>18</sup>F]<b>29</b> (conditions: Reprosil-Pur 120 C18-AQ (5 μm, 250 × 10 mm), 65% CH<sub>3</sub>CN/20 mM NH<sub>4</sub>OAc aq., 4.2 mL/min); (B) analytical UV- and radio-HPLC chromatogram of [<sup>18</sup>F]<b>29</b> spiked with corresponding reference compound <b>29</b> (conditions: Reprosil-Pur C18-AQ (5 μm, 250 × 4.6 mm), 70% CH<sub>3</sub>CN/20 mM NH<sub>4</sub>OAc aq., 1 mL/min) (solid line, γ-trace; gray line, UV-trace).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Autoradiography Studies: Radiotracer Characterization</h3><div class="NLM_p">[<sup>18</sup>F]<b>29</b> was further evaluated in vitro by receptor autoradiography using rat spleen, an organ that expresses high levels of CB<sub>2</sub> under physiological conditions.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> For a displacement study, tissue slices were incubated with [<sup>18</sup>F]<b>29</b> without or with the CB<sub>2</sub>-selective inverse agonist <i>N</i>-[(1<i>S</i>)-endo-1,3,3-trimethylbicyclo [2.2.1]-heptane-2-yl]-5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-1<i>H</i>-pyrazole-3-carboxamide (SR144528, <b>54</b>), the CB<sub>1</sub>-selective antagonist <i>N</i>-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1<i>H</i>-pyrazole-3-carboxamide (SR141716A, <b>55</b>), the CB<sub>1</sub>/CB<sub>2</sub>-selective agonist (<b>−</b>)-<i>cis</i>-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-<i>trans</i>-4-(3-hydroxypropyl)cyclohexanol (CP55,940, <b>56</b>), or nonlabeled reference compound <b>29</b>. The autoradiograms of the binding of [<sup>18</sup>F]<b>29</b> without and with 1 μM of the indicated compounds are presented in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. [<sup>18</sup>F]<b>29</b> selectively binds to CB<sub>2</sub> receptors in vitro. (A) Rat spleen autoradiograms of [<sup>18</sup>F]<b>29</b> without and with coincubation of the radioligand with 1 μM of CB<sub>2</sub>-specific <b>54</b>, CB<sub>1</sub>-specific <b>55</b>, CB<sub>1</sub>/CB<sub>2</sub>-specific <b>56</b>, and <b>29</b>. (B) Evaluation of the specific binding and displacement of [<sup>18</sup>F]<b>29</b> on sections of rat spleen determined without and with coincubation of the radioligand with CB<sub>2</sub>-specific <b>54</b> at 10 nM and 1 μM, CB<sub>1</sub>-specific <b>55</b> at 10 nM and 1 μM, CB<sub>1</sub>/CB<sub>2</sub>-specific <b>56</b> at 1 μM, and <b>29</b> at 1 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The specific binding of [<sup>18</sup>F]<b>29</b> in wild-type spleen (100%) was displaced by the CB<sub>2</sub>-selective compounds <b>54</b> at 10 nM (−8%) and 1 μM (−39%) as well as 1 μM of <b>56</b> (−56%) and the nonlabeled reference compound <b>29</b> (−70%), but remained unaffected by coincubation with CB<sub>1</sub>-targeting <b>55</b> at 10 nM and 1 μM (114 and 107%, respectively) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vivo Metabolism of [<sup>18</sup>F]<b>29</b></h3><div class="NLM_p">In vivo metabolism of [<sup>18</sup>F]<b>29</b> in blood plasma and brain tissue was assessed in female CD-1 mice. Blood samples and brain homogenates were obtained at 30 min post radiotracer injection, and proteins were removed by organic solvent deproteinization. In general, extraction efficiencies of radioactivity higher than 90% were achieved using MeOH/H<sub>2</sub>O (9:1, v/v) as the extraction solvent for both tissues.</div><div class="NLM_p">The radiometabolite analysis of plasma reflects a rapid metabolism of [<sup>18</sup>F]<b>29</b> with only 7% of intact radiotracer accounting for the total plasma activity at 30 min post injection (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Brain homogenates (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B) revealed that 36% of the extracted radioactivity was attributable to the intact radiotracer.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo metabolism of [<sup>18</sup>F]<b>29</b> at 30 min p.i. (A) Plasma samples [extraction with MeOH/H<sub>2</sub>O (9:1); 94% extraction yield] and (B) brain homogenates [extraction with MeOH/H<sub>2</sub>O (9:1); 93% extraction yield]. HPLC conditions: Reprosil-Pur C18-AQ (250 × 4.6 mm; 5 μm); Gradient mode (10–90% CH<sub>3</sub>CN/20 mM NH<sub>4</sub>OAc aq.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> PET Imaging in Healthy CD-1 Mice</h3><div class="NLM_p">Dynamic small animal PET/MR scans under baseline conditions were performed in three healthy female CD-1 mice after a bolus i.v. injection of 12.0 ± 4.1 MBq of [<sup>18</sup>F]<b>29.</b> The in vivo time–activity curves (TACs) (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A) reflect high uptake in liver and kidneys followed by a fast washout, whereas the activity concentration is constantly increasing in the intestines, urinary bladder, and gallbladder. The summed whole body PET/MR image (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B) illustrates these high uptakes for liver and urinary bladder. As a region with high CB<sub>2</sub> expression, the spleen was investigated separately. The respective TAC (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A) shows a clear uptake of activity in the spleen (mean SUV, <i>n</i> = 3 animals) followed by a washout. In addition, the spleen is visible in the 30 min PET and T1-weighted MR image (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B). Finally, blocking studies using CB<sub>2</sub>-specific compound <b>1</b> were performed to prove the specificity of [<sup>18</sup>F]<b>29</b> toward CB<sub>2</sub>. Preblocking (3 mg of <b>1</b>/kg i.p. at 15 min before tracer administration and PET start) significantly reduced the uptake of activity in the spleen (<i>p</i> < 0.05, students <i>t</i> test) compared to that of the baseline conditions (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>C).</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Whole-body pharmacokinetics of [<sup>18</sup>F]<b>29</b>. (A) Small animal PET/MR-derived TACs in healthy female CD-1 mice (<i>n</i> = 3). (B) (left) Summed whole body PET image (0–60 min p.i.); (middle) T1-weighted whole body MR image; (right) fused PET/MR images of one representative animal.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Spleen uptake of [<sup>18</sup>F]<b>29</b>. (A) TAC of the spleen showing mean SUV (<i>n</i> = 3) and standard deviation. (B) Detailed view of the abdominal region (left: PET; middle: T1-weighted MR; right: PET/MR fusion) with main organs highlighted by arrows. (C) Spleen uptake under baseline and preblocking conditions (3 mg/kg of <b>1</b>, i.p. at 15 min before tracer). Activity uptake at 10 min p.i. of [<sup>18</sup>F]<b>29</b> is signifcantly reduced by preblocking (<i>p</i> < 0.05, students <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> PET [<sup>18</sup>F]<b>29</b> Imaging in a Mouse Model of Neuroinflammation</h3><div class="NLM_p">PET scans with [<sup>18</sup>F]<b>29</b> were performed in a lipopolysaccharide (LPS) mouse model of neuroinflammation. In this model, mice are injected i.p. with 5 mg/kg of LPS, which results in a rapid increase of brain TNFα that remains activated for a prolonged period of time.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p">In our study, three pairs of mice (LPS-treated and control) were scanned side-by-side after the bolus iv administration of [<sup>18</sup>F]<b>29</b> (7.4–11.1 MBq, specific activity >370 GBq/μmol), and time-activity curves (whole brain) were generated (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A). When comparing the area-under-the-curve (AUC) using the nonparametric Mann–Whitney test (one tailed), a statistically significant difference (<i>p</i> = 0.05) was observed between the control and LPS groups. The study demonstrated significantly increased brain uptake of [<sup>18</sup>F]<b>29</b> in the LPS-treated animals versus control animals. In a separate experiment using the same arrangement, the LPS-treated mice were preinjected with the highly selective CB<sub>2</sub> binding affinity agonist <b>1</b> (1 mg/kg, i.p.) and compared to control animals injected with vehicle (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B). Almost identical average time–activity curves were observed, demonstrating no difference between the LPS-treated animals preinjected with the CB<sub>2</sub> agonist and the control animals. This result further demonstrates that the elevated uptake of [<sup>18</sup>F]<b>29</b> in the LPS-treated animals in the baseline study is specific and mediated by the CB<sub>2</sub> receptor.</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0009.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. PET whole brain uptake of [<sup>18</sup>F]<b>29</b> in LPS-treated (red) and control (green) mice. (A) Comparison of [<sup>18</sup>F]<b>29</b> baseline uptake in LPS-treated and control mice. There was a statistically significant difference between the LPS-treated and control animals (<i>p</i> < 0.05, nonparametric Mann–Whitney test (one tailed) of the area-under-curve); data are the mean SUV ± SD (<i>n</i> = 3). (insert) Representative images of LPS and control mice (0–35 min). (B) Whole brain uptake of [<sup>18</sup>F]<b>29</b> in the LPS-treated mice is reduced with injection of CB<sub>2</sub> agonist <b>1</b> (solution in 50% aq DMSO, i.p.) to nearly the same level as that in control mice injected with vehicle. Data are the averaged (10–30 min) SUV ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our previous studies with [<sup>11</sup>C]<b>1</b> showed the potential of this radioligand to image neuroinflammation-induced increases of CB<sub>2</sub> receptor densities in LPS-treated mice<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and in a mouse model of Aβ amyloidosis.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">To achieve a PET radioligand with a longer half-life for CB<sub>2</sub> receptor imaging in the brain, a new series of <b>1</b> derivatives has been synthesized (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). First, the influence of the thiazole <i>N</i>-alkyl chain length and atomic composition on the CB<sub>2</sub> receptors binding affinity and selectivity against CB<sub>1</sub> receptors was investigated for the possibility to introduce the fluorine atom. Large substituents like the hydrophobic tri- and tetraethylene glycols have been implemented to increase hydrophilicity and also <i>N</i>-alkyl ethers, which are comparable in size to <b>1</b>. The role of the oxygen atom at the <i>N</i>-alkyl chain was investigated by shifting its position and also by excluding it in the case of the more lipophilic fluoro-ethyl, -propyl, and -butyl derivatives <b>27</b>, <b>28</b>, and <b>29</b>, respectively.</div><div class="NLM_p">The <i>N</i>-alkylation of the 2-amino-4,5-dimethyl thiazole (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) was generally performed at elevated temperatures in a sealed tube, neat, except for compounds <b>7</b> and <b>8</b>, where DMF was used to solubilize the reaction mixture because tosylates <b>34</b> and <b>35</b> are solid compounds. The resulting <i>N</i>-alkylated compounds (<b>7</b>–<b>16</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) were obtained as salts. The amide formation step was mediated by the BOP coupling reagent as described earlier (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In further efforts to functionalize the structure of <b>1</b>, modifications at the cyclopropyl and at the thiazole subunit were performed (<a class="ref internalNav" href="#sch3" aria-label="Schemes 3">Schemes 3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). As a result, alcohols <b>44</b> and <b>50</b> have been obtained (<a class="ref internalNav" href="#sch3" aria-label="Schemes 3">Schemes 3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, respectively), which are important key building blocks for further derivatizations at these subunits.</div><div class="NLM_p">Our structure–activity relationship study shows that implementation of large substituents at the thiazole nitrogen (<b>20</b> and <b>21</b>) cause a sharp decrease in CB<sub>2</sub> binding affinity. By taking advantage of the <i>N</i>-alkyl ether chain of lead <b>1</b>, elongation to ethyl and propyl derivatives (<b>15</b> and <b>19</b>, respectively) kept the binding affinity whereas an average 9-fold decrease in selectivity toward CB<sub>1</sub> was observed. Aside from branched analogues <b>25</b> and <b>26</b>, a CB<sub>2</sub> binding affinity in the same range as that of the lead compound (along with a decreased selectivity) was found when the oxygen atom position was changed in the <i>N</i>-alkyl chain (<b>23</b> and <b>24</b>).</div><div class="NLM_p">Derivatization at both the cyclopropyl and thiazole 5-positions were not well-tolerated as reflected by the average 16-fold decrease in binding affinity for derivatives <b>45</b> and <b>50</b>. The replacement of the thiazole <i>N</i>-methoxyethyl with fluoroalkyl (e.g., fluoro <i>N</i>-ethyl (<b>27</b>), -propyl (<b>28</b>), and -butyl (<b>29</b>) derivatives) resulted in a progressive increase in binding affinity and selectivity with the chain length. As a result, the robust subnanomolar affinity of thiazole <i>N</i>-butyl-4-fluoro derivative <b>29</b> (CB<sub>2</sub> = 0.39 nM) in combination with the ≥900-fold selectivity toward CB<sub>1</sub> and suitable lipophilicity (LogD<sub>7.4</sub> = 3.22 ± 0.03) led us to perform the radiosynthesis and biological investigation of [<sup>18</sup>F]<b>29</b>.</div><div class="NLM_p">The precursor for the radiosynthesis (compound <b>53</b>, <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>) was obtained by first coupling 4,5-dimethylthiazol-2-amine (<b>6</b>) with 2,2,3,3-tetramethylcyclopropane-1-carboxylic acid in the presence of BOP reagent followed by deprotonative <i>N</i>-alkylation of the thiazole with 1,2-dibromobutane in 10% yield over two steps.</div><div class="NLM_p">A fully automated radiosynthesis of [<sup>18</sup>F]<b>29</b> was successfully accomplished via aliphatic nucleophilic substitution of corresponding halo precursor <b>53</b> in high radiochemical purity (≥98%) and specific activity of up to 1073 GBq/μmol at the end of the synthesis (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><div class="NLM_p">The target specificity of [<sup>18</sup>F]<b>29</b> was further evaluated in autoradiographic studies in vitro using CB<sub>2</sub> expressing rat spleen.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The distribution pattern of [<sup>18</sup>F]<b>29</b> corresponds with the binding of [<sup>3</sup>H]<b>56</b> in the spleen, which is assumed to detect CB<sub>2</sub>-expressing B lymphocytes in the immune system of rats.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Blocking experiments with reference compound <b>29</b> and the CB<sub>2</sub>-selective inverse agonist <b>54</b> confirmed saturable and specific binding of [<sup>18</sup>F]<b>29</b> to CB<sub>2</sub>. Plasma and brain samples were investigated at 30 min post injection via radio-HPLC, and a fast metabolism of [<sup>18</sup>F]<b>29</b> was observed in vivo. Thus, at this time point, ∼7% intact [<sup>18</sup>F]<b>29</b> was found in plasma and ∼36% in the brain samples.</div><div class="NLM_p">Small-animal PET/MR experiments were performed in healthy female CD-1 mice to investigate the peripheral pharmacokinetics of [<sup>18</sup>F]<b>29</b>. The studies revealed high uptake in liver, kidneys, intestines, urinary bladder, and gallbladder, confirming a hepatic tracer excretion pathway. Furthermore, a clear and marked uptake was found in the spleen as a target-specific tissue. It could be blocked by CB<sub>2</sub> selective agonist <b>1</b>.</div><div class="NLM_p last">Compound [<sup>18</sup>F]<b>29</b> was studied with micro-PET in both healthy CD-1 mice and a murine neuroinflammation mouse model induced by LPS. Elevated radiotracer uptake in the brain of the LPS-treated mice was observed compared to that in control mice. Moreover, blocking experiments performed by preinjecting the LPS-treated mice with a CB<sub>2</sub>-selective ligand proved the CB<sub>2</sub> specificity of the herein described radiotracer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A novel series of derivatives of <b>1</b> with high affinity for CB<sub>2</sub> has been developed for PET imaging. Compound <b>29</b> demonstrated high CB<sub>2</sub> binding affinity and selectivity, and therefore, it was selected for <sup>18</sup>F radiolabeling. [<sup>18</sup>F]<b>29</b> was successfully synthesized with high radiochemical purity and specific activities. In vitro autoradiography findings using rat spleen as well as in vivo small-animal PET/MR imaging confirmed CB<sub>2</sub>-specific binding. In addition, small-animal PET studies showed that [<sup>18</sup>F]<b>29</b> readily entered the mouse brain and specifically labeled brain CB<sub>2</sub> receptors in a mouse model of neuroinflammation. Rapid metabolism and the presence of brain-penetrating radiometabolites diminishes the potential of [<sup>18</sup>F]<b>29</b> to image CB<sub>2</sub> receptors with PET.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents were used directly as obtained commercially unless otherwise noted. Reaction progress was monitored by thin-layer chromatography (TLC) using silica gel 60 F254 (0.040–0.063 mm) with detection by UV. All moisture-sensitive reactions were performed under an argon atmosphere using oven-dried glassware and anhydrous solvents. Column flash chromatography was carried out using E. Merck silica gel 60F (230–400 mesh). Analytical TLC was performed on aluminum sheets coated with silica gel 60 F254 (0.25 mm thickness, E. Merck, Darmstadt, Germany). Melting points were determined with a Fisher-Johns apparatus and were not corrected. <sup>1</sup>H NMR spectra were recorded with a Bruker-400 NMR spectrometer at nominal resonance frequencies of 400 MHz in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> (referenced to internal Me<sub>4</sub>Si at δ H 0 ppm). The chemical shifts (δ) were expressed in parts per million (ppm). High-resolution mass spectra were recorded utilizing electrospray ionization (ESI) at the University of Notre Dame Mass Spectrometry facility. All compounds that were tested in the biological assays were analyzed by combustion analysis (CHN) to confirm a purity of >95%. Elemental analyses were determined by Galbraith Laboratories (Knoxville, TN). A dose calibrator (Capintec 15R) was used for all radioactivity measurements. Radiofluorination was performed with a modified GE MicroLab radiochemistry box. The experimental animal protocols were approved by the Animal Care and Use Committee of the Johns Hopkins Medical Institutions and by the respective State of Saxony Animal Care and Use Committee in accordance with the German Law for the Protection of Animals and EU directive 2010/63/EU.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure 1</h4><div class="NLM_p last">2-Amino-4,5-dimethylthiazole (<b>2</b>, 1 equiv) and the appropriate alkyl-bromide, -mesylate, or -tosylate (see <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, 1.5 equiv) were reacted in a sealed vessel at 90 °C for 16 h. The resulting residue was triturated with the minimum amount of <i>i</i>-PrOH; the solid was filtered, dried under high vacuum, and used in the next step without further purification. 2,2,3,3-Tetramethylcyclopropane acid (1 mmol, 1 equiv), Et<sub>3</sub>N (3 mmol, 3 equiv), and BOP (1.3 mmol, 1.3 equiv) were added to a suspension of the alkylated 2-aminoimidazole (1 mmol, 1 equiv) in 5 mL of DCM at 0 °C, and the mixture was stirred at room temperature for 20 h. The reaction was quenched by the addition of 2 mL of water followed by a 10 mL aqueous saturated solution of NaHCO<sub>3</sub> and 15 mL of EtOAc. The phases were separated, and the aqueous phase was washed with 2 × 10 mL of EtOAc. The combined organic fractions were washed with 20 mL of brine, dried over MgSO<sub>4</sub>, and concentrated by rotary evaporation. The obtained residue was purified by column chromatography (silica, EtOAc:Petrolether, 1:9 to 1:4 for fluorinated and methoxylated derivatives and 2:3 to 1:1 for alcohols).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure 2</h4><div class="NLM_p last">NaH was added (60% in mineral oil, 2 mmol, 2 equiv) to a solution of alcohol <b>17</b> (1 mmol, 1 equiv) in 0.5 mL of DMF, and the mixture was stirred for 5 min at room temperature. Thereafter, the alkylating agent RX (5 mmol, 5 equiv) was added, and the reaction mixture was stirred overnight at room temperature. The reaction was quenched by the addition of H<sub>2</sub>O (2 mL), followed by 15 mL of an aqueous saturated solution of NaHCO<sub>3</sub> and 20 mL of EtOAc while stirring. The phases were separated; the organic phase was washed with 20 mL of EtOAc, and the combined organic fractions were dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The resulting residue was subjected to column chromatography purification (silica, EtOAc:Petrolether, 1:9 to 1:4).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>Z</i>)-<i>N</i>-(3-(2-(2-Fluoroethoxy)ethyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>18</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 48% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.35 (s, 6 H), 1.53 (s, 1 H), 2.16 (s, 3 H), 2.22 (s, 3 H), 3.65 (t, <i>J</i> = 6.06 Hz, 2 H), 3.72 (t, <i>J</i> = 5.31 Hz, 2 H), 4.28 (t, <i>J</i> = 5.31 Hz, 2 H), 4.44 (t, <i>J</i> = 5.94 Hz, 1 H), 4.56 (t, <i>J</i> = 5.94 Hz, 1 H); Elemental Anal. C 59.42, H 7.85, N 8.09; Calcd C 59.62, H 7.95, N 8.18.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>Z</i>)-<i>N</i>-(3-(2-(3-Fluoropropoxy)ethyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>19</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 43% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.35 (s, 6 H), 1.53 (s, 1 H), 1.83–2.02 (m, 2 H), 2.17 (d, <i>J</i> = 0.76 Hz, 3 H), 2.21 (d, <i>J</i> = 0.76 Hz, 3 H), 3.54 (t, <i>J</i> = 6.06 Hz, 2 H), 3.77 (t, <i>J</i> = 5.31 Hz, 2 H), 4.26 (t, <i>J</i> = 5.31 Hz, 2 H), 4.43 (t, <i>J</i> = 5.94 Hz, 1 H), 4.55 (t, <i>J</i> = 5.94 Hz, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.41, 11.71, 17.00, 24.10, 30.20, 30.63, 30.83, 42.33, 42.35, 46.30, 66.88, 68.49, 80.27, 81.90, 112.61, 128.32, 135.04, 181.49; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>18</sub>H<sub>30</sub>FN<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> 357.2004, calcd 357.2012; Elemental Anal. C 61.09, H 8.14, N 7.31; Calcd C 60.64, H 8.20, N 7.86.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>Z</i>)-<i>N</i>-(3-(2-(2-(2-Fluoroethoxy)ethoxy)ethyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>20</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 30% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.35 (s, 6 H), 1.53 (s, 1 H), 2.16 (d, <i>J</i> = 0.76 Hz, 3 H), 2.22 (d, <i>J</i> = 1.01 Hz, 3 H), 3.58–3.64 (m, 4 H), 3.64–3.67 (m, 1 H), 3.70–3.78 (m, 1 H), 3.82 (t, <i>J</i> = 5.31 Hz, 2 H), 4.27 (t, <i>J</i> = 5.31 Hz, 2 H), 4.46–4.51 (m, 1 H), 4.56–4.66 (m, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.43, 11.70, 17.00 (2 C), 24.11, 30.19, 42.32, 46.27, 68.72, 70.27, 70.46, 70.57, 70.75, 82.28, 83.96, 112.50, 128.51, 164.37, 181.45; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>19</sub>H<sub>32</sub>FN<sub>2</sub>O<sub>3</sub>S<sup>+</sup> [M + H]<sup>+</sup> 387.2127, calcd 387.2118; Elemental Anal. C 59.53, H 8.14, N 6.93; Calcd C 59.04, H 8.08, N 7.25.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>Z</i>)-<i>N</i>-(3-(2-(2-(2-(2-Fluoroethoxy)ethoxy)ethoxy)ethyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>21</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 30% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.34 (s, 6 H), 1.53 (s, 1 H), 2.16 (d, <i>J</i> = 1.01 Hz, 3 H), 2.22 (d, <i>J</i> = 1.01 Hz, 3 H), 3.54–3.76 (m, 9 H), 3.76–3.86 (m, 3 H), 4.26 (t, <i>J</i> = 5.43 Hz, 2 H), 4.47–4.55 (m, 1 H), 4.58–4.68 (m, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.46, 11.72, 17.01, 24.12 (4 C), 30.20, 42.32, 46.30, 68.71, 70.53, 70.61, 70.65, 70.84, 82.33, 84.01, 114.53, 127.26, 165.13, 181.10; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>21</sub>H<sub>36</sub>FN<sub>2</sub>O<sub>4</sub>S<sup>+</sup> [M + H]<sup>+</sup> 431.2392, calcd 431.2380; Elemental Anal. C 58.44, H 8.19, N, 6.71; Calcd C 58.58, H 8.19, N 6.51.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>Z</i>)-<i>N</i>-(3-(3-Hydroxypropyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>22</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 39% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.21 (s, 7 H), 1.31 (s, 6 H), 1.45 (s, 1 H), 1.76–1.95 (m, 2 H), 2.18 (d, <i>J</i> = 0.76 Hz, 3 H), 2.21 (d, <i>J</i> = 1.01 Hz, 3 H), 3.39–3.49 (m, 2 H), 4.24–4.36 (m, 2 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.01, 11.58, 16.93 (2 C), 23.86 (4 C), 30.48, 32.11 (2 C), 41.91, 42.48, 56.62, 114.64, 127.68, 165.45, 180.57.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>Z</i>)-<i>N</i>-(3-(3-Methoxypropyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>23</b>)</h4><div class="NLM_p last">General procedure 2; white solid, 78% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.35 (s, 6 H), 1.55 (s, 1 H), 1.97–2.09 (m, 2 H), 2.16 (d, <i>J</i> = 1.01 Hz, 3 H), 2.19 (d, <i>J</i> = 0.76 Hz, 3 H), 3.36 (s, 3 H), 3.41 (t, <i>J</i> = 5.81 Hz, 2 H), 4.14–4.23 (m, 2 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 10.96, 11.70, 17.01 (4 C), 24.12, 28.58, 30.12, 42.32, 43.61, 58.61, 69.56, 114.86, 127.65, 164.37, 181.53; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>17</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> 325.1968, calcd 325.1950; Elemental Anal. C 62.93, H 8.92, N 8.67; Calcd C 62.93, H 8.70, N 8.63.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>Z</i>)-<i>N</i>-(3-(3-(2-Fluoroethoxy)propyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>24</b>)</h4><div class="NLM_p last">General procedure 2, white solid, 65% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.35 (s, 6 H), 1.54 (s, 1 H), 2.03–2.13 (m, 2 H), 2.17 (s, 3 H), 2.20 (s, 3 H), 3.54 (t, <i>J</i> = 5.81 Hz, 2 H), 3.66 (dd, <i>J</i> = 4.67, 3.66 Hz, 1 H), 3.74 (dd, <i>J</i> = 4.80, 3.54 Hz, 1 H), 4.22 (t, <i>J</i> = 6.95 Hz, 2 H), 4.47–4.56 (m, 1 H), 4.59–4.69 (m, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 10.97, 11.69, 17.00 (4 C), 24.12, 28.57, 30.17, 42.81, 68.31, 69.89, 70.09, 81.52, 100.00, 117.88, 154.02, 183.54; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>18</sub>H<sub>30</sub>FN<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> 357.2030, calcd 357.2012; Elemental Anal. C 60.77, H 8.26, N 7.74; Calcd C 60.64, H 8.20, N 7.86.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>Z</i>)-<i>N</i>-(3-(2-Methoxypropyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>25</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 35% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.25 (d, <i>J</i> = 3.40 Hz, 6 H), 1.33 (s, 3 H), 1.36 (s, 3 H), 1.52 (s, 1 H), 2.16 (d, <i>J</i> = 0.76 Hz, 3 H), 2.20 (d, <i>J</i> = 0.76 Hz, 3 H), 3.23 (s, 3 H), 3.73–3.83 (m, 1 H), 3.83–3.93 (m, 1 H), 4.24 (dd, <i>J</i> = 13.39, 3.28 Hz, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.63, 17.04, 17.06, 17.10 (2 C), 24.09, 24.15, 29.93, 30.05, 42.37, 51.79, 57.00, 74.89, 112.39, 128.75, 164.46, 181.44; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>17</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> 325.1962, calcd 325.1950; Elemental Anal. C 62.23, H 8.59, N 8.26; Calcd C 62.93, H 8.70, N 8.63.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>Z</i>)-<i>N</i>-(3-(1-Methoxypropan-2-yl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>26</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 38% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.21 (d, <i>J</i> = 3.40 Hz, 3 H), 1.34 (s, 6 H), 1.52 (s, 1 H), 2.14 (s, 3 H), 2.17 (s, 3 H), 3.32 (s, 3 H), 3.70–3.83 (m, 1 H), 4.20–4.60 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 12.06, 17.07 (4 C) 24.10 (2 C), 29.86 (2 C), 42.55, 52.19, 59.00, 73.33, 117.07, 128.13, 155.82, 167.82; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>17</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> 325.1980, calcd 325.1950; Elemental Anal. C 62.30, H 8.72, N 8.25; Calcd C 62.93, H 8.70, N 8.63.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>Z</i>)-<i>N</i>-(3-(2-Fluoroethyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>27</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 42% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.34 (s, 6 H), 1.52 (s, 1 H), 2.17 (d, <i>J</i> = 0.76 Hz, 3 H), 2.20 (s, 3 H), 4.34 (t, <i>J</i> = 4.55 Hz, 1 H), 4.41 (t, <i>J</i> = 4.67 Hz, 1 H), 4.72 (t, <i>J</i> = 4.67 Hz, 1 H), 4.84 (t, <i>J</i> = 4.55 Hz, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.35, 11.71, 16.95 (4 C), 24.07, 42.35, 46.46, 46.65, 81.82, 112.93, 127.87, 143.37, 181.48; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>15</sub>H<sub>24</sub>FN<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> 299.1604, calcd 299.1593; Elemental Anal. C 60.25, H 7.43, N 9.55; Calcd C 60.37, H 7.77, N 9.39.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>Z</i>)-<i>N</i>-(3-(3-Fluoropropyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>28</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 40% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.34 (s, 6 H), 1.54 (s, 1 H), 2.17 (s, 3 H), 1.14–2.27 (m, 2 H), 2.20 (d, <i>J</i> = 0.76 Hz, 3 H), 4.23 (t, <i>J</i> = 7.07 Hz, 2 H), 4.45 (t, <i>J</i> = 5.56 Hz, 1 H), 4.57 (t, <i>J</i> = 5.56 Hz, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 10.97, 11.70, 16.98 (4 C), 24.09, 29.25, 30.25, 42.52, 42.67, 81.42, 113.27, 127.40, 143.31, 181.58; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>16</sub>H<sub>26</sub>FN<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> 313.1765, calcd 313.1750; Elemental Anal. C 61.85, H 8.09, N 8.33; Calcd C 61.51, H 8.06, N 8.97.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>Z</i>)-<i>N</i>-(3-(4-Fluorobutyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>29</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 35% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.35 (s, 6 H), 1.53 (s, 1 H), 1.75 (d, <i>J</i> = 8.34 Hz, 1 H), 1.79–1.93 (m, 3 H), 2.16 (d, <i>J</i> = 1.01 Hz, 3 H), 2.20 (d, <i>J</i> = 1.01 Hz, 3 H), 4.10–4.20 (m, 2 H), 4.48 (t, <i>J</i> = 5.81 Hz, 1 H), 4.60 (t, <i>J</i> = 5.68 Hz, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.06, 11.63, 17.03 (4 C), 24.23, 27.44, 29.59, 30.13, 33.04, 42.35, 44.96, 113.52, 127.09, 164.52, 181.51; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>17</sub>H<sub>28</sub>FN<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> 327.1912, calcd 327.1906; Elemental Anal. C 62.43, H 8.25, N 8.73; Calcd C 62.54, H 8.34, N 8.58.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Ethyl 3-(3-(2-Methoxyethyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidenecarbamoyl)-2,2-dimethyl-cyclopropanecarboxylate (<b>43</b>)</h4><div class="NLM_p last">General procedure 1, 42% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.28 (t, <i>J</i> = 7.07 Hz, 3 H), 1.35 (s, 6 H), 2.17 (s, 3 H), 2.24 (s, 3 H), 2.36 (d, <i>J</i> = 5.81 Hz, 1 H), 2.51 (d, <i>J</i> = 5.56 Hz, 1 H), 3.32 (s, 3 H), 3.69 (t, <i>J</i> = 4.8 Hz, 2 H), 4.05–4.27 (m, 3 H), 4.27–4.39 (m, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.53, 11.78, 14.40, 20.57, 21.01, 31.12, 33.84, 39.84, 46.54, 59.10, 60.38, 70.20, 113.49, 129.16, 165.53, 171.86, 178.08.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(Hydroxymethyl)-<i>N</i>-(3-(2-methoxyethyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2-dimethyl-cyclopropanecarboxamide (<b>44</b>)</h4><div class="NLM_p last">Compound <b>43</b> (500 mg, 1.4 mmol, 1 equiv) in 10 mL of THF was added to a suspension of LiAlH<sub>4</sub> (53.6 mg, 1.4 mmol, 1 equiv) in 10 mL of THF at 0 °C, and the reaction was stirred at the same temperature for 1 h. Saturated aqueous NH<sub>4</sub>Cl (20) mL and 20 mL EtOAc were added; the phases were separated, and the organic phase was washed once with 20 mL of brine, dried over MgSO<sub>4</sub>, and evaporated under reduced pressure to provide <b>44</b> (440 mg, 1.4 mmol) as a colorless solid in quantitative yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.27 (s, 3 H), 1.31 (s, 3 H), 1.70 (d, <i>J</i> = 5.56 Hz, 1 H), 1.87 (ddd, <i>J</i> = 8.34, 6.69, 5.43 Hz, 1 H), 2.18 (d, <i>J</i> = 1.01 Hz, 3 H), 2.22 (d, <i>J</i> = 0.76 Hz, 3 H), 3.32 (s, 3 H), 3.65 (dd, <i>J</i> = 11.49, 8.46 Hz, 1 H), 3.70 (t, <i>J</i> = 5.31 Hz, 2 H), 3.82 (dd, <i>J</i> = 11.50, 6.69 Hz, 1 H), 4.14–4.25 (m, 1 H), 4.26–4.38 (m, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.51, 11.78, 20.99, 21.77, 27.50, 34.78, 37.78, 46.44, 59.11, 62.82, 70.23, 113.24, 128.89, 165.39, 180.11; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>15</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub>S<sup>+</sup> [M + H]<sup>+</sup> 313.1603, calcd 313.1586; Elemental Anal. C 57.63, H 7.86, N 8.92; Calcd C 57.66, H 7.74, N 8.97.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(3-(2-Methoxyethyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-3-(methoxymethyl)-2,2-dimethyl-cyclopropanecarboxamide (<b>45</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 42% yield; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.24 (s, 3 H), 1.31 (s, 3 H), 1.65 (d, <i>J</i> = 5.56 Hz, 1 H), 1.86 (dt, <i>J</i> = 8.84, 5.68 Hz, 1 H), 2.18 (s, 3 H), 2.21 (d, <i>J</i> = 0.76 Hz, 3 H), 3.31 (s, 3 H), 3.37 (s, 3 H), 3.65 (dd, <i>J</i> = 10.61, 5.81 Hz, 1 H), 3.69 (t, <i>J</i> = 5.31 Hz, 2 H), 4.14–4.25 (m, 1 H), 4.25–4.37 (m, 1 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.50, 11.77, 20.81, 21.76, 27.43, 31.66, 37.55, 46.39, 58.21, 59.09, 70.21, 72.14, 113.14, 117.89, 128.80, 180.17; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>16</sub>H<sub>27</sub>N<sub>2</sub>O<sub>3</sub>S<sup>+</sup> [M + H]<sup>+</sup> 327.1760 calcd 327.1742; Elemental Anal. C 59.07, H,8.23, N 8.36; Calcd C 58.87, H,8.03, N 8.58.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Ethyl 2-Amino-4-methylthiazole-5-carboxylate (<b>48</b>)</h4><div class="NLM_p last">A mixture of ethyl 3-oxobutanoate (<b>46</b>, 5 g, 38 mmol, 1 equiv), KBr (23 g, 192 mmol, 5 equiv), 1 M HCl (185 mL, 192 mmol, 5 equiv), and 30% aqueous H<sub>2</sub>O<sub>2</sub> (86 mL) in 185 mL of toluene was stirred at room temperature for 1 h. The reaction was quenched by the slow addition of saturated aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (250 mL) followed by saturated aqueous NaHCO<sub>3</sub>. The phases were separated, and the aqueous phase was washed with EtOAc (2 × 200 mL). The combined organic phase was washed with 400 mL of brine, dried over MgSO<sub>4</sub>, and evaporated under reduced pressure to afford ethyl 2-bromo-3-oxobutanoate (<b>47</b>) (8 g, 38 mmol, quantitative) as a colorless liquid. Thiourea (0.5 g, 6.6 mmol, 1 equiv) was added to a solution of <b>47</b> (1.6 g, 7.2 mmol, 1.1 equiv) in 10 mL of EtOH, and the reaction was refluxed for 1 h. A white solid was formed during the reaction. Most of the solvent was eliminated under reduced pressure. Thereafter, 20 mL of 1 N aqueous NaOH was added, the resulting mixture was sonicated and placed at 4 °C overnight. The resulting solid was filtrated, washed with water and cold EtOH, and dried to give <b>48</b> as free base (1.2 g, white solid, 6.6 mmol, quantitative). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.34 (t, <i>J</i> = 7.20 Hz, 3 H), 2.54 (s, 3 H), 4.28 (q, <i>J</i> = 7.16 Hz, 2 H), 5.65 (s, 2 H).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Ethyl 3-(2-Methoxyethyl)-4-methyl-2-(2,2,3,3-tetramethyl-cyclopropanecarbonylimino)-2,3-dihydrothiazole-5-carboxylate (<b>49</b>)</h4><div class="NLM_p last">General procedure 1, white solid, 36% yield over two steps; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.24 (s, 6 H), 1.31–1.35 (m, 3 H), 1.35–1.36 (s, 6 H), 1.60 (s, 1 H), 2.73 (s, 3 H), 3.31 (s, 3 H), 3.73 (t, <i>J</i> = 5.05 Hz, 2 H), 4.28 (q, <i>J</i> = 4.20, 11.82 Hz, 2 H), 4.33 (t, <i>J</i> = 5.18 Hz, 2 H).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(5-(2-Hydroxypropan-2-yl)-3-(2-methoxyethyl)-4-methylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>50</b>)</h4><div class="NLM_p last">A solution of <b>49</b> (500 mg, 1.3 mmol, 1 equiv) in 20 mL of dry THF was cooled to −78 °C, and a 1.6 M solution of MeLi in Et<sub>2</sub>O (4.25 mL, 6.8 mmol, 5 equiv) was added dropwise. After 30 min, the reaction was quenched by the addition of 20 mL of saturated aqueous NH<sub>4</sub>Cl, and the solution was extracted with 3 × 20 mL of EtOAc. The combined organic solutions were washed with brine, dried over MgSO<sub>4</sub>, and subjected to column chromatography. The product was obtained in 72% (346 mg, 0.94 mmol) yield as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.35 (s, 6 H), 1.55 (s, 1 H), 1.61 (s, 6 H), 2.48 (s, 3 H), 3.33 (s, 3 H), 3.71 (t, <i>J</i> = 5.43 Hz, 2 H), 4.27 (t, <i>J</i> = 5.43 Hz, 2 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 12.71, 17.01 (4 C), 24.10 (2 C), 30.37, 31.57 (2 C), 42.34, 45.71, 59.04, 70.07, 100.00, 124.60, 138.45, 182.57; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>18</sub>H<sub>31</sub>N<sub>2</sub>O<sub>3</sub>S<sup>+</sup> [M + H]<sup>+</sup> 355.2055, calcd 355.2055; Elemental Anal. C 60.63, H 8.44, N 7.82; Calcd C 60.98, H 8.53, N 7.90.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>Z</i>)-<i>N</i>-(3-(2-Methoxyethyl)-5-(2-methoxypropan-2-yl)-4-methylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>51</b>)</h4><div class="NLM_p last">General procedure 2, 79% yield, light yellow solid; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.22 (s, 6 H), 1.36 (s, 6 H), 1.54 (s, 6 H), 1.56 (s, 1 H), 2.06 (s, 1 H), 2.42 (s, 3 H), 3.05–3.19 (m, 3 H), 3.27–3.36 (m, 3 H), 3.72 (t, <i>J</i> = 5.43 Hz, 2 H), 4.28 (t, <i>J</i> = 5.43 Hz, 2 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 12.02, 17.00 (4 C), 24.10 (2 C), 28.12, 30.43 (2 C), 42.34, 45.71, 50.34, 59.06, 70.01, 120.72, 130.56, 133.96, 181.74.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>Z</i>)-<i>N</i>-(3-(4-Bromobutyl)-4,5-dimethylthiazol-2(3<i>H</i>)-ylidene)-2,2,3,3-tetramethyl-cyclopropanecarboxamide (<b>53</b>)</h4><div class="NLM_p last">2,2,3,3-Tetramethylcyclopropane acid (1.42 g, 10 mmol, 1 equiv), Et<sub>3</sub>N (2.2 mL, 3 mmol, 3 equiv), and BOP (5.7 g, 1.3 mmol, 1.3 equiv) were added to a solution of 4,5-dimethylthiazol-2(3<i>H</i>)-imine (<b>2</b>, 1.28 g, 10 mmol, 1 equiv) in 15 mL of DCM at 0 °C, and the mixture was stirred at room temperature for 20 h. The reaction was quenched by the addition of 20 mL of water followed by 50 mL of aqueous saturated solution NaHCO<sub>3</sub> and 75 mL of EtOAc. The phases were separated, and the aqueous phase was washed with 2 × 50 mL of EtOAc. The combined organic fractions were washed with 75 mL of brine, dried over MgSO<sub>4</sub>, and concentrated by rotary evaporation. The obtained residue was purified by column chromatography (silica, EtOAc:Petrolether, 1:9 to 1:4) to give <b>52</b> (0.45 g, 18% yield) as a colorless solid. NaH was added (60% in mineral oil, 33 mg, 0.78 mmol, 2 equiv) to a solution of <b>52</b> (100 mg, 0.39 mmol, 1 equiv) in 0.5 mL of DMF, and the mixture was stirred for 5 min at room temperature. Then, Br(CH<sub>2</sub>)<sub>4</sub>Br (0.5 mL, 3.9 mmol, 10 equiv) was added, and the whole mixture was stirred overnight at room temperature. The reaction was quenched by the addition of H<sub>2</sub>O (2 mL) followed by 15 mL of aqueous saturated solution NaHCO<sub>3</sub> and 20 mL of EtOAc under stirring. The phases were separated; the organic phase was washed with 20 mL of EtOAc, and the combined organic fractions were dried over MgSO<sub>4</sub> and concentrated under reduced pressure. The resulting oil was subjected to column chromatography purification (silica, EtOAc:Petrolether, 1:9 to 1:4) to give 86 mg of <b>53</b> (56% yield) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.23 (s, 6 H), 1.35 (s, 6 H), 1.54 (s, 1 H), 2.02–1.79 (m, 4 H), 2.17 (s, 3 H), 2.20 (s, 3 H), 3.53 (t, <i>J</i> = 6.0 Hz, 2 H), 4.15 (t, <i>J</i> = 6.7 Hz, 2 H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 11.14, 11.64, 17.01 (4 C), 24.09, 27.34, 29.60, 30.13, 33.04, 42.35, 44.96, 113.52, 127.09, 164.52, 181.51; HRMS (ESI+) <i>m</i>/<i>z</i> (%) for C<sub>17</sub>H<sub>28</sub><sup>79</sup>BrN<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> 387.1103 calcd 387.1106.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Radioligand Binding Assay</h3><div class="NLM_p last">The binding affinity toward CB<sub>1</sub> and CB<sub>2</sub> receptors was determined according to a previously published protocol.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In brief, membrane preparations obtained from CHO cell lines stably transfected with either human CB<sub>1</sub> (hCB<sub>1</sub>–CHO; obtained from Euroscreen, Gosselies, Belgium) or human CB<sub>2</sub> (hCB<sub>2</sub>–CHO; obtained from Paul L. Prather, Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, USA) were used in combination with [<sup>3</sup>H]<b>56</b> (6,438 GBq/mmol; PerkinElmer Life and Analytical Sciences, Rodgau, Germany) as radioligand. The incubation was performed in binding buffer (50 mM TRIS-HCl, pH 7.4, 0.1% bovine serum albumin (BSA), 5 mM MgCl<sub>2</sub>, 1 mM EDTA) for 90 min at room temperature. Various concentrations of test compounds were administered, and the nonspecific binding was determined in the presence of 10 μM <b>56</b>. Incubations were terminated by rapid filtration through a GF-B glass fiber filter preincubated for 90 min at room temperature in a freshly prepared solution of polyvinylpyrrolidone/Tween 20 (0.5%/0.1%) using a 48-well cell harvester (Brandel, Gaithersburg, MD, USA). Bound radioactivity was analyzed for <i>K</i><sub>i</sub> values using nonlinear regression analysis (GraphPad Prism 2.01) with the <i>K</i><sub>D</sub> values for [<sup>3</sup>H]<b>56</b> determined from saturation experiments.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Radiochemistry</h3><div class="NLM_p">No-carrier-added [<sup>18</sup>F]fluoride (<i>t</i><sub>1/2</sub> = 109.8 min) was produced via the [<sup>18</sup>O(p,n)<sup>18</sup>F] nuclear reaction by irradiation of [<sup>18</sup>O]H<sub>2</sub>O (Hyox 18-enriched water, Rotem Industries Ltd., Israel) on a Cyclone18/9 (iba RadioPharma Solutions, Belgium) with a fixed energy proton beam using Nirta [<sup>18</sup>F]fluoride XL target. All radioactivity measurements were performed with an ISOMED 2010 (MED GmbH, Dresden, Germany) dose calibrator. Radio-TLC plates were further processed using a BAS-1800 II system Bioimaging Analyzer (Fuji Photo Film, Co. Ltd., Tokyo, Japan), and the obtained images were quantified with AIDA 2.31 software (raytest Isotopenmessgeräte GmbH, Straubenhardt, Germany).</div><div class="NLM_p">For manual optimization, [<sup>18</sup>F]fluoride was trapped on a Chromafix 30 PS-HCO<sub>3</sub><sup>–</sup> cartridge, eluted with a 20 mg/mL aqueous solution of K<sub>2</sub>CO<sub>3</sub> (1.78 mg, 12.9 mmol), and subsequently added to a 5 mL V vial in the Discover PETwave microwave CEM (CEM Corporation, Matthews, NC, USA) cavity in the presence of Kryptofix222 (K2.2.2., 11.2 mg, 29.7 mmol) in 1 mL of CH<sub>3</sub>CN. The aqueous [<sup>18</sup>F]fluoride was dried under vacuum and argon flow in the microwave cavity (75 W, 20 cycles) at 50–60 °C for 10–12 min. Additional aliquots of CH<sub>3</sub>CN (2 × 1.0 mL) were added for azeotropic drying. With regard to the reactive anhydrous K[<sup>18</sup>F]F–K2.2.2./K<sub>2</sub>CO<sub>3</sub> complex, reaction parameters were optimized by varying the amount of halo precursor <b>53</b>, reaction time, temperature, solvent (CH<sub>3</sub>CN, DMF, DMSO), and heating mode (thermal vs microwave-assisted).</div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Automated Radiosynthesis of [<sup>18</sup>F]<b>29</b></h4><div class="NLM_p">Remote-controlled radiosynthesis was performed using a TRACERLab FX F–N synthesizer (GE Healthcare, USA) equipped with a PU-980 pump (JASCO, Germany), a WellChrom K-2001 UV detector (KNAUER GmbH, Berlin, Germany), NaI(Tl) counter, and automated data acquisition (NINA software version 4.8 rev. 4, Nuclear Interface GmbH, Dortmund, Germany). Reaction conditions were set up as depicted in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. Briefly, [<sup>18</sup>F]fluoride (4–10 GBq) was trapped on a Chromafix 30 PS-HCO<sub>3</sub><sup>–</sup> cartridge (entry <b>1</b>, MACHEREY-NAGEL GmbH & Co. KG, Düren, Germany) in the remotely controlled synthesis module. [<sup>18</sup>F]Fluoride was eluted with K<sub>2</sub>CO<sub>3</sub> solution (1.78 mg/0.4 mL water; entry <b>2</b>), mixed with K2.2.2 (11.5 mg/1 mL CH<sub>3</sub>CN; entry <b>3</b>)] in the reaction vessel (entry <b>6</b>), and azeotropically dried for approximately 10 min. Thereafter, 3.5 mg of the bromo precursor (<b>53</b>), dissolved in 1 mL of CH<sub>3</sub>CN (entry <b>4</b>), was added, and the reaction mixture was stirred at 80 °C for 10 min. After cooling, the reaction mixture was diluted with 3 mL of H<sub>2</sub>O/CH<sub>3</sub>CN (1:1, entry <b>5</b>) and transferred into the injection vial. Semipreparative HPLC was performed using the Reprosil-Pur C18-AQ column with a solvent composition of 65% CH<sub>3</sub>CN/20 mM aq NH<sub>4</sub>OAc at a flow rate of 4.2 mL/min (entry 7). [<sup>18</sup>F]<b>29</b> was collected in entry <b>8</b> previously loaded with 40 mL of H<sub>2</sub>O. Final purification was performed by passing the solution through a Sep Pak C18 light cartridge (entry <b>11</b>), followed by washing with 2 mL of water (entry <b>9</b>) and elution of [<sup>18</sup>F]<b>29</b> with 1.25 mL of EtOH (entry <b>10</b>) in the product vial (entry <b>12</b>). For an injectable solution to be obtained, the solvent was reduced under a gentle argon stream at 70 °C, and the radiotracer was formulated in saline-alcohol solution (90%:10%, NaCl/EtOH).</div><div class="NLM_p last">Radiochemical yield, radiochemical purity, and specific activity were assessed following the methods described in the <a class="ref internalNav" href="#sec5_3_2" aria-label="Quality Control">Quality Control</a> section.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Quality Control</h4><div class="NLM_p last">For the radiosynthesis of [<sup>18</sup>F]<b>29</b>, radio-TLC was performed on Polygram SIL/UV254 plates (Macherey-Nagel, Germany) with petroleum ether/ethyl acetate (PE:EE; 6:4, v/v). The spots of the reference compound were visualized using UV light at 254 nm. Labeling efficiencies and radiochemical purities were determined by radio-TLC and calculated as the percentage of the product peak to the sum of the measured activity. Radio-HPLC was performed on a JASCO LC-2000 system, incorporating a PU-2080<i>Plus</i> pump, AS-2055<i>Plus</i> auto injector (100 mL sample loop), and UV-2070<i>Plus</i> detector coupled with a gamma radioactivity HPLC detector (Gabi Star, raytest Isotopenmessgeräte GmbH). Labeling efficiencies, radiochemical purities, specific activities, and metabolic studies were investigated with analytical radio-HPLC using a Reprosil-Pur C18-AQ (250 × 4.6 mm, 5 μm) column with an eluent composition of 70% CH<sub>3</sub>CN/20 mM aq. NH<sub>4</sub>OAc at a flow rate of 1 mL/min. Data analysis was performed with the Galaxie chromatography software (Agilent Technologies) using the chromatograms obtained at 312 nm.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Determination of in Vitro Stability and Lipophilicity (Log <i>D</i><sub>7.4</sub>)</h4><div class="NLM_p">The in vitro radiochemical stability of [<sup>18</sup>F]<b>29</b> was investigated in 0.9% NaCl solution at 40 °C and EtOH at room temperature for up to 90 min. Samples were taken at 15, 30, 60, and 90 min of incubation and analyzed by radio-TLC and radio-HPLC.</div><div class="NLM_p last">The partition coefficient of <b>29</b> was calculated theoretically by the commercially available software ACD/Laboratories. Log <i>D</i><sub>7.4</sub> of [<sup>18</sup>F]<b>29</b> was experimentally determined in <i>n</i>-octanol/phosphate-buffered saline (PBS; 0.01 M, pH 7.4) at room temperature by the shake-flask method. The measurement was performed twice in triplicate.</div></div><div id="sec5_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> In Vitro Autoradiography</h4><div class="NLM_p last">The in vitro autoradiographic experiments were performed according to a previously published protocol<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> using four to six tissue slices (thickness = 12 μm) from spleen obtained from two animals. Each tissue slice was delineated as a single region of interest (ROI), the background-corrected intensity per area (in terms of “QL/pixel”) for each ROI calculated, and the relative amount of bound activity estimated (incubation with radioligand alone = 100%). In brief, spleen tissue from female SPRD rats (10–12 weeks) was cut into 12 μm thick sections using a cryostat microtome (Microm International GmbH, Walldorf, Germany). The slices were mounted on microscopic glass slides (Superfrost, Menzel, Germany) and stored at −25 °C until use. For autoradiographic experiments, the slides were adapted to room temperature, dried in a stream of cold air, preincubated in binding buffer (50 mM TRIS-HCl, pH 7.4, 5% bovine serum albumin (BSA), 5 mM MgCl<sub>2</sub>, 1 mM EDTA) for 15 min at room temperature, and dried again in a stream of cold air. Then, samples were incubated for 1 h at room temperature with [<sup>18</sup>F]<b>29</b> without (total binding) or with <b>54</b> (CB<sub>2</sub>-selective inverse agonist), <b>55</b> (CB<sub>1</sub>-selective antagonist), <b>56</b> (CB<sub>1</sub>/CB<sub>2</sub>-selective agonist), or <b>29</b>. Thereafter, the samples were washed twice for 2 min at 4 °C in 50 mM TRIS-HCl, pH 7.4, containing 1% BSA, dipped briefly in ice-cold deionized water (5 s), dried in a stream of cold air, and exposed to appropriate imaging plates (Fuji Photo Film, Co. Ltd., Tokyo, Japan), which were eventually scanned using an HD-CR 35 scanner (raytest Isotopenmessgeraete GmbH, Straubenhardt, Germany). The scan data were visualized and processed by computer-assisted microdensitometry (Aida version 2.31, raytest Isotopenmessgeräte GmbH, Straubenhardt, Germany).</div></div><div id="sec5_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> In Vivo Metabolism</h4><div class="NLM_p last">[<sup>18</sup>F]<b>29</b> (100–150 MBq, 169.7 ± 11.7 GBq/μmol in 150 μL of NaCl 0.9%/10% EtOH) was injected via the tail vein in CD-1 female mice (10–12 weeks old, 20–25 g, <i>n</i> = 3). Blood samples and brain homogenates were obtained at 30 min p.i. Plasma samples were obtained by centrifugation of the blood at 15,000 rpm at 4 °C for 2 min, and the brain tissue was homogenized in ice-cold 50 mM Tris-HCl (pH 7.4) using a Glass/PTFE Potter Elvehjem tissue grinder (Potter S, B. Braun Biotech International, Sartorius AG, Goettingen, Germany). The samples were vortexed, incubated on ice, and centrifuged at 10,000 rpm for 3 min. Two-fold extractions of plasma and brain samples were performed using ice-cold MeOH/H<sub>2</sub>O (9:1, v/v). Supernatants were collected, and the precipitates were redissolved in ice-cold MeOH/H<sub>2</sub>O (9:1, v/v) for the second extraction. The supernatants from the two extractions were combined, concentrated under a gentle argon stream at 70 °C, and analyzed by radio-TLC and gradient analytical HPLC (see <a class="ref internalNav" href="#sec5_3_2" aria-label="Quality Control">Quality Control</a> section). Aliquots from each extraction supernatant and the precipitates were also taken and quantified by γ counting (Wallac Wizard 1470, PerkinElmer Inc., Waltham U.S.A.) along with the respective aliquots of intact plasma samples and brain homogenates.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Small-Animal PET/MR Experiments (Pharmacokinetics and Specificity)</h3><div class="NLM_p last">The animals were initially anesthetized with 4% of isoflurane and were positioned prone into a small-animal PET/MR (nanoScan, MEDISO, Budapest, Hungary) on a heated (37 °C) mouse bed while respiration rate was continuously monitored. The anesthesia (Anaesthesia Unit U-410, agntho’s, Lidingö, Sweden) was maintained at 1.8% isoflurane in a 60% oxygen/40% air gas mixture (Gas blender 100 series, MCQ Instruments, Rome, Italy) with 350 mL/min airflow. Prior to the PET scan, a scout image MR sequence was performed to outline the animal dimensions. Female CD-1 mice (<i>n</i> = 3, age: 12 weeks, weight: 33.6 ± 2.6 g) received an i.v. injection of 12.0 ± 4.1 MBq [<sup>18</sup>F]<b>29</b>. A dynamic whole body 60 min animal PET scan was started simultaneously, and data was collected in list mode. Following the PET scan, a T1-weighted whole-body MR scan (gradient echo sequence, TR = 20 ms, TE = 3.2 ms) was performed for anatomical orientation after coregistration and attenuation correction at the reconstruction step (OSEM, 4 iterations, 6 subsets; MR-based attenuation correction). After 24 h of recovery, the same animals received an i.p. injection of specific blocking compound <b>1</b> (3 mg/kg) 15 min prior to the i.v. injection of 12.8 ± 5.3 MBq [<sup>18</sup>F]<b>29</b> and simultaneously started PET scan.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Small-Animal PET Experiments (LPS study)</h3><div class="NLM_p">A small-animal PET/CT scanner ARGUS (Sedecal, Madrid, Spain) was used. In all experiments, a PET session was conducted simultaneously for two mice (LPS-treated and -controls, three pairs). CD-1 male mice (25–27 g) were used in all experiments. The LPS-treated mice were injected with LPS (5 mg/kg, ip)<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> five days before the PET studies. The experimental animal protocols were approved by the Animal Care and Use Committee of the Johns Hopkins Medical Institutions.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Baseline</h4><div class="NLM_p last">One mouse from a pair belonged to the control group whereas the other mouse belonged to the experimental group (LPS-treated). Mice were anesthetized by isoflurane. Dynamic PET scans were acquired for 30 min (20 s × 3, 30 s × 2, 1 min × 2, 2 min × 3, 5 min × 4) immediately after an intravenous bolus injection of [<sup>18</sup>F]<b>29</b> (4–8 MBq) that was prepared with specific radioactivity of 681 GBq/μmol. A CT scan was acquired shortly before the PET scan, and the two images were fused. This was used as a reference for localization of the radiotracer uptake in various brain regions. In all PET experiments, a 250–700 keV energy window was used, and the data were reconstructed using an iterative 2D ordered-subject expectation-maximization method with a trans-axial pixel size of 0.4 mm and axial slice thickness of 0.8 mm.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> No attenuation or scatter corrections were applied, as they have a relatively small impact on mouse brain imaging.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Blocking</h4><div class="NLM_p last">The LPS-treated mice were injected with the CB<sub>2</sub> selective agonist <b>1</b> (3 mg/kg, i.p., 0.1 mL in 50% aqueous DMSO) 15 min before the radiotracer injection, whereas the control mice were injected with 0.1 mL of vehicle solution. The PET experiment was performed similarly to the baseline experiment.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00554">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00554" class="ext-link">10.1021/acs.jmedchem.6b00554</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C, COSY 2D, HMBC 2D, and NOESY 2D NMRs of compound <b>44</b>; <sup>1</sup>H NMR of compounds <b>18</b>–<b>21</b>, <b>23</b>–<b>29</b>, <b>44</b>, <b>45</b>, <b>50</b>, and <b>53</b>; and molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00554/suppl_file/jm6b00554_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">CB<sub>1</sub> and CB<sub>2</sub><i>K</i><sub>i</sub> values of compounds <b>1</b>, <b>18</b>–<b>21</b>, <b>23</b>–<b>29</b>, <b>44</b>, <b>45</b>, and <b>50</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00554/suppl_file/jm6b00554_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00554/suppl_file/jm6b00554_si_001.pdf">jm6b00554_si_001.pdf (423.11 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00554/suppl_file/jm6b00554_si_002.csv">jm6b00554_si_002.csv (0.88 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00554" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rareş-Petru Moldovan</span> - <span class="hlFld-Affiliation affiliation">Helmholtz-Zentrum
Dresden-Rossendorf e.V., Institute of Radiopharmaceutical
Cancer Research, Leipzig, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#74065a191b18101b02151a341c0e10065a1011"><span class="__cf_email__" data-cfemail="71035f1c1e1d151e07101f31190b15035f1514">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew G. Horti</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins School of Medicine, Department of
Radiology, Baltimore, 21287 United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d2b3babda0a6bbe392b8babfbbfcb7b6a7"><span class="__cf_email__" data-cfemail="89e8e1e6fbfde0b8c9e3e1e4e0a7ecedfc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rodrigo Teodoro</span> - <span class="hlFld-Affiliation affiliation">Helmholtz-Zentrum
Dresden-Rossendorf e.V., Institute of Radiopharmaceutical
Cancer Research, Leipzig, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongjun Gao</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins School of Medicine, Department of
Radiology, Baltimore, 21287 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Winnie Deuther-Conrad</span> - <span class="hlFld-Affiliation affiliation">Helmholtz-Zentrum
Dresden-Rossendorf e.V., Institute of Radiopharmaceutical
Cancer Research, Leipzig, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathias Kranz</span> - <span class="hlFld-Affiliation affiliation">Helmholtz-Zentrum
Dresden-Rossendorf e.V., Institute of Radiopharmaceutical
Cancer Research, Leipzig, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuchuan Wang</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins School of Medicine, Department of
Radiology, Baltimore, 21287 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroto Kuwabara</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins School of Medicine, Department of
Radiology, Baltimore, 21287 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masayoshi Nakano</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins School of Medicine, Department of
Radiology, Baltimore, 21287 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Valentine</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins School of Medicine, Department of
Radiology, Baltimore, 21287 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steffen Fischer</span> - <span class="hlFld-Affiliation affiliation">Helmholtz-Zentrum
Dresden-Rossendorf e.V., Institute of Radiopharmaceutical
Cancer Research, Leipzig, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin G. Pomper</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins School of Medicine, Department of
Radiology, Baltimore, 21287 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean F. Wong</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins School of Medicine, Department of
Radiology, Baltimore, 21287 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert F. Dannals</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins School of Medicine, Department of
Radiology, Baltimore, 21287 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Brust</span> - <span class="hlFld-Affiliation affiliation">Helmholtz-Zentrum
Dresden-Rossendorf e.V., Institute of Radiopharmaceutical
Cancer Research, Leipzig, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>R.T. and A.G.H. designed and conducted the radiochemical experiments. R.-P.M., Y.G., and A.G.H. conceived and performed the chemical syntheses. W.D.-C. and A.G.H. planned and performed the radioligand binding studies. A.G.H., Y.W., H.K., M.N., W.D.-C., M.K., and P.B. designed and performed the PET/MR imaging experiments. R.-P.M., R.T., Y.G., W.D.-C., M.K., Y.W., H.K., M.N., H.V., S.F., M.G.P., D.F.W., R.F.D., P.B., and A.G.H. analyzed the data, wrote, and revised the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4185-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25436" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25436" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Tina Spalholz for help with radioligand binding studies, Paige Finley for help with animal experiments, and Judy W. Buchanan for editorial help. This research was supported by NIH grant AG037298 (A.G.H.), DFG fellowship MO 2677/1-1 (R.-P.M.) and in part by Division of Nuclear Medicine of The Johns Hopkins University School of Medicine.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> Abbreviations</h2><tr><td class="NLM_term">CB<sub>2</sub></td><td class="NLM_def"><p class="first last">cannabinoid receptors type 2</p></td></tr><tr><td class="NLM_term">CB<sub>1</sub></td><td class="NLM_def"><p class="first last">cannabinoid receptors type 1</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">THC</td><td class="NLM_def"><p class="first last">(−)-trans-Δ9-tetrahydrocannabinol</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">K2.2.2</td><td class="NLM_def"><p class="first last">2.2.2-Cryptand</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standardized uptake value</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gaoni, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span> </span><span class="NLM_article-title">Isolation, structure, and partial synthesis of an active constituent of Hashish</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1646</span><span class="NLM_x">–</span> <span class="NLM_lpage">1647</span><span class="refDoi"> DOI: 10.1021/ja01062a046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01062a046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaF2cXkt1GhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1964&pages=1646-1647&author=Y.+Gaoniauthor=R.+Mechoulam&title=Isolation%2C+structure%2C+and+partial+synthesis+of+an+active+constituent+of+Hashish&doi=10.1021%2Fja01062a046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hashish. III. Isolation, structure, and partial synthesis of an active constituent of hashish</span></div><div class="casAuthors">Gaoni, Y.; Mechoulam, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1646-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">cf. CA 60, 6876d.  Chromatography of a hexane ext. of hashish on florisil gave cannabinol (I) and Δ1-3,4-trans-tetrahydrocannabinol (II).  S dehydrogenation of II gave I.  Cannabidiol (III) heated 2 hrs. in alc. contg. 0.05% HCl gave I and unchanged III.  I, II, and III were compared by their nuclear magnetic resonance spectra.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgTMczY36d7bVg90H21EOLACvtfcHk0ljB1gJlYsf9Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXkt1GhtLs%253D&md5=da595d192eb0484e6e66971b49b41eb1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fja01062a046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01062a046%26sid%3Dliteratum%253Aachs%26aulast%3DGaoni%26aufirst%3DY.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DIsolation%252C%2520structure%252C%2520and%2520partial%2520synthesis%2520of%2520an%2520active%2520constituent%2520of%2520Hashish%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1964%26volume%3D86%26spage%3D1646%26epage%3D1647%26doi%3D10.1021%2Fja01062a046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shvo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashish, I.</span><span> </span><span class="NLM_article-title">The structure of cannabidiol</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span><span class="refDoi"> DOI: 10.1016/0040-4020(63)85022-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2F0040-4020%2863%2985022-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1963&pages=2073-2078&author=R.+Mechoulamauthor=Y.+Shvoauthor=I.+Hashish&title=The+structure+of+cannabidiol&doi=10.1016%2F0040-4020%2863%2985022-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0040-4020%2863%2985022-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4020%252863%252985022-X%26sid%3Dliteratum%253Aachs%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DShvo%26aufirst%3DY.%26aulast%3DHashish%26aufirst%3DI.%26atitle%3DThe%2520structure%2520of%2520cannabidiol%26jtitle%3DTetrahedron%26date%3D1963%26volume%3D19%26spage%3D2073%26epage%3D2078%26doi%3D10.1016%2F0040-4020%2863%2985022-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">McPartland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">Are cannabidiol and Δ(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span><span class="refDoi"> DOI: 10.1111/bph.12944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1111%2Fbph.12944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25257544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1GisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=737-753&author=J.+M.+McPartlandauthor=M.+Duncanauthor=V.+Di+Marzoauthor=R.+G.+Pertwee&title=Are+cannabidiol+and+%CE%94%289%29-tetrahydrocannabivarin+negative+modulators+of+the+endocannabinoid+system%3F+A+systematic+review&doi=10.1111%2Fbph.12944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review</span></div><div class="casAuthors">McPartland, John M.; Duncan, Marnie; Di Marzo, Vincenzo; Pertwee, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-753</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Based upon evidence that the therapeutic properties of Cannabis prepns. are not solely dependent upon the presence of Δ9-tetrahydrocannabinol (THC), pharmacol. studies have been recently carried out with other plant cannabinoids (phytocannabinoids), particularly cannabidiol (CBD) and Δ9-tetrahydrocannabivarin (THCV).  Results from some of these studies have fostered the view that CBD and THCV modulate the effects of THC via direct blockade of cannabinoid CB1 receptors, thus behaving like first-generation CB1 receptor inverse agonists, such as rimonabant.  Here, we review in vitro and ex vivo mechanistic studies of CBD and THCV, and synthesize data from these studies in a meta-anal.  Synthesized data regarding mechanisms are then used to interpret results from recent pre-clin. animal studies and clin. trials.  The evidence indicates that CBD and THCV are not rimonabant-like in their action and thus appear very unlikely to produce unwanted CNS effects.  They exhibit markedly disparate pharmacol. profiles particularly at CB1 receptors: CBD is a very low-affinity CB1 ligand that can nevertheless affect CB1 receptor activity in vivo in an indirect manner, while THCV is a high-affinity CB1 receptor ligand and potent antagonist in vitro and yet only occasionally produces effects in vivo resulting from CB1 receptor antagonism.  THCV has also high affinity for CB2 receptors and signals as a partial agonist, differing from both CBD and rimonabant.  These cannabinoids illustrate how in vitro mechanistic studies do not always predict in vivo pharmacol. and underlie the necessity of testing compds. in vivo before drawing any conclusion on their functional activity at a given target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_W6xdFBwCQbVg90H21EOLACvtfcHk0liB0Zs8bvd_Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1GisQ%253D%253D&md5=ca76db42227dadff65ef93b30a723625</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fbph.12944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12944%26sid%3Dliteratum%253Aachs%26aulast%3DMcPartland%26aufirst%3DJ.%2BM.%26aulast%3DDuncan%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DAre%2520cannabidiol%2520and%2520%25CE%2594%25289%2529-tetrahydrocannabivarin%2520negative%2520modulators%2520of%2520the%2520endocannabinoid%2520system%253F%2520A%2520systematic%2520review%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D737%26epage%3D753%26doi%3D10.1111%2Fbph.12944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Svizenska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubovy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulcova, A.</span><span> </span><span class="NLM_article-title">Cannabinoid receptors 1 and 2 (CB<sub>1</sub> and CB<sub>2</sub>), their distribution, ligands and functional involvement in nervous system structures-a short review</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1016/j.pbb.2008.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.pbb.2008.05.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=501-511&author=I.+Svizenskaauthor=P.+Dubovyauthor=A.+Sulcova&title=Cannabinoid+receptors+1+and+2+%28CB1+and+CB2%29%2C+their+distribution%2C+ligands+and+functional+involvement+in+nervous+system+structures-a+short+review&doi=10.1016%2Fj.pbb.2008.05.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DSvizenska%26aufirst%3DI.%26aulast%3DDubovy%26aufirst%3DP.%26aulast%3DSulcova%26aufirst%3DA.%26atitle%3DCannabinoid%2520receptors%25201%2520and%25202%2520%2528CB1%2520and%2520CB2%2529%252C%2520their%2520distribution%252C%2520ligands%2520and%2520functional%2520involvement%2520in%2520nervous%2520system%2520structures-a%2520short%2520review%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2008%26volume%3D90%26spage%3D501%26epage%3D511%26doi%3D10.1016%2Fj.pbb.2008.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Panagis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlachou, S.</span><span> </span><span class="NLM_article-title">Cannabinoid regulation of brain reward processing with n emphasis on the role of CB<sub>1</sub> receptors: a step back into the future</span> <span class="citation_source-journal">Front. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.3389/fpsyt.2014.00092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.3389%2Ffpsyt.2014.00092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24478729" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1-20&author=G.+Panagisauthor=B.+Mackeyauthor=S.+Vlachou&title=Cannabinoid+regulation+of+brain+reward+processing+with+n+emphasis+on+the+role+of+CB1+receptors%3A+a+step+back+into+the+future&doi=10.3389%2Ffpsyt.2014.00092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2014.00092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2014.00092%26sid%3Dliteratum%253Aachs%26aulast%3DPanagis%26aufirst%3DG.%26aulast%3DMackey%26aufirst%3DB.%26aulast%3DVlachou%26aufirst%3DS.%26atitle%3DCannabinoid%2520regulation%2520of%2520brain%2520reward%2520processing%2520with%2520n%2520emphasis%2520on%2520the%2520role%2520of%2520CB1%2520receptors%253A%2520a%2520step%2520back%2520into%2520the%2520future%26jtitle%3DFront.%2520Psychiatry%26date%3D2014%26volume%3D5%26spage%3D1%26epage%3D20%26doi%3D10.3389%2Ffpsyt.2014.00092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Console-Bram, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abood, M. E.</span><span> </span><span class="NLM_article-title">Cannabinoid receptors: nomenclature and pharmacological principles</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/j.pnpbp.2012.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.pnpbp.2012.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=22421596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC38vmvFOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=4-15&author=L.+Console-Bramauthor=J.+Marcuauthor=M.+E.+Abood&title=Cannabinoid+receptors%3A+nomenclature+and+pharmacological+principles&doi=10.1016%2Fj.pnpbp.2012.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors: nomenclature and pharmacological principles</span></div><div class="casAuthors">Console-Bram Linda; Marcu Jahan; Abood Mary E</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neuro-psychopharmacology & biological psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The CB1 and CB2 cannabinoid receptors are members of the G protein-coupled receptor (GPCR) family that are pharmacologically well defined.  However, the discovery of additional sites of action for endocannabinoids as well as synthetic cannabinoid compounds suggests the existence of additional cannabinoid receptors.  Here we review this evidence, as well as the current nomenclature for classifying a target as a cannabinoid receptor.  Basic pharmacological definitions, principles and experimental conditions are discussed in order to place in context the mechanisms underlying cannabinoid receptor activation.  Constitutive (agonist-independent) activity is observed with the overexpression of many GPCRs, including cannabinoid receptors.  Allosteric modulators can alter the pharmacological responses of cannabinoid receptors.  The complex molecular architecture of each of the cannabinoid receptors allows for a single receptor to recognize multiple classes of compounds and produce an array of distinct downstream effects.  Natural polymorphisms and alternative splice variants may also contribute to their pharmacological diversity.  As our knowledge of the distinct differences grows, we may be able to target select receptor conformations and their corresponding pharmacological responses.  Importantly, the basic biology of the endocannabinoid system will continue to be revealed by ongoing investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNFfefR2I-qrjnyZkbE8yXfW6udTcc2eYzDm-CQh40iLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vmvFOktg%253D%253D&md5=8bc96ed2bc737597f4d985ef786ecaf4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DConsole-Bram%26aufirst%3DL.%26aulast%3DMarcu%26aufirst%3DJ.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DCannabinoid%2520receptors%253A%2520nomenclature%2520and%2520pharmacological%2520principles%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2012%26volume%3D38%26spage%3D4%26epage%3D15%26doi%3D10.1016%2Fj.pnpbp.2012.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Matsuda, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lolait, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownstein, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, T. I.</span><span> </span><span class="NLM_article-title">Structure of a cannabinoid receptor and functional expression of the cloned cDNA</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1038/346561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1038%2F346561a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=2165569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=561-564&author=L.+A.+Matsudaauthor=S.+J.+Lolaitauthor=M.+J.+Brownsteinauthor=A.+C.+Youngauthor=T.+I.+Bonner&title=Structure+of+a+cannabinoid+receptor+and+functional+expression+of+the+cloned+cDNA&doi=10.1038%2F346561a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a cannabinoid receptor and functional expression of the cloned cDNA</span></div><div class="casAuthors">Matsuda, Lisa A.; Lolait, Stephen J.; Brownstein, Michael J.; Young, Alice C.; Bonner, Tom I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6284</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner.  CNS depression and analgesia are well documented effects of the cannabinoids, but the mechanisms responsible for the cannabinoid-induced effects are not known.  The hydrophobic nature of these substances has suggested that cannabinoids resemble anesthetic agents in their action and nonspecifically disrupt cellular membranes.  Recent evidence has supported a mechanism involving a G-protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner.  Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids.  This study reported the cloning and expression of a cDNA that encodes a G-protein-coupled receptor with all of these properties.  Its mRNA is found in cell lines and regions of the brain that have cannabinoid receptors.  This protein may be involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrydatT83mLVg90H21EOLACvtfcHk0lgJ5NjbIZ-Itw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D&md5=a99aeb39544d87392cee18b82a08003d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F346561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346561a0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DL.%2BA.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BC.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26atitle%3DStructure%2520of%2520a%2520cannabinoid%2520receptor%2520and%2520functional%2520expression%2520of%2520the%2520cloned%2520cDNA%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D561%26epage%3D564%26doi%3D10.1038%2F346561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Shaar, M.</span><span> </span><span class="NLM_article-title">Molecular characterization of a peripheral receptor for cannabinoids</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1038/365061a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1038%2F365061a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=7689702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1993&pages=61-65&author=S.+Munroauthor=K.+L.+Thomasauthor=M.+Abu-Shaar&title=Molecular+characterization+of+a+peripheral+receptor+for+cannabinoids&doi=10.1038%2F365061a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of a peripheral receptor for cannabinoids</span></div><div class="casAuthors">Munro, Sean; Thomas, Kerrie L.; Abu-Shaar, Muna</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6441</span>),
    <span class="NLM_cas:pages">61-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The major active ingredient of marijuana, Δ9-tetrahydrocannabinol (Δ-THC), has been used as a psychoactive agent for thousands of years.  Marijuana, and Δ9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting.  The clin. application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochem. bases of their action.  Progress stemmed initially from the synthesis of potent derivs. of Δ9-THC4,5, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids.  This receptor is expressed in the brain but not in the periphery, except for a low level in testes.  It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins.  Here the authors report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsq4vy1XH17Vg90H21EOLACvtfcHk0lgaRi0SGqmoQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D&md5=476435b57bd0f24483e2f24b813cc32f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F365061a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F365061a0%26sid%3Dliteratum%253Aachs%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DK.%2BL.%26aulast%3DAbu-Shaar%26aufirst%3DM.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520peripheral%2520receptor%2520for%2520cannabinoids%26jtitle%3DNature%26date%3D1993%26volume%3D365%26spage%3D61%26epage%3D65%26doi%3D10.1038%2F365061a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Brown, A. J.</span><span> </span><span class="NLM_article-title">Novel cannabinoid receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1038%2Fsj.bjp.0707481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=17906678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ejt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=567-575&author=A.+J.+Brown&title=Novel+cannabinoid+receptors&doi=10.1038%2Fsj.bjp.0707481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Novel cannabinoid receptors</span></div><div class="casAuthors">Brown, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">567-575</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cannabinoids have numerous physiol. effects.  In the years since the mol. identification of the G protein-coupled receptors CB1 and CB2, the ion channel TRPV1, and their corresponding endogenous ligand systems, many cannabinoid-evoked actions have been shown conclusively to be mediated by one of these specific receptor targets.  However, there remain several examples where these classical cannabinoid receptors do not explain obsd. pharmacol.  Studies using mice genetically deleted for the known receptors have confirmed the existence of addnl. targets, which have come to be known collectively as non-CB1/CB2 receptors.  Despite intense research efforts, the mol. identity of these non-CB1/CB2 receptors remains for the most part unclear.  Two orphan G protein-coupled receptors have recently been implicated as novel cannabinoid receptors; these are GPR119, which has been proposed as a receptor for oleoylethanolamide, and GPR55 which has been proposed as a receptor activated by multiple different cannabinoid ligands.  This review presents an introduction to non-CB1/CB2 pharmacol., summarize information on GPR55 and GPR119 currently available, and consider their phylogenetic origin and what aspects of non-CB1/CB2 pharmacol., if any, they help explain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo0rVSQgej9rVg90H21EOLACvtfcHk0lgaRi0SGqmoQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ejt7%252FN&md5=87a88f7e93d44d1575cf1f42bd30841b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707481%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26atitle%3DNovel%2520cannabinoid%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D567%26epage%3D575%26doi%3D10.1038%2Fsj.bjp.0707481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiley, C. R.</span><span> </span><span class="NLM_article-title">In silico patent searching reveals a new cannabinoid receptor</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1016/j.tips.2005.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.tips.2005.11.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1-4&author=D.+Bakerauthor=G.+Pryceauthor=W.+L.+Daviesauthor=C.+R.+Hiley&title=In+silico+patent+searching+reveals+a+new+cannabinoid+receptor&doi=10.1016%2Fj.tips.2005.11.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DPryce%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DW.%2BL.%26aulast%3DHiley%26aufirst%3DC.%2BR.%26atitle%3DIn%2520silico%2520patent%2520searching%2520reveals%2520a%2520new%2520cannabinoid%2520receptor%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D1%26epage%3D4%26doi%3D10.1016%2Fj.tips.2005.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babbs, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doel, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasamison, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang-Christensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.cmet.2006.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=16517404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=167-175&author=H.+A.+Overtonauthor=A.+J.+Babbsauthor=S.+M.+Doelauthor=M.+C.+Fyfeauthor=L.+S.+Gardnerauthor=G.+Griffinauthor=H.+C.+Jacksonauthor=M.+J.+Procterauthor=C.+M.+Rasamisonauthor=M.+Tang-Christensenauthor=P.+S.+Widdowsonauthor=G.+M.+Williamsauthor=C.+Reynet&title=Deorphanization+of+a+G+protein-coupled+receptor+for+oleoylethanolamide+and+its+use+in+the+discovery+of+small-molecule+hypophagic+agents&doi=10.1016%2Fj.cmet.2006.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span></div><div class="casAuthors">Overton, Hilary A.; Babbs, Adam J.; Doel, Sheila M.; Fyfe, Matthew C. T.; Gardner, Lisa S.; Griffin, Graeme; Jackson, Helen C.; Procter, Martin J.; Rasamison, Chrystelle M.; Tang-Christensen, Mads; Widdowson, Peter S.; Williams, Geoffery M.; Reynet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The endogenous lipid signaling agent oleoylethanolamide (OEA) has recently been described as a peripherally acting agent that reduces food intake and body wt. gain in rat feeding models.  This paper presents evidence that OEA is an endogenous ligand of the orphan receptor GPR119, a G protein-coupled receptor (GPCR) expressed predominantly in the human and rodent pancreas and gastrointestinal tract and also in rodent brain, suggesting that the reported effects of OEA on food intake may be mediated, at least in part, via the GPR119 receptor.  Furthermore, we have used the recombinant receptor to discover novel selective small-mol. GPR119 agonists, typified by PSN632408, which suppress food intake in rats and reduce body wt. gain and white adipose tissue deposition upon subchronic oral administration to high-fat-fed rats.  GPR119 therefore represents a novel and attractive potential target for the therapy of obesity and related metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8xt3VqDV07Vg90H21EOLACvtfcHk0ljuu4wkEKsvlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D&md5=85c2756aa0809be0069ea515e2a1574d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DBabbs%26aufirst%3DA.%2BJ.%26aulast%3DDoel%26aufirst%3DS.%2BM.%26aulast%3DFyfe%26aufirst%3DM.%2BC.%26aulast%3DGardner%26aufirst%3DL.%2BS.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DH.%2BC.%26aulast%3DProcter%26aufirst%3DM.%2BJ.%26aulast%3DRasamison%26aufirst%3DC.%2BM.%26aulast%3DTang-Christensen%26aufirst%3DM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DWilliams%26aufirst%3DG.%2BM.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DDeorphanization%2520of%2520a%2520G%2520protein-coupled%2520receptor%2520for%2520oleoylethanolamide%2520and%2520its%2520use%2520in%2520the%2520discovery%2520of%2520small-molecule%2520hypophagic%2520agents%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D167%26epage%3D175%26doi%3D10.1016%2Fj.cmet.2006.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Vemuri, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of cannabinoids</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span><span class="refDoi"> DOI: 10.1002/cpt.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1002%2Fcpt.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25801236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFKrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=553-558&author=V.+K.+Vemuriauthor=A.+Makriyannis&title=Medicinal+chemistry+of+cannabinoids&doi=10.1002%2Fcpt.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of cannabinoids</span></div><div class="casAuthors">Vemuri, V. Kiran; Makriyannis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-558</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The endocannabinoid system comprises the two well characterized Gi/o-protein coupled receptors (cannabinoid receptor 1 (CB1) and CB2), their endogenous lipid ligands, and the enzymes involved in their biosynthesis and biotransformation.  Drug discovery efforts relating to the endocannabinoid system have been focused mainly on the two cannabinoid receptors and the two endocannabinoid deactivating enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGL).  This review provides an overview of cannabinergic agents used in drug research and those being explored clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUhg1K1g6d67Vg90H21EOLACvtfcHk0ljuu4wkEKsvlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFKrsbc%253D&md5=89e98ec89810137591045fa3ee57c701</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fcpt.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt.115%26sid%3Dliteratum%253Aachs%26aulast%3DVemuri%26aufirst%3DV.%2BK.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DMedicinal%2520chemistry%2520of%2520cannabinoids%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2015%26volume%3D97%26spage%3D553%26epage%3D558%26doi%3D10.1002%2Fcpt.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Roche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, D. P.</span><span> </span><span class="NLM_article-title">Brain CB<sub>2</sub> receptors: implications for neuropsychiatric disorders</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2517</span><span class="NLM_x">–</span> <span class="NLM_lpage">2553</span><span class="refDoi"> DOI: 10.3390/ph3082517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.3390%2Fph3082517" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=2517-2553&author=M.+Rocheauthor=D.+P.+Finn&title=Brain+CB2+receptors%3A+implications+for+neuropsychiatric+disorders&doi=10.3390%2Fph3082517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fph3082517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3082517%26sid%3Dliteratum%253Aachs%26aulast%3DRoche%26aufirst%3DM.%26aulast%3DFinn%26aufirst%3DD.%2BP.%26atitle%3DBrain%2520CB2%2520receptors%253A%2520implications%2520for%2520neuropsychiatric%2520disorders%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26spage%3D2517%26epage%3D2553%26doi%3D10.3390%2Fph3082517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Horti, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span> </span><span class="NLM_article-title">Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB<sub>1</sub>) in human brain</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3363</span><span class="NLM_x">–</span> <span class="NLM_lpage">3383</span><span class="refDoi"> DOI: 10.2174/138161208786549380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.2174%2F138161208786549380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=19075713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtV2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3363-3383&author=A.+G.+Hortiauthor=K.+Van+Laere&title=Development+of+radioligands+for+in+vivo+imaging+of+type+1+cannabinoid+receptors+%28CB1%29+in+human+brain&doi=10.2174%2F138161208786549380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain</span></div><div class="casAuthors">Horti, Andrew G.; Van Laere, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3363-3383</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cerebral cannabinoid receptor (CB1) and cannabinoid drugs constitute a vibrant field in modern medicine and pharmacol.  However, the physiol. and pharmacol. roles played by the cannabinoid receptor in the central nervous system are still not fully understood.  Positron-emission tomog. (PET) is the most advanced technique for non-invasive research of cerebral receptors.  Quant. PET imaging of CB1 in animal and human brains has been limited by drawbacks of the available CB1 radioligands that manifested low specific binding, high non-specific binding and/or low brain uptake.  The latest research revealed three CB1 PET radioligands ([11C]JHU75528, [18F]MK9470 and [11C]MePPEP) with improved imaging properties.  These compds. are now being employed for the quant. evaluation of CB1 in human subjects with PET.  Mol. imaging of the CB1 receptor with these radioligands has now become possible and their application in healthy humans and in patients is underway.  Despite the substantial progress in development of CB1 PET radioligands even the latest radioligands manifest certain disadvantages.  Current research efforts on the development of CB1 radioligands with higher binding potential, greater brain uptake and more optimal brain kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMybxdwa52k7Vg90H21EOLACvtfcHk0ljSMvr8m_WwlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtV2quw%253D%253D&md5=27771b15f344d8e628ec984cbe3da791</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F138161208786549380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208786549380%26sid%3Dliteratum%253Aachs%26aulast%3DHorti%26aufirst%3DA.%2BG.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26atitle%3DDevelopment%2520of%2520radioligands%2520for%2520in%2520vivo%2520imaging%2520of%2520type%25201%2520cannabinoid%2520receptors%2520%2528CB1%2529%2520in%2520human%2520brain%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D3363%26epage%3D3383%26doi%3D10.2174%2F138161208786549380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guevara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ming, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grachev, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascella, N.</span><span> </span><span class="NLM_article-title">Quantification of cerebral cannabinoid receptors subtype 1 (CB<sub>1</sub>) in healthy subjects and schizophrenia by the novel PET radioligand [<sup>11</sup>C]OMAR</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1505</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2010.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.neuroimage.2010.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=20406692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVGnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=1505-1513&author=D.+F.+Wongauthor=H.+Kuwabaraauthor=A.+G.+Hortiauthor=V.+Raymontauthor=J.+Brasicauthor=M.+Guevaraauthor=W.+Yeauthor=R.+F.+Dannalsauthor=H.+T.+Ravertauthor=A.+Nandiauthor=A.+Rahmimauthor=J.+E.+Mingauthor=I.+Grachevauthor=C.+Royauthor=N.+Cascella&title=Quantification+of+cerebral+cannabinoid+receptors+subtype+1+%28CB1%29+in+healthy+subjects+and+schizophrenia+by+the+novel+PET+radioligand+%5B11C%5DOMAR&doi=10.1016%2Fj.neuroimage.2010.04.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR</span></div><div class="casAuthors">Wong, Dean F.; Kuwabara, Hiroto; Horti, Andrew G.; Raymont, Vanessa; Brasic, James; Guevara, Maria; Ye, Weiguo; Dannals, Robert F.; Ravert, Hayden T.; Nandi, Ayon; Rahmim, Arman; Ming, Jeffrey E.; Grachev, Igor; Roy, Christine; Cascella, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1505-1513</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several studies have examd. the link between the cannabinoid CB1 receptor and several neuropsychiatric illnesses, including schizophrenia.  As such, there is a need for in vivo imaging tracers so that the relationship between CB1 and schizophrenia (SZ) can be further studied.  In this paper, we present our first human studies in both healthy control patients and patients with schizophrenia using the novel PET tracer, [11C]OMAR (JHU75528), we have shown its utility as a tracer for imaging human CB1 receptors and to investigate normal aging and the differences in the cannabinoid system of healthy controls vs. patients with schizophrenia.  A total of ten healthy controls and nine patients with schizophrenia were included and studied with high specific activity [11C]OMAR.  The CB1 binding (expressed as the distribution vol.; VT) was highest in the globus pallidus and the cortex in both controls and patients with schizophrenia.  Controls showed a correlation with the known distribution of CB1 and decline of [11C]OMAR binding with age, most significantly in the globus pallidus.  Overall, we obsd. elevated mean binding in patients with schizophrenia across all regions studied, and this increase was statistically significant in the pons (p < 0.05), by the Students t-test.  When we ran a regression of the control subjects VT values with age and then compared the patient data to 95% prediction limits of the linear regression, three patients fell completely outside for the globus pallidus, and in all other regions there were at least 1-3 patients outside of the prediction intervals.  There was no statistically significant correlations between PET measures and the individual Brief Psychiatry Rating Score (BPRS) subscores (r = 0.49), but there was a significant correlation between VT and the ratio of the BPRS psychosis to withdrawal score in the frontal lobe (r = 0.60), and middle and posterior cingulate regions (r = 0.71 and r = 0.79 resp.).  In conclusion, we found that [11C]OMAR can image human CB1 receptors in normal aging and schizophrenia.  In addn., our initial data in subjects with schizophrenia seem to suggest an assocn. of elevated binding specific brain regions and symptoms of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOEH2Wkw4jW7Vg90H21EOLACvtfcHk0lh2e-BrINfuTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVGnt70%253D&md5=6f7bf8d2410075a00b7f7f1969106823</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2010.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2010.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DKuwabara%26aufirst%3DH.%26aulast%3DHorti%26aufirst%3DA.%2BG.%26aulast%3DRaymont%26aufirst%3DV.%26aulast%3DBrasic%26aufirst%3DJ.%26aulast%3DGuevara%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DNandi%26aufirst%3DA.%26aulast%3DRahmim%26aufirst%3DA.%26aulast%3DMing%26aufirst%3DJ.%2BE.%26aulast%3DGrachev%26aufirst%3DI.%26aulast%3DRoy%26aufirst%3DC.%26aulast%3DCascella%26aufirst%3DN.%26atitle%3DQuantification%2520of%2520cerebral%2520cannabinoid%2520receptors%2520subtype%25201%2520%2528CB1%2529%2520in%2520healthy%2520subjects%2520and%2520schizophrenia%2520by%2520the%2520novel%2520PET%2520radioligand%2520%255B11C%255DOMAR%26jtitle%3DNeuroImage%26date%3D2010%26volume%3D52%26spage%3D1505%26epage%3D1513%26doi%3D10.1016%2Fj.neuroimage.2010.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Onaivi, E. S.</span><span> </span><span class="NLM_article-title">Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB<sub>2</sub> receptors in the brain</span> <span class="citation_source-journal">Neuropsychobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.1159/000100778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1159%2F000100778" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=231-246&author=E.+S.+Onaivi&title=Neuropsychobiological+evidence+for+the+functional+presence+and+expression+of+cannabinoid+CB2+receptors+in+the+brain&doi=10.1159%2F000100778"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1159%2F000100778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000100778%26sid%3Dliteratum%253Aachs%26aulast%3DOnaivi%26aufirst%3DE.%2BS.%26atitle%3DNeuropsychobiological%2520evidence%2520for%2520the%2520functional%2520presence%2520and%2520expression%2520of%2520cannabinoid%2520CB2%2520receptors%2520in%2520the%2520brain%26jtitle%3DNeuropsychobiology%26date%3D2006%26volume%3D54%26spage%3D231%26epage%3D246%26doi%3D10.1159%2F000100778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Van Sickle, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouihate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittman, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharkey, K. A.</span><span> </span><span class="NLM_article-title">Identification and functional characterization of brainstem cannabinoid CB<sub>2</sub> receptors</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1126/science.1115740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1126%2Fscience.1115740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=16224028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2hurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=329-332&author=M.+D.+Van+Sickleauthor=M.+Duncanauthor=P.+J.+Kingsleyauthor=A.+Mouihateauthor=P.+Urbaniauthor=K.+Mackieauthor=N.+Stellaauthor=A.+Makriyannisauthor=D.+Piomelliauthor=J.+S.+Davisonauthor=L.+J.+Marnettauthor=V.+Di+Marzoauthor=Q.+J.+Pittmanauthor=K.+D.+Patelauthor=K.+A.+Sharkey&title=Identification+and+functional+characterization+of+brainstem+cannabinoid+CB2+receptors&doi=10.1126%2Fscience.1115740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and functional characterization of brainstem cannabinoid CB2 receptors</span></div><div class="casAuthors">Van Sickle, Marja D.; Duncan, Marnie; Kingsley, Philip J.; Mouihate, Abdeslam; Urbani, Paolo; Mackie, Ken; Stella, Nephi; Makriyannis, Alexandros; Piomelli, Daniele; Davison, Joseph S.; Marnett, Lawrence J.; Di Marzo, Vincenzo; Pittman, Quentin J.; Patel, Kamala D.; Sharkey, Keith A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">5746</span>),
    <span class="NLM_cas:pages">329-332</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The presence and function of CB2 receptors in central nervous system (CNS) neurons are controversial.  The authors report the expression of CB2 receptor mRNA and protein localization on brainstem neurons.  These functional CB2 receptors in the brainstem were activated by a CB2 receptor agonist, 2-arachidonoylglycerol, and by elevated endogenous levels of endocannabinoids, which also act at CB1 receptors.  CB2 receptors represent an alternative site of action of endocannabinoids that opens the possibility of nonpsychotropic therapeutic interventions using enhanced endocannabinoid levels in localized brain areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWgg6LDIT0bVg90H21EOLACvtfcHk0li0MASizj77QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2hurvL&md5=ab457ab0bd1b8e30ea927a1e61366323</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1115740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1115740%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BSickle%26aufirst%3DM.%2BD.%26aulast%3DDuncan%26aufirst%3DM.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DMouihate%26aufirst%3DA.%26aulast%3DUrbani%26aufirst%3DP.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DStella%26aufirst%3DN.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DDavison%26aufirst%3DJ.%2BS.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPittman%26aufirst%3DQ.%2BJ.%26aulast%3DPatel%26aufirst%3DK.%2BD.%26aulast%3DSharkey%26aufirst%3DK.%2BA.%26atitle%3DIdentification%2520and%2520functional%2520characterization%2520of%2520brainstem%2520cannabinoid%2520CB2%2520receptors%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2005%26volume%3D310%26spage%3D329%26epage%3D332%26doi%3D10.1126%2Fscience.1115740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ashton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. F.</span><span> </span><span class="NLM_article-title">Expression of the cannabinoid CB<sub>2</sub> receptor in the rat cerebellum: an immunohistochemical study</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span><span class="refDoi"> DOI: 10.1016/j.neulet.2005.11.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.neulet.2005.11.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2006&pages=113-116&author=J.+C.+Ashtonauthor=D.+Fribergauthor=C.+L.+Darlingtonauthor=P.+F.+Smith&title=Expression+of+the+cannabinoid+CB2+receptor+in+the+rat+cerebellum%3A+an+immunohistochemical+study&doi=10.1016%2Fj.neulet.2005.11.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2005.11.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2005.11.038%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DJ.%2BC.%26aulast%3DFriberg%26aufirst%3DD.%26aulast%3DDarlington%26aufirst%3DC.%2BL.%26aulast%3DSmith%26aufirst%3DP.%2BF.%26atitle%3DExpression%2520of%2520the%2520cannabinoid%2520CB2%2520receptor%2520in%2520the%2520rat%2520cerebellum%253A%2520an%2520immunohistochemical%2520study%26jtitle%3DNeurosci.%2520Lett.%26date%3D2006%26volume%3D396%26spage%3D113%26epage%3D116%26doi%3D10.1016%2Fj.neulet.2005.11.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Sheng, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabral, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokensgard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, P. K.</span><span> </span><span class="NLM_article-title">Synthetic cannabinoid WIN55,212–2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1002/glia.20108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1002%2Fglia.20108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=211-219&author=W.+S.+Shengauthor=S.+Huauthor=X.+Minauthor=G.+A.+Cabralauthor=J.+R.+Lokensgardauthor=P.+K.+Peterson&title=Synthetic+cannabinoid+WIN55%2C212%E2%80%932+inhibits+generation+of+inflammatory+mediators+by+IL-1beta-stimulated+human+astrocytes&doi=10.1002%2Fglia.20108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fglia.20108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20108%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DW.%2BS.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DCabral%26aufirst%3DG.%2BA.%26aulast%3DLokensgard%26aufirst%3DJ.%2BR.%26aulast%3DPeterson%26aufirst%3DP.%2BK.%26atitle%3DSynthetic%2520cannabinoid%2520WIN55%252C212%25E2%2580%25932%2520inhibits%2520generation%2520of%2520inflammatory%2520mediators%2520by%2520IL-1beta-stimulated%2520human%2520astrocytes%26jtitle%3DGlia%26date%3D2005%26volume%3D49%26spage%3D211%26epage%3D219%26doi%3D10.1002%2Fglia.20108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Golech, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shohami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spatz, M.</span><span> </span><span class="NLM_article-title">Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1016/j.molbrainres.2004.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.molbrainres.2004.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=15548432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSktr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2004&pages=87-92&author=S.+A.+Golechauthor=R.+M.+McCarronauthor=Y.+Chenauthor=J.+Bembryauthor=F.+Lenzauthor=R.+Mechoulamauthor=E.+Shohamiauthor=M.+Spatz&title=Human+brain+endothelium%3A+coexpression+and+function+of+vanilloid+and+endocannabinoid+receptors&doi=10.1016%2Fj.molbrainres.2004.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors</span></div><div class="casAuthors">Golech, Susanne Andrea; McCarron, Richard M.; Chen, Ye; Bembry, Joliet; Lenz, Frederick; Mechoulam, Raphael; Shohami, Esther; Spatz, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The arachidonic acid deriv., 2-arachidonoyl-glycerol (2-AG), was initially isolated from gut and brain; it is also produced and released from blood and vascular cells.  Many of the 2-AG-induced cellular responses (i.e., neuromodulation, cytoprotection and vasodilation) are mediated by cannabinoid receptors CB1 and CB2.  The findings presented here demonstrate the expression of CB1, CB2 and TRPV1 receptors on cerebromicrovascular endothelial cells (HBEC).  The expression of TRPV1, CB1 and CB2 receptor mRNA and proteins were demonstrated by RT-PCR and polyclonal antibodies, resp.  The endocannabinoid 2-AG, and other related compds. [anandamide (ANA), methanandamide (m-ANA), N-(4-hydroxyphenyl-arachidonyl-ethanolamide) (AM404) and capsaicin] dose-dependently stimulated Ca2+ influx in HBEC.  The selective TRPV1 receptor antagonist (capsazepine), CB1 receptor antagonist (SR141716A) and CB2 receptor antagonist (SR144528) inhibited these responses.  The effects of capsaicin, a specific agonist for TRPV1 receptors, were inhibited by capsazepine, but only weakly by CB1 or CB2 receptor antagonists.  2-AG also induced phosphorylation of vasodilator-stimulated phosphoprotein (VASP); this response was mediated by VR1 receptors.  These studies clearly indicate that 2-AG and other related compds. may function as agonists on VR1 receptors, as well as CB1 and CB2 receptors, and implicated these factors in various HBEC functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxdzokfZjGN7Vg90H21EOLACvtfcHk0lgZI1XnzF-ZOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSktr3F&md5=88cc9f723c71a8af745f9128015302c1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.molbrainres.2004.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbrainres.2004.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DGolech%26aufirst%3DS.%2BA.%26aulast%3DMcCarron%26aufirst%3DR.%2BM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBembry%26aufirst%3DJ.%26aulast%3DLenz%26aufirst%3DF.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DSpatz%26aufirst%3DM.%26atitle%3DHuman%2520brain%2520endothelium%253A%2520coexpression%2520and%2520function%2520of%2520vanilloid%2520and%2520endocannabinoid%2520receptors%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D2004%26volume%3D132%26spage%3D87%26epage%3D92%26doi%3D10.1016%2Fj.molbrainres.2004.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrier, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">Cannabinoid CB<sub>2</sub> receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer’s disease brains</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">11136</span><span class="NLM_x">–</span> <span class="NLM_lpage">11141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=14657172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=11136-11141&author=C.+Benitoauthor=E.+Nunezauthor=R.+M.+Tolonauthor=E.+J.+Carrierauthor=A.+Rabanoauthor=C.+J.+Hillardauthor=J.+Romero&title=Cannabinoid+CB2+receptors+and+fatty+acid+amide+hydrolase+are+selectively+overexpressed+in+neuritic+plaque-associated+glia+in+Alzheimer%E2%80%99s+disease+brains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains</span></div><div class="casAuthors">Benito, Cristina; Nunez, Estefania; Tolon, Rosa M.; Carrier, Erica J.; Rabano, Alberto; Hillard, Cecilia J.; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11136-11141</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The endocannabinoid system is still poorly understood.  Recently, the basic elements that constitute it, i.e., membrane receptors, endogenous ligands, and mechanisms for termination of the signaling process, have been partially characterized.  There is a considerable lack of information, however, concerning the distribution, concn., and function of those components in the human body, particularly during pathol. events.  We have studied the status of some of the components of the endocannabinoid system, fatty acid amide hydrolase and cannabinoid CB1 and CB2 receptors, in postmortem brains from patients with Alzheimer's disease.  Using specific polyclonal antibodies, we have performed immunohistochem. anal. in hippocampus and entorhinal cortex sections from brains of Alzheimer's disease patients.  Our results show that both fatty acid amide hydrolase and cannabinoid CB2 receptors are abundantly and selectively expressed in neuritic plaque-assocd. astrocytes and microglia, resp., whereas the expression of CB1 receptors remains unchanged.  In addn., the hydrolase activity seems to be elevated in the plaques and surrounding areas.  Thus, some elements of the endocannabinoid system may be postulated as possible modulators of the inflammatory response assocd. with this neurodegenerative process and as possible targets for new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8Gm8V3n8jrVg90H21EOLACvtfcHk0lgZI1XnzF-ZOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtbw%253D&md5=c324980efac10a672fc425ef376694f1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DNunez%26aufirst%3DE.%26aulast%3DTolon%26aufirst%3DR.%2BM.%26aulast%3DCarrier%26aufirst%3DE.%2BJ.%26aulast%3DRabano%26aufirst%3DA.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB2%2520receptors%2520and%2520fatty%2520acid%2520amide%2520hydrolase%2520are%2520selectively%2520overexpressed%2520in%2520neuritic%2520plaque-associated%2520glia%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D11136%26epage%3D11141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemente, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Docagne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guaza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2396</span><span class="NLM_x">–</span> <span class="NLM_lpage">2402</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4814-06.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1523%2FJNEUROSCI.4814-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=17329437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVymsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=2396-2402&author=C.+Benitoauthor=J.+P.+Romeroauthor=R.+M.+Tolonauthor=D.+Clementeauthor=F.+Docagneauthor=C.+J.+Hillardauthor=C.+Guazaauthor=J.+Romero&title=Cannabinoid+CB1+and+CB2+receptors+and+fatty+acid+amide+hydrolase+are+specific+markers+of+plaque+cell+subtypes+in+human+multiple+sclerosis&doi=10.1523%2FJNEUROSCI.4814-06.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis</span></div><div class="casAuthors">Benito, Cristina; Romero, Juan Pablo; Tolon, Rosa Maria; Clemente, Diego; Docagne, Fabian; Hillard, Cecilia J.; Guaza, Camen; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2396-2402</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Increasing evidence supports the idea of a beneficial effect of cannabinoid compds. for the treatment of multiple sclerosis (MS).  However, most exptl. data come from animal models of MS.  We investigated the status of cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase (FAAH) enzyme in brain tissue samples obtained from MS patients.  Areas of demyelination were identified and classified as active, chronic, and inactive plaques.  CB1 and CB2 receptors and FAAH densities and cellular sites of expression were examd. using immunohistochem. and immunofluorescence.  In MS samples, cannabinoid CB1 receptors were expressed by cortical neurons, oligodendrocytes, and also oligodendrocyte precursor cells, demonstrated using double immunofluorescence with antibodies against the CB1 receptor with antibodies against type 2 microtubule-assocd. protein, myelin basic protein, and the platelet-derived growth factor receptor-α, resp.  CB1 receptors were also present in macrophages and infiltrated T-lymphocytes.  Conversely, CB2 receptors were present in T-lymphocytes, astrocytes, and perivascular and reactive microglia (major histocompatibility complex class-II pos.) in MS plaques.  Specifically, CB2-pos. microglial cells were evenly distributed within active plaques but were located in the periphery of chronic active plaques.  FAAH expression was restricted to neurons and hypertrophic astrocytes.  As seen for other neuroinflammatory conditions, selective glial expression of cannabinoid CB1 and CB2 receptors and FAAH enzyme is induced in MS, thus supporting a role for the endocannabinoid system in the pathogenesis and/or evolution of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbJVv49pGA7Vg90H21EOLACvtfcHk0lg_RUlNzBQPDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVymsLY%253D&md5=597beaa5d37154540dd56bd58b2034bc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4814-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4814-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%2BP.%26aulast%3DTolon%26aufirst%3DR.%2BM.%26aulast%3DClemente%26aufirst%3DD.%26aulast%3DDocagne%26aufirst%3DF.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB1%2520and%2520CB2%2520receptors%2520and%2520fatty%2520acid%2520amide%2520hydrolase%2520are%2520specific%2520markers%2520of%2520plaque%2520cell%2520subtypes%2520in%2520human%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D2396%26epage%3D2402%26doi%3D10.1523%2FJNEUROSCI.4814-06.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Yiangou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banati, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shaughnessy, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessell, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span> </span><span class="NLM_article-title">Cannabinoid receptor CB<sub>2</sub> expression in activated microglia of multiple sclerosis and amyotrophic lateral sclerosis spinal cord</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">–</span> <span class="NLM_lpage">1226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2004&pages=1226-1226&author=Y.+Yiangouauthor=P.+Facerauthor=R.+B.+Banatiauthor=C.+T.+O%E2%80%99Shaughnessyauthor=I.+P.+Chessellauthor=P.+Anand&title=Cannabinoid+receptor+CB2+expression+in+activated+microglia+of+multiple+sclerosis+and+amyotrophic+lateral+sclerosis+spinal+cord"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYiangou%26aufirst%3DY.%26aulast%3DFacer%26aufirst%3DP.%26aulast%3DBanati%26aufirst%3DR.%2BB.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DC.%2BT.%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DAnand%26aufirst%3DP.%26atitle%3DCannabinoid%2520receptor%2520CB2%2520expression%2520in%2520activated%2520microglia%2520of%2520multiple%2520sclerosis%2520and%2520amyotrophic%2520lateral%2520sclerosis%2520spinal%2520cord%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2004%26volume%3D75%26spage%3D1226%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nunez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">Glial expression of cannabinoid CB<sub>2</sub> receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down’s syndrome</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2007.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.neuroscience.2007.10.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2008&pages=104-110&author=E.+Nunezauthor=C.+Benitoauthor=R.+M.+Tolonauthor=C.+J.+Hillardauthor=W.+S.+Griffinauthor=J.+Romero&title=Glial+expression+of+cannabinoid+CB2+receptors+and+fatty+acid+amide+hydrolase+are+beta+amyloid-linked+events+in+Down%E2%80%99s+syndrome&doi=10.1016%2Fj.neuroscience.2007.10.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2007.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2007.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DNunez%26aufirst%3DE.%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DTolon%26aufirst%3DR.%2BM.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DGriffin%26aufirst%3DW.%2BS.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DGlial%2520expression%2520of%2520cannabinoid%2520CB2%2520receptors%2520and%2520fatty%2520acid%2520amide%2520hydrolase%2520are%2520beta%2520amyloid-linked%2520events%2520in%2520Down%25E2%2580%2599s%2520syndrome%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D151%26spage%3D104%26epage%3D110%26doi%3D10.1016%2Fj.neuroscience.2007.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Palazuelos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguado, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazos, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagredo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azcoitia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Ruiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galve-Roperh, I.</span><span> </span><span class="NLM_article-title">Microglial CB<sub>2</sub> cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">3152</span><span class="NLM_x">–</span> <span class="NLM_lpage">3164</span><span class="refDoi"> DOI: 10.1093/brain/awp239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1093%2Fbrain%2Fawp239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=19805493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BD1MjhvFWhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2009&pages=3152-3164&author=J.+Palazuelosauthor=T.+Aguadoauthor=M.+R.+Pazosauthor=B.+Julienauthor=C.+Carrascoauthor=E.+Reselauthor=O.+Sagredoauthor=C.+Benitoauthor=J.+Romeroauthor=I.+Azcoitiaauthor=J.+Fernandez-Ruizauthor=M.+Guzmanauthor=I.+Galve-Roperh&title=Microglial+CB2+cannabinoid+receptors+are+neuroprotective+in+Huntington%E2%80%99s+disease+excitotoxicity&doi=10.1093%2Fbrain%2Fawp239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity</span></div><div class="casAuthors">Palazuelos Javier; Aguado Tania; Pazos M Ruth; Julien Boris; Carrasco Carolina; Resel Eva; Sagredo Onintza; Benito Cristina; Romero Julian; Azcoitia Inigo; Fernandez-Ruiz Javier; Guzman Manuel; Galve-Roperh Ismael</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">Pt 11</span>),
    <span class="NLM_cas:pages">3152-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cannabinoid-derived drugs are promising agents for the development of novel neuroprotective strategies.  Activation of neuronal CB(1) cannabinoid receptors attenuates excitotoxic glutamatergic neurotransmission, triggers prosurvival signalling pathways and palliates motor symptoms in animal models of neurodegenerative disorders.  However, in Huntington's disease there is a very early downregulation of CB(1) receptors in striatal neurons that, together with the undesirable psychoactive effects triggered by CB(1) receptor activation, foster the search for alternative pharmacological treatments.  Here, we show that CB(2) cannabinoid receptor expression increases in striatal microglia of Huntington's disease transgenic mouse models and patients.  Genetic ablation of CB(2) receptors in R6/2 mice, that express human mutant huntingtin exon 1, enhanced microglial activation, aggravated disease symptomatology and reduced mice lifespan.  Likewise, induction of striatal excitotoxicity in CB(2) receptor-deficient mice by quinolinic acid administration exacerbated brain oedema, microglial activation, proinflammatory-mediator state and medium-sized spiny neuron degeneration.  Moreover, administration of CB(2) receptor-selective agonists to wild-type mice subjected to excitotoxicity reduced neuroinflammation, brain oedema, striatal neuronal loss and motor symptoms.  Studies on ganciclovir-induced depletion of astroglial proliferation in transgenic mice expressing thymidine kinase under the control of the glial fibrillary acidic protein promoter excluded the participation of proliferating astroglia in CB(2) receptor-mediated actions.  These findings support a pivotal role for CB(2) receptors in attenuating microglial activation and preventing neurodegeneration that may pave the way to new therapeutic strategies for neuroprotection in Huntington's disease as well as in other neurodegenerative disorders with a significant excitotoxic component.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJn0l4kFQOHDDnmmyUf5qOfW6udTcc2eZZToDFJt1dlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjhvFWhsQ%253D%253D&md5=4fbcfbef2441cb9542ea1302bd851f46</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawp239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawp239%26sid%3Dliteratum%253Aachs%26aulast%3DPalazuelos%26aufirst%3DJ.%26aulast%3DAguado%26aufirst%3DT.%26aulast%3DPazos%26aufirst%3DM.%2BR.%26aulast%3DJulien%26aufirst%3DB.%26aulast%3DCarrasco%26aufirst%3DC.%26aulast%3DResel%26aufirst%3DE.%26aulast%3DSagredo%26aufirst%3DO.%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DAzcoitia%26aufirst%3DI.%26aulast%3DFernandez-Ruiz%26aufirst%3DJ.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DGalve-Roperh%26aufirst%3DI.%26atitle%3DMicroglial%2520CB2%2520cannabinoid%2520receptors%2520are%2520neuroprotective%2520in%2520Huntington%25E2%2580%2599s%2520disease%2520excitotoxicity%26jtitle%3DBrain%26date%3D2009%26volume%3D132%26spage%3D3152%26epage%3D3164%26doi%3D10.1093%2Fbrain%2Fawp239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Donat, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodhun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span> </span><span class="NLM_article-title">Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet</span> <span class="citation_source-journal">Acta Neurobiol. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24993629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC2cfptVaqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=197-210&author=C.+K.+Donatauthor=F.+Fischerauthor=B.+Walterauthor=W.+Deuther-Conradauthor=M.+Brodhunauthor=R.+Bauerauthor=P.+Brust&title=Early+increase+of+cannabinoid+receptor+density+after+experimental+traumatic+brain+injury+in+the+newborn+piglet"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet</span></div><div class="casAuthors">Donat Cornelius K; Fischer Felix; Walter Bernd; Deuther-Conrad Winnie; Brodhun Michael; Bauer Reinhard; Brust Peter</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurobiologiae experimentalis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-210</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Paediatric traumatic brain injury (TBI) is a leading cause of death and disability.  Previous studies showed neuroprotection after TBI by (endo)cannabinoid mechanisms, suggesting involvement of cannabinoid receptors (CBR).  We therefore determined CBR densities and expression of the translocator protein 18 kDA (TSPO) in newborn piglets after experimental TBI.  Newborn female piglets were subjected to sham operation (n=6) or fluid-percussion (FP) injury (n=7) under controlled physiological conditions.  After six hours, brains were frozen, sagittally cut and incubated with radioligands for CBR ([3HCP-55,940, [3H]SR141716A) and TSPO ([3H]PK11195), an indicator of gliosis/brain injury.  Early after injury, FP-TBI elicited a significant ICP increase at a temporary reduced cerebral perfusion pressure; however, CBF and CMRO2 remained within physiological range.  At 6 hours post injury, we found a statistically significant increase in binding of the non-selective agonist [3H]CP-55,940 in 15 of the 24 investigated brain regions of injured animals.  By contrast, no significant changes in binding of the CB1R-selective antagonist [3H]SR141716A were observed.  A non-significant trend towards increased binding of [3H]PK11195 was observed, suggesting an incipient microglial activation.  We therefore conclude that in this model and time span after injury, the increase in [3H]CP-55,940 binding reflects changes in CB2R density, while CB1R density is not affected.  The results may provide explanation for the neuroprotective properties of cannabinoid ligands and future therapeutic strategies of TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8Wbh92eIbqsSzjBFCN0BJfW6udTcc2eYO93K5PG43_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfptVaqtw%253D%253D&md5=9a408ead808ea8d78498a919f6d2352f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonat%26aufirst%3DC.%2BK.%26aulast%3DFischer%26aufirst%3DF.%26aulast%3DWalter%26aufirst%3DB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DBrodhun%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DEarly%2520increase%2520of%2520cannabinoid%2520receptor%2520density%2520after%2520experimental%2520traumatic%2520brain%2520injury%2520in%2520the%2520newborn%2520piglet%26jtitle%3DActa%2520Neurobiol.%2520Exp.%26date%3D2014%26volume%3D74%26spage%3D197%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Páldyová, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bereczki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sántha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsodi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benyhe, S.</span><span> </span><span class="NLM_article-title">Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation <i>via</i> CB<sub>2</sub> cannabinoid receptors</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1016/j.neuint.2007.06.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.neuint.2007.06.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=17698254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=321-328&author=E.+P%C3%A1ldyov%C3%A1author=E.+Bereczkiauthor=M.+S%C3%A1nthaauthor=T.+Wengerauthor=A.+Borsodiauthor=S.+Benyhe&title=Noladin+ether%2C+a+putative+endocannabinoid%2C+inhibits+%CE%BC-opioid+receptor+activation+via+CB2+cannabinoid+receptors&doi=10.1016%2Fj.neuint.2007.06.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation via CB2 cannabinoid receptors</span></div><div class="casAuthors">Paldyova, Estera; Bereczki, Erika; Santha, Miklos; Wenger, Tibor; Borsodi, Anna; Benyhe, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">321-328</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the occurrence of possible changes in mRNA expression and the functional activity of opioid receptors after acute in vivo and in vitro treatment with the putative endogenous cannabinoid noladin ether.  While noladin ether (NE) demonstrates agonist activity at CB1 cannabinoid receptors, recent data indicate that NE acts as a full agonist at CB2 cannabinoid receptors too.  Considering the functional interactions between opioids and cannabinoids, it is of interest to examine whether NE affects the opioid system.  To that end, we studied the influence of NE on μ-opioid receptor (MOR) mRNA expression and MOR mediated G-protein signaling.  We used real-time PCR and [35S]GTPγS binding assays to examine the changes of MOR mRNA levels and the capability of the μ-opioid agonist peptide [D-Ala2,N-Me-Phe4,Gly5-ol]enkephalin (DAMGO) in activating regulatory G-proteins via MORs in forebrain membrane fractions of wild-type (w.t., CB1+/+) and CB1 receptor deficient transgenic mice (knockout, CB1-/-).  We found, that the expression of MOR mRNAs significantly decreased both in CB1+/+ and CB1-/- forebrain after a single injection of NE at 1 mg/kg when compared to control.  Consequently, MOR-mediated signaling is attenuated after acute in vivo treatment with NE in both CB1+/+ and CB1-/- mice.  Inhibition on MOR mediated activation is obsd. after in vitro NE administration as well.  Radioligand binding competition studies showed that the noticed effect of NE on MOR signaling is not mediated through MORs.  Both in vivo and in vitro attenuations of NE can be antagonized by the CB2 selective antagonist SR 144528.  Taken together, our data suggest that the NE caused pronounced decrease in the activity of MOR is mediated via CB2 cannabinoid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbO2jGTRGMcLVg90H21EOLACvtfcHk0lhjUIAkjNUODw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjtL%252FK&md5=7179296aae301f1f1c542385e4ed7c40</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2007.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2007.06.033%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A1ldyov%25C3%25A1%26aufirst%3DE.%26aulast%3DBereczki%26aufirst%3DE.%26aulast%3DS%25C3%25A1ntha%26aufirst%3DM.%26aulast%3DWenger%26aufirst%3DT.%26aulast%3DBorsodi%26aufirst%3DA.%26aulast%3DBenyhe%26aufirst%3DS.%26atitle%3DNoladin%2520ether%252C%2520a%2520putative%2520endocannabinoid%252C%2520inhibits%2520%25CE%25BC-opioid%2520receptor%2520activation%2520via%2520CB2%2520cannabinoid%2520receptors%26jtitle%3DNeurochem.%2520Int.%26date%3D2008%26volume%3D52%26spage%3D321%26epage%3D328%26doi%3D10.1016%2Fj.neuint.2007.06.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavarria, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2530</span><span class="NLM_x">–</span> <span class="NLM_lpage">2536</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3923-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1523%2FJNEUROSCI.3923-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=15758162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1ygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=2530-2536&author=C.+Benitoauthor=W.+K.+Kimauthor=I.+Chavarriaauthor=C.+J.+Hillardauthor=K.+Mackieauthor=R.+M.+Tolonauthor=K.+Williamsauthor=J.+Romero&title=A+glial+endogenous+cannabinoid+system+is+upregulated+in+the+brains+of+macaques+with+simian+immunodeficiency+virus-induced+encephalitis&doi=10.1523%2FJNEUROSCI.3923-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis</span></div><div class="casAuthors">Benito, Cristina; Kim, Wong-Ki; Chavarria, Ivan; Hillard, Ceceila J.; Mackie, Ken; Tolon, Rosa M.; Williams, Ken; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2530-2536</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent evidence supports the notion that the endocannabinoid system may play a crucial role in neuroinflammation.  We explored the changes that some elements of this system exhibit in a macaque model of encephalitis induced by simian immunodeficiency virus.  These results show that profound alterations in the distribution of specific components of the endocannabinoid system occur as a consequence of the viral infection of the brain.  Specifically, expression of cannabinoid receptors of the CB2 subtype was induced in the brains of infected animals, mainly in perivascular macrophages, microglial nodules, and T-lymphocytes, most likely of the CD8 subtype.  In addn., the endogenous cannabinoid-degrading enzyme fatty acid amide hydrolase was overexpressed in perivascular astrocytes as well as in astrocytic processes reaching cellular infiltrates.  Finally, the pattern of CB1 receptor expression was not modified in the brains of infected animals compared with that in control animals.  These results resemble previous data obtained in Alzheimer's disease human tissue samples and suggest that the endocannabinoid system may participate in the development of human immunodeficiency virus-induced encephalitis, because activation of CB2 receptors expressed by immune cells is likely to reduce their antiviral response and thus could favor the CNS entry of infected monocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXNr4cW4QrirVg90H21EOLACvtfcHk0li1RPf6RP7yWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1ygs74%253D&md5=12762f8109130916e997eb06db6fa166</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3923-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3923-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DW.%2BK.%26aulast%3DChavarria%26aufirst%3DI.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DTolon%26aufirst%3DR.%2BM.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DA%2520glial%2520endogenous%2520cannabinoid%2520system%2520is%2520upregulated%2520in%2520the%2520brains%2520of%2520macaques%2520with%2520simian%2520immunodeficiency%2520virus-induced%2520encephalitis%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D2530%26epage%3D2536%26doi%3D10.1523%2FJNEUROSCI.3923-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chakravarti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganju, R. K.</span><span> </span><span class="NLM_article-title">Cannabinoids as therapeutic agents in cancer: current status and future implications</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5852</span><span class="NLM_x">–</span> <span class="NLM_lpage">5872</span><span class="refDoi"> DOI: 10.18632/oncotarget.2233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.18632%2Foncotarget.2233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25115386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Fht1SgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5852-5872&author=B.+Chakravartiauthor=J.+Raviauthor=R.+K.+Ganju&title=Cannabinoids+as+therapeutic+agents+in+cancer%3A+current+status+and+future+implications&doi=10.18632%2Foncotarget.2233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids as therapeutic agents in cancer: current status and future implications</span></div><div class="casAuthors">Chakravarti Bandana; Ravi Janani; Ganju Ramesh K</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5852-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmacological importance of cannabinoids has been in study for several years.  Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant, (b) endogenous as well as (c) synthetic cannabinoids.  Though cannabinoids are clinically used for anti-palliative effects, recent studies open a promising possibility as anti-cancer agents.  They have been shown to possess anti-proliferative and anti-angiogenic effects in vitro as well as in vivo in different cancer models.  Cannabinoids regulate key cell signaling pathways that are involved in cell survival, invasion, angiogenesis, metastasis, etc.  There is more focus on CB1 and CB2, the two cannabinoid receptors which are activated by most of the cannabinoids.  In this review article, we will focus on a broad range of cannabinoids, their receptor dependent and receptor independent functional roles against various cancer types with respect to growth, metastasis, energy metabolism, immune environment, stemness and future perspectives in exploring new possible therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI4t9ZrFEBIXy-c-E1v-fmfW6udTcc2eY8G-pYNb3rELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Fht1SgtA%253D%253D&md5=a7337b09f46c5df725ab7ce07fd5fee5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2233%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarti%26aufirst%3DB.%26aulast%3DRavi%26aufirst%3DJ.%26aulast%3DGanju%26aufirst%3DR.%2BK.%26atitle%3DCannabinoids%2520as%2520therapeutic%2520agents%2520in%2520cancer%253A%2520current%2520status%2520and%2520future%2520implications%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D5852%26epage%3D5872%26doi%3D10.18632%2Foncotarget.2233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ellert-Miklaszewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciechomska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminska, B.</span><span> </span><span class="NLM_article-title">Cannabinoid signaling in glioma cells</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">986</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1007/978-94-007-4719-7_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1007%2F978-94-007-4719-7_11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=986&publication_year=2013&pages=209-220&author=A.+Ellert-Miklaszewskaauthor=I.+Ciechomskaauthor=B.+Kaminska&title=Cannabinoid+signaling+in+glioma+cells&doi=10.1007%2F978-94-007-4719-7_11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2F978-94-007-4719-7_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-94-007-4719-7_11%26sid%3Dliteratum%253Aachs%26aulast%3DEllert-Miklaszewska%26aufirst%3DA.%26aulast%3DCiechomska%26aufirst%3DI.%26aulast%3DKaminska%26aufirst%3DB.%26atitle%3DCannabinoid%2520signaling%2520in%2520glioma%2520cells%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2013%26volume%3D986%26spage%3D209%26epage%3D220%26doi%3D10.1007%2F978-94-007-4719-7_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Evens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G. M.</span><span> </span><span class="NLM_article-title">Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1543</span><span class="refDoi"> DOI: 10.2174/156802610793176819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.2174%2F156802610793176819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=20583994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ahtr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1527-1543&author=N.+Evensauthor=G.+M.+Bormans&title=Non-invasive+imaging+of+the+type+2+cannabinoid+receptor%2C+focus+on+positron+emission+tomography&doi=10.2174%2F156802610793176819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography</span></div><div class="casAuthors">Evens, Nele; Bormans, Guy M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1527-1543</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The type 2 cannabinoid receptor (CB2R) is a relatively new target for drug development, as the receptor was only discovered in 1993.  The CB2R is mainly expressed in tissues and organs related to the immune system.  However, in pathol. conditions, mostly inflammatory, a strong upregulation has been obsd.  Because of its expression in activated microglia, the type 2 cannabinoid receptor might play an important role in pathologies with a neuroinflammatory component.  Positron emission tomog. provides a sensitive non-invasive imaging technique to study and quantify receptor expression.  In this review, the importance of CB2R imaging, the current status and the future possibilities for the development of CB2R PET radioligands are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq56zuWZZDbYbVg90H21EOLACvtfcHk0ljnUg7q-TuhEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ahtr3O&md5=7145b2e47502b702015c9882d9f69389</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F156802610793176819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610793176819%26sid%3Dliteratum%253Aachs%26aulast%3DEvens%26aufirst%3DN.%26aulast%3DBormans%26aufirst%3DG.%2BM.%26atitle%3DNon-invasive%2520imaging%2520of%2520the%2520type%25202%2520cannabinoid%2520receptor%252C%2520focus%2520on%2520positron%2520emission%2520tomography%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D1527%26epage%3D1543%26doi%3D10.2174%2F156802610793176819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ory, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">PET radioligands for in vivo visualization of neuroinflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5897</span><span class="NLM_x">–</span> <span class="NLM_lpage">5913</span><span class="refDoi"> DOI: 10.2174/1381612820666140613120212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.2174%2F1381612820666140613120212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24939192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CntbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=5897-5913&author=D.+Oryauthor=S.+Celenauthor=A.+Verbruggenauthor=G.+Bormans&title=PET+radioligands+for+in+vivo+visualization+of+neuroinflammation&doi=10.2174%2F1381612820666140613120212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PET Radioligands for In Vivo Visualization of Neuroinflammation</span></div><div class="casAuthors">Ory, Dieter; Celen, Sofie; Verbruggen, Alfons; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5897-5913</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuroinflammation is a well-orchestrated, dynamic, multicellular process playing a major role in neurodegenerative disorders.  The microglia which make up the innate immune system of the central nervous system are key cellular mediators of neuroinflammatory processes.  In normal condition they exert a protective function, providing tissue repair by releasing anti-inflammatory cytokines and neurotrophic factors.  Upon neuronal injury or infection, they become overactivated, thereby releasing neurotoxic substances, amplifying neuroinflammation leading to neurodegeneration.  Positron emission tomog. (PET) provides a sensitive non-invasive imaging technique to study and quantify receptor and enzyme expression.  A radiolabeled tracer for a protein (over)expressed in neuroinflammation and more specifically for the overactivated microglia would be useful as a diagnostic tool in the follow-up of neuroinflammation progression and to study the efficacy of anti-inflammatory therapy over time.  In this manuscript, an overview of potential PET tracer targets upregulated during neuroinflammation is provided together with the current radiotracers used to image these targets.  In addn., lead structures to develop radiotracers for new targets are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXoaVwMntYOLVg90H21EOLACvtfcHk0liRxGqThqAh-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CntbfI&md5=73f79ddec9f9143b5bbbf9368de54dc7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140613120212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140613120212%26sid%3Dliteratum%253Aachs%26aulast%3DOry%26aufirst%3DD.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPET%2520radioligands%2520for%2520in%2520vivo%2520visualization%2520of%2520neuroinflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D5897%26epage%3D5913%26doi%3D10.2174%2F1381612820666140613120212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. Q.</span><span> </span><span class="NLM_article-title">Latest advances in novel cannabinoid CB<sub>2</sub> ligands for drug abuse and their therapeutic potential</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.4155/fmc.11.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.4155%2Ffmc.11.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=22300098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=187-204&author=P.+Yangauthor=L.+Wangauthor=X.+Q.+Xie&title=Latest+advances+in+novel+cannabinoid+CB2+ligands+for+drug+abuse+and+their+therapeutic+potential&doi=10.4155%2Ffmc.11.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Latest advances in novel cannabinoid CB2 ligands for drug abuse and their therapeutic potential</span></div><div class="casAuthors">Yang, Peng; Wang, Lirong; Xie, Xiang-Qun</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-204</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The field of cannabinoid (CB) drug research is experiencing a challenge as the CB1 antagonist Rimonabant, launched in 2006 as an anorectic/anti-obesity drug, was withdrawn from the European market due to the complications of suicide and depression as side effects.  There is interest in developing CB2 drugs without CB1 psychotropic side effects for drug-abuse treatment and therapeutic medication.  The CB1 receptor was discovered predominantly in the brain, whereas the CB2 is mainly expressed in peripheral cells and tissues, and is involved in immune signal transduction.  Conversely, the CB2 receptor was recently detected in the CNS, for example, in the microglial cells and the neurons.  While the CB2 neurons activity remains controversial, the CB2 receptor is an attractive therapeutic target for neuropathic pain, immune system, cancer and osteoporosis without psychoactivity.  This review addresses CB drug abuse and therapeutic potential with a focus on the most recent advances on new CB2 ligands from the literature as well as patents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo8oI_xh-woLVg90H21EOLACvtfcHk0liRxGqThqAh-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGgs7k%253D&md5=8aad3cf73fc56e4324889a942cd6287d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.179%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DX.%2BQ.%26atitle%3DLatest%2520advances%2520in%2520novel%2520cannabinoid%2520CB2%2520ligands%2520for%2520drug%2520abuse%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D187%26epage%3D204%26doi%3D10.4155%2Ffmc.11.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kohnz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span> </span><span class="NLM_article-title">Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6859</span><span class="NLM_x">–</span> <span class="NLM_lpage">6869</span><span class="refDoi"> DOI: 10.1039/C4CS00047A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1039%2FC4CS00047A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24676249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6859-6869&author=R.+A.+Kohnzauthor=D.+K.+Nomura&title=Chemical+approaches+to+therapeutically+target+the+metabolism+and+signaling+of+the+endocannabinoid+2-AG+and+eicosanoids&doi=10.1039%2FC4CS00047A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids</span></div><div class="casAuthors">Kohnz, Rebecca A.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6859-6869</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid system, most popularly known as the target of the psychoactive component of marijuana, Δ9-tetrahydrocannabinol (THC), is a signaling network that modulates a diverse range of physiol. processes including nociception, behavior, cognitive function, appetite, metab., motor control, memory formation, and inflammation.  While THC and its derivs. have garnered notoriety in the eyes of the public, the endocannabinoid system consists of two endogenous signaling lipids, 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (anandamide), which activate cannabinoid receptors CB1 and CB2 in the nervous system and peripheral tissues.  This review will focus on the recent efforts to chem. manipulate 2-AG signaling through the development of inhibitors of the 2-AG-synthesizing enzyme diacylglycerol lipase (DAGL) or the 2-AG-degrading enzyme monoacylglycerol lipase (MAGL), and assessing the therapeutic potential of DAGL and MAGL inhibitors in pain, inflammation, degenerative diseases, tissue injury, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo061VrnQ7sP7Vg90H21EOLACvtfcHk0lhQ5qkHsMjTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtrjM&md5=930d2e70ae5741c872c870860b61d5a7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC4CS00047A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00047A%26sid%3Dliteratum%253Aachs%26aulast%3DKohnz%26aufirst%3DR.%2BA.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DChemical%2520approaches%2520to%2520therapeutically%2520target%2520the%2520metabolism%2520and%2520signaling%2520of%2520the%2520endocannabinoid%25202-AG%2520and%2520eicosanoids%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6859%26epage%3D6869%26doi%3D10.1039%2FC4CS00047A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Therapeutic utility of cannabinoid receptor type 2 (CB<sub>2</sub>) selective agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8224</span><span class="NLM_x">–</span> <span class="NLM_lpage">8256</span><span class="refDoi"> DOI: 10.1021/jm4005626</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005626" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeru7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8224-8256&author=S.+Hanauthor=J.+Thatteauthor=D.+J.+Buzardauthor=R.+M.+Jones&title=Therapeutic+utility+of+cannabinoid+receptor+type+2+%28CB2%29+selective+agonists&doi=10.1021%2Fjm4005626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists</span></div><div class="casAuthors">Han, Sangdon; Thatte, Jayant; Buzard, Daniel J.; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8224-8256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The cannabinoid receptor type 2 (CB2) is a class A GPCR that was cloned in 1993 while looking for an alternative receptor that could explain the pharmacol. properties of Δ9-tetrahydrocannabinol.  CB2 was identified among cDNAs based on its similarity in amino acid sequence to the CB1 receptor and helped provide an explanation for the established effects of cannabinoids on the immune system.  In addn. to the immune system, CB2 has widespread tissue expression and has been found in brain, peripheral nervous system, and gastrointestinal tract.  Several "mixed" cannabinoid agonists are currently in clin. use primarily for controlling pain, and it is believed that selective CB2 agonism may afford a superior analgesic agent devoid of the centrally mediated CB1 effects.  Thus, selective CB2 receptor agonists represent high value putative therapeutics for treating pain and other disease states.  In this Perspective, we seek to provide a concise update of progress in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqncpGbOhjA5bVg90H21EOLACvtfcHk0lhQ5qkHsMjTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeru7bO&md5=bb532e5c81b475aa04a3311a017c82f1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm4005626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005626%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DTherapeutic%2520utility%2520of%2520cannabinoid%2520receptor%2520type%25202%2520%2528CB2%2529%2520selective%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8224%26epage%3D8256%26doi%3D10.1021%2Fjm4005626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Aso, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, I.</span><span> </span><span class="NLM_article-title">Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.3389/fphar.2014.00037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.3389%2Ffphar.2014.00037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24634659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC2cflslSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=37&author=E.+Asoauthor=I.+Ferrer&title=Cannabinoids+for+treatment+of+Alzheimer%E2%80%99s+disease%3A+moving+toward+the+clinic&doi=10.3389%2Ffphar.2014.00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic</span></div><div class="casAuthors">Aso Ester; Ferrer Isidre</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">The limited effectiveness of current therapies against Alzheimer's disease (AD) highlights the need for intensifying research efforts devoted to developing new agents for preventing or retarding the disease process.  During the last few years, targeting the endogenous cannabinoid system has emerged as a potential therapeutic approach to treat Alzheimer.  The endocannabinoid system is composed by a number of cannabinoid receptors, including the well-characterized CB1 and CB2 receptors, with their endogenous ligands and the enzymes related to the synthesis and degradation of these endocannabinoid compounds.  Several findings indicate that the activation of both CB1 and CB2 receptors by natural or synthetic agonists, at non-psychoactive doses, have beneficial effects in Alzheimer experimental models by reducing the harmful β-amyloid peptide action and tau phosphorylation, as well as by promoting the brain's intrinsic repair mechanisms.  Moreover, endocannabinoid signaling has been demonstrated to modulate numerous concomitant pathological processes, including neuroinflammation, excitotoxicity, mitochondrial dysfunction, and oxidative stress.  The present paper summarizes the main experimental studies demonstrating the polyvalent properties of cannabinoid compounds for the treatment of AD, which together encourage progress toward a clinical trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCYty_MiAZP50d-O_J5C0AfW6udTcc2eazl99A2A4rRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflslSltg%253D%253D&md5=18ab4f10157b9f6be7cf343ed9c3bde5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00037%26sid%3Dliteratum%253Aachs%26aulast%3DAso%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DI.%26atitle%3DCannabinoids%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520moving%2520toward%2520the%2520clinic%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D37%26doi%3D10.3389%2Ffphar.2014.00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Varley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edison, P.</span><span> </span><span class="NLM_article-title">Imaging neuroinflammation in Alzheimer’s and other dementias: Recent advances and future directions</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.jalz.2014.08.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.jalz.2014.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25443857" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=1-11&author=J.+Varleyauthor=D.+J.+Brooksauthor=P.+Edison&title=Imaging+neuroinflammation+in+Alzheimer%E2%80%99s+and+other+dementias%3A+Recent+advances+and+future+directions&doi=10.1016%2Fj.jalz.2014.08.105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2014.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2014.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DVarley%26aufirst%3DJ.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DEdison%26aufirst%3DP.%26atitle%3DImaging%2520neuroinflammation%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520other%2520dementias%253A%2520Recent%2520advances%2520and%2520future%2520directions%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.jalz.2014.08.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Dhopeshwarkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span> </span><span class="NLM_article-title">CB<sub>2</sub> Cannabinoid receptors as a therapeutic target-what does the future hold?</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1124/mol.114.094649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1124%2Fmol.114.094649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25106425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12iu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=430-437&author=A.+Dhopeshwarkarauthor=K.+Mackie&title=CB2+Cannabinoid+receptors+as+a+therapeutic+target-what+does+the+future+hold%3F&doi=10.1124%2Fmol.114.094649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 cannabinoid receptors as a therapeutic target - what does the future hold?</span></div><div class="casAuthors">Dhopeshwarkar, Amey; Mackie, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">430-437, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The past decades have seen an exponential rise in our understanding of the endocannabinoid system, comprising CB1 and CB2 cannabinoid receptors, endogenous cannabinoids (endocannabinoids), and the enzymes that synthesize and degrade endocannabinoids.  The primary focus of this review is the CB2 receptor.  CB2 receptors have been the subject of considerable attention, primarily due to their promising therapeutic potential for treating various pathologies while avoiding the adverse psychotropic effects that can accompany CB1 receptor-based therapies.  With the appreciation that CB2-selective ligands show marked functional selectivity, there is a renewed opportunity to explore this promising area of research from both a mechanistic as well as a therapeutic perspective.  In this review, we summarize our present knowledge of CB2 receptor signaling, localization, and regulation.  We discuss the availability of genetic tools (and their limitations) to study CB2 receptors and also provide an update on preclin. data on CB2 agonists in pain models.  Finally, we suggest possible reasons for the failure of CB2 ligands in clin. pain trials and offer possible ways to move the field forward in a way that can help reconcile the inconsistencies between preclin. and clin. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtBsnApceQu7Vg90H21EOLACvtfcHk0lhYiQ9Gs1rzzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12iu7nN&md5=76d3335b4ef5194f805f67619466739b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.094649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.094649%26sid%3Dliteratum%253Aachs%26aulast%3DDhopeshwarkar%26aufirst%3DA.%26aulast%3DMackie%26aufirst%3DK.%26atitle%3DCB2%2520Cannabinoid%2520receptors%2520as%2520a%2520therapeutic%2520target-what%2520does%2520the%2520future%2520hold%253F%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D430%26epage%3D437%26doi%3D10.1124%2Fmol.114.094649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Slavik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cermak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ametamey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, L.</span><span> </span><span class="NLM_article-title">Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.2533/chimia.2014.208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.2533%2Fchimia.2014.208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=208-210&author=R.+Slavikauthor=D.+Bieriauthor=S.+Cermakauthor=A.+Mullerauthor=S.+D.+Kramerauthor=M.+Weberauthor=R.+Schibliauthor=S.+M.+Ametameyauthor=L.+Mu&title=Development+and+evaluation+of+novel+PET+tracers+for+imaging+cannabinoid+receptor+type+2+in+brain&doi=10.2533%2Fchimia.2014.208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2014.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2014.208%26sid%3Dliteratum%253Aachs%26aulast%3DSlavik%26aufirst%3DR.%26aulast%3DBieri%26aufirst%3DD.%26aulast%3DCermak%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DKramer%26aufirst%3DS.%2BD.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DMu%26aufirst%3DL.%26atitle%3DDevelopment%2520and%2520evaluation%2520of%2520novel%2520PET%2520tracers%2520for%2520imaging%2520cannabinoid%2520receptor%2520type%25202%2520in%2520brain%26jtitle%3DChimia%26date%3D2014%26volume%3D68%26spage%3D208%26epage%3D210%26doi%3D10.2533%2Fchimia.2014.208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Horti, A. G.; Raymont, V.; Terry, G. E.</span><span> </span><span class="NLM_article-title">PET imaging of endocannabinoid system</span>. In  <span class="citation_source-book">PET and SPECT of Neurobiological Systems</span>; <span class="NLM_contrib-group">Dierckx, R. A. J. O.; Otte, A.; de Vries, E. F. J.; van Waarde, A.; Luiten, P. G. M.</span>, Eds.; <span class="NLM_publisher-name">Springer:</span><span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1007%2F978-3-642-42014-6_11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=249-319&author=A.+G.+Horti&author=V.+Raymont&author=G.+E.+Terryauthor=R.+A.+J.+O.+Dierckx&author=A.+Otte&author=E.+F.+J.+de+Vries&author=A.+van+Waarde&author=P.+G.+M.+Luiten&title=PET+and+SPECT+of+Neurobiological+Systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-42014-6_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-42014-6_11%26sid%3Dliteratum%253Aachs%26aulast%3DHorti%26aufirst%3DA.%2BG.%26atitle%3DPET%2520imaging%2520of%2520endocannabinoid%2520system%26btitle%3DPET%2520and%2520SPECT%2520of%2520Neurobiological%2520Systems%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26pub%3DSpringer%253A%26date%3D2014%26spage%3D249%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Casteels, C.; Ahmad, R.; Vandenbulcke, M.; Vandenberghe, W.; Van Laere, K.</span><span> </span><span class="NLM_article-title">Chapter 4 - Cannabinoids and Huntington’s disease</span>. In  <span class="citation_source-book">Cannabinoids in Neurologic and Mental Disease</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2FB978-0-12-417041-4.00004-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=61-97&author=C.+Casteels&author=R.+Ahmad&author=M.+Vandenbulcke&author=W.+Vandenberghe&author=K.+Van+Laere&title=Cannabinoids+in+Neurologic+and+Mental+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417041-4.00004-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-417041-4.00004-7%26sid%3Dliteratum%253Aachs%26aulast%3DCasteels%26aufirst%3DC.%26atitle%3DChapter%25204%2520-%2520Cannabinoids%2520and%2520Huntington%25E2%2580%2599s%2520disease%26btitle%3DCannabinoids%2520in%2520Neurologic%2520and%2520Mental%2520Disease%26pub%3DAcademic%2520Press%26date%3D2015%26spage%3D61%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Horti, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savonenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span> </span><span class="NLM_article-title">Synthesis and biodistribution of [<sup>11</sup>C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB<sub>2</sub>)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5202</span><span class="NLM_x">–</span> <span class="NLM_lpage">5207</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.05.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.bmc.2010.05.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=20554448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3cXoslagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5202-5207&author=A.+G.+Hortiauthor=Y.+Gaoauthor=H.+T.+Ravertauthor=P.+Finleyauthor=H.+Valentineauthor=D.+F.+Wongauthor=C.+J.+Endresauthor=A.+V.+Savonenkoauthor=R.+F.+Dannals&title=Synthesis+and+biodistribution+of+%5B11C%5DA-836339%2C+a+new+potential+radioligand+for+PET+imaging+of+cannabinoid+type+2+receptors+%28CB2%29&doi=10.1016%2Fj.bmc.2010.05.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2)</span></div><div class="casAuthors">Horti, Andrew G.; Gao, Yongjun; Ravert, Hayden T.; Finley, Paige; Valentine, Heather; Wong, Dean F.; Endres, Christopher J.; Savonenko, Alena V.; Dannals, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5202-5207</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently, A-836339 [2,2,3,3-tetramethylcyclopropanecarboxylic acid [3-(2-methoxyethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]amide] (1) was reported to be a selective CB2 agonist with high binding affinity.  Here we describe the radiosynthesis of [11C]A-836339 ([11C]1) via its desmethyl precursor as a candidate radioligand for imaging CB2 receptors with positron-emission tomog. (PET).  Whole body and the regional brain distribution of [11C]1 in control CD1 mice demonstrated that this radioligand exhibits specific uptake in the CB2-rich spleen and little specific in vivo binding in the control mouse brain.  However, [11C]1 shows specific cerebral uptake in the lipopolysaccharide (LPS)-induced mouse model of neuroinflammation and in the brain areas with Aβ amyloid plaque deposition in a mouse model of Alzheimer's disease (APPswe/PS1dE9 mice).  These data establish a proof of principle that CB2 receptors binding in the neuroinflammation and related disorders can be measured in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrriR2pw_HawbVg90H21EOLACvtfcHk0lhYiQ9Gs1rzzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXoslagurc%253D&md5=1baba739bf8db92d34ac41f16906482c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.058%26sid%3Dliteratum%253Aachs%26aulast%3DHorti%26aufirst%3DA.%2BG.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DFinley%26aufirst%3DP.%26aulast%3DValentine%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DEndres%26aufirst%3DC.%2BJ.%26aulast%3DSavonenko%26aufirst%3DA.%2BV.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26atitle%3DSynthesis%2520and%2520biodistribution%2520of%2520%255B11C%255DA-836339%252C%2520a%2520new%2520potential%2520radioligand%2520for%2520PET%2520imaging%2520of%2520cannabinoid%2520type%25202%2520receptors%2520%2528CB2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5202%26epage%3D5207%26doi%3D10.1016%2Fj.bmc.2010.05.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Savonenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnikova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayyida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiatt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A. G.</span><span> </span><span class="NLM_article-title">Cannabinoid CB<sub>2</sub> receptors in a mouse model of Aβ amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0129618</span><span class="refDoi"> DOI: 10.1371/journal.pone.0129618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1371%2Fjournal.pone.0129618" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0129618&author=A.+V.+Savonenkoauthor=T.+Melnikovaauthor=Y.+Wangauthor=H.+Ravertauthor=Y.+Gaoauthor=J.+Koppelauthor=D.+Leeauthor=O.+Pletnikovaauthor=E.+Choauthor=N.+Sayyidaauthor=A.+Hiattauthor=J.+Troncosoauthor=P.+Daviesauthor=R.+F.+Dannalsauthor=M.+G.+Pomperauthor=A.+G.+Horti&title=Cannabinoid+CB2+receptors+in+a+mouse+model+of+A%CE%B2+amyloidosis%3A+immunohistochemical+analysis+and+suitability+as+a+PET+biomarker+of+neuroinflammation&doi=10.1371%2Fjournal.pone.0129618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0129618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0129618%26sid%3Dliteratum%253Aachs%26aulast%3DSavonenko%26aufirst%3DA.%2BV.%26aulast%3DMelnikova%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRavert%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DKoppel%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DPletnikova%26aufirst%3DO.%26aulast%3DCho%26aufirst%3DE.%26aulast%3DSayyida%26aufirst%3DN.%26aulast%3DHiatt%26aufirst%3DA.%26aulast%3DTroncoso%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DHorti%26aufirst%3DA.%2BG.%26atitle%3DCannabinoid%2520CB2%2520receptors%2520in%2520a%2520mouse%2520model%2520of%2520A%25CE%25B2%2520amyloidosis%253A%2520immunohistochemical%2520analysis%2520and%2520suitability%2520as%2520a%2520PET%2520biomarker%2520of%2520neuroinflammation%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0129618%26doi%3D10.1371%2Fjournal.pone.0129618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Evens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandeputte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coolen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciot, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G. M.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of [<sup>11</sup>C]NE40, a type 2 cannabinoid receptor PET tracer</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2011.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.nucmedbio.2011.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=22154685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Oqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=389-399&author=N.+Evensauthor=C.+Vandeputteauthor=C.+Coolenauthor=P.+Janssenauthor=R.+Sciotauthor=V.+Baekelandtauthor=A.+M.+Verbruggenauthor=Z.+Debyserauthor=K.+Van+Laereauthor=G.+M.+Bormans&title=Preclinical+evaluation+of+%5B11C%5DNE40%2C+a+type+2+cannabinoid+receptor+PET+tracer&doi=10.1016%2Fj.nucmedbio.2011.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer</span></div><div class="casAuthors">Evens, Nele; Vandeputte, Caroline; Coolen, Charlotte; Janssen, Peter; Sciot, Raf; Baekelandt, Veerle; Verbruggen, Alfons M.; Debyser, Zeger; Van Laere, Koen; Bormans, Guy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Up-regulation of the type 2 cannabinoid receptor (CB2R) has been reported in (neuro)inflammatory diseases.  In this study, we report the preclin. evaluation of [11C]NE40 as positron emission tomog. (PET) radioligand for visualization of the CB2R.  The selectivity of NE40 for CB2R and its toxicity and mutagenicity were detd.  [11C]NE40 was evaluated by biodistribution and autoradiog. studies in normal rats and a microPET study in normal mice, rats and a rhesus monkey.  Specific in vivo binding of [11C]NE40 to human CB2R (hCB2R) was studied in a rat model with hCB2R overexpression.[11C]NE40 shows specific CB2R binding in the spleen and blood of normal rats and high brain uptake in rhesus monkey.  [11C]NE40 showed specific and reversible binding to hCB2R in vivo in a rat model with local hCB2R overexpression.  [11C]NE40 shows favorable characteristics as radioligand for in vivo visualization of the CB2R and is a promising candidate for hCB2R PET imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJz5-qNs-FbVg90H21EOLACvtfcHk0lipZ10ijVuGlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Oqu7k%253D&md5=be1c9b2ff6196d6f7cbe5f4ab02150bb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2011.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2011.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DEvens%26aufirst%3DN.%26aulast%3DVandeputte%26aufirst%3DC.%26aulast%3DCoolen%26aufirst%3DC.%26aulast%3DJanssen%26aufirst%3DP.%26aulast%3DSciot%26aufirst%3DR.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DVerbruggen%26aufirst%3DA.%2BM.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DBormans%26aufirst%3DG.%2BM.%26atitle%3DPreclinical%2520evaluation%2520of%2520%255B11C%255DNE40%252C%2520a%2520type%25202%2520cannabinoid%2520receptor%2520PET%2520tracer%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2012%26volume%3D39%26spage%3D389%26epage%3D399%26doi%3D10.1016%2Fj.nucmedbio.2011.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span> </span><span class="NLM_article-title">Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [<sup>11</sup>C]NE40 in healthy subjects</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1007/s11307-013-0626-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1007%2Fs11307-013-0626-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=23508466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC3svnsFSlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=384-390&author=R.+Ahmadauthor=M.+Kooleauthor=N.+Evensauthor=K.+Serdonsauthor=A.+Verbruggenauthor=G.+Bormansauthor=K.+Van+Laere&title=Whole-body+biodistribution+and+radiation+dosimetry+of+the+cannabinoid+type+2+receptor+ligand+%5B11C%5DNE40+in+healthy+subjects&doi=10.1007%2Fs11307-013-0626-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects</span></div><div class="casAuthors">Ahmad Rawaha; Koole Michel; Evens Nele; Serdons Kim; Verbruggen Alfons; Bormans Guy; Van Laere Koen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">384-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The type 2 cannabinoid receptor (CB2R) is part of the human endocannabinoid system and is involved in central and peripheral inflammatory processes.  In vivo imaging of the CB2R would allow study of several (neuro)inflammatory disorders.  In this study we have investigated the safety and tolerability of [11C]-NE40, a CB2R positron emission tomography (PET) ligand, in healthy human male subjects and determined its biodistribution and radiation dosimetry.  PROCEDURE:  Six healthy male subjects (age 20-65 years) underwent a dynamic series of nine whole-body PET/CT scans for up to 140 min, after injection of an average bolus of 286 MBq of [11C]-NE40.  Organ absorbed and total effective doses were calculated through OLINDA.  RESULTS:  [11C]-NE40 showed high initial uptake in the spleen and a predominant hepatobiliary excretion.  In the brain, rapid uptake and swift washout were seen.  Organ absorbed doses were largest for the small intestine and liver, with 15.6 and 11.5 μGy/MBq, respectively.  The mean effective dose was 3.64±0.81 μSv/MBq.  There were no changes with aging observed.  No adverse events were encountered.  CONCLUSIONS:  This first-in-man study of [11C]-NE40 showed an expected biodistribution compatible with lymphoid tissue uptake and appropriate fast brain kinetics in the healthy human brain, underscoring the potential of this tracer for further application in central and peripheral inflammation imaging.  The effective dose is within the typical expected range for 11C ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFnNFqZ5cQjxe4jJGKT5N0fW6udTcc2eZIYOXqJgY3aLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svnsFSlsQ%253D%253D&md5=e0371073d056817582cb62788e4bf19c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs11307-013-0626-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-013-0626-y%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DEvens%26aufirst%3DN.%26aulast%3DSerdons%26aufirst%3DK.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26atitle%3DWhole-body%2520biodistribution%2520and%2520radiation%2520dosimetry%2520of%2520the%2520cannabinoid%2520type%25202%2520receptor%2520ligand%2520%255B11C%255DNE40%2520in%2520healthy%2520subjects%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2013%26volume%3D15%26spage%3D384%26epage%3D390%26doi%3D10.1007%2Fs11307-013-0626-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Postnov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versijpt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenbulcke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaqub, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span> </span><span class="NLM_article-title">Quantification of [<sup>11</sup>C]NE40, a novel PET radioligand for CB<sub>2</sub> receptor imaging</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=188&author=A.+Postnovauthor=R.+Ahmadauthor=N.+Evensauthor=J.+Versijptauthor=M.+Vandenbulckeauthor=M.+Yaqubauthor=A.+Verbruggenauthor=G.+Bormansauthor=W.+Vandenbergheauthor=K.+Van+Laere&title=Quantification+of+%5B11C%5DNE40%2C+a+novel+PET+radioligand+for+CB2+receptor+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPostnov%26aufirst%3DA.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DEvens%26aufirst%3DN.%26aulast%3DVersijpt%26aufirst%3DJ.%26aulast%3DVandenbulcke%26aufirst%3DM.%26aulast%3DYaqub%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVandenberghe%26aufirst%3DW.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26atitle%3DQuantification%2520of%2520%255B11C%255DNE40%252C%2520a%2520novel%2520PET%2520radioligand%2520for%2520CB2%2520receptor%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Hortala, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oustric, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury-Donat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alagille, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barret, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagnan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, F.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB<sub>2</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.bmcl.2013.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24291040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVOhs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=283-287&author=L.+Hortalaauthor=J.+Arnaudauthor=P.+Rouxauthor=D.+Oustricauthor=L.+Bouluauthor=F.+Oury-Donatauthor=P.+Avenetauthor=T.+Rooneyauthor=D.+Alagilleauthor=O.+Barretauthor=G.+Tamagnanauthor=F.+Barth&title=Synthesis+and+preliminary+evaluation+of+a+new+fluorine-18+labelled+triazine+derivative+for+PET+imaging+of+cannabinoid+CB2+receptor&doi=10.1016%2Fj.bmcl.2013.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor</span></div><div class="casAuthors">Hortala, Laurent; Arnaud, Joelle; Roux, Pascale; Oustric, Didier; Boulu, Laurent; Oury-Donat, Florence; Avenet, Patrick; Rooney, Thomas; Alagille, David; Barret, Olivier; Tamagnan, Gilles; Barth, Francis</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-287</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cannabinoid CB2 PET tracers are considered as a promising alternative to PBR/TSPO tracers for the in-vivo imaging of neuroinflammation.  We describe here the synthesis and characterization of compd. I, a new potent and brain penetrating CB2 ligand based on an original triazine template.  The PET tracer [18F]-dideutero-I (II) was prepd. in a three steps radiosynthesis, and demonstrated significant uptake in rhesus macaque and baboon brain with a max. SUV of about 0.7-0.9 g/mL, followed by a moderate washout over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOttCEg3j-SLVg90H21EOLACvtfcHk0liC0z-7hBjhxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVOhs7zM&md5=280f4f22351c8468b1147c9dac62d766</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DHortala%26aufirst%3DL.%26aulast%3DArnaud%26aufirst%3DJ.%26aulast%3DRoux%26aufirst%3DP.%26aulast%3DOustric%26aufirst%3DD.%26aulast%3DBoulu%26aufirst%3DL.%26aulast%3DOury-Donat%26aufirst%3DF.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DRooney%26aufirst%3DT.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DTamagnan%26aufirst%3DG.%26aulast%3DBarth%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520preliminary%2520evaluation%2520of%2520a%2520new%2520fluorine-18%2520labelled%2520triazine%2520derivative%2520for%2520PET%2520imaging%2520of%2520cannabinoid%2520CB2%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D283%26epage%3D287%26doi%3D10.1016%2Fj.bmcl.2013.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Yrjölä, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarparanta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Airaksinen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hytti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauppinen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasonen-Seppanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adinolfi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keinanen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkari, T.</span><span> </span><span class="NLM_article-title">Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB<sub>2</sub> receptor agonists</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1016/j.ejps.2014.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.ejps.2014.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25447744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCnt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=85-96&author=S.+Yrj%C3%B6l%C3%A4author=M.+Sarparantaauthor=A.+J.+Airaksinenauthor=M.+Hyttiauthor=A.+Kauppinenauthor=S.+Pasonen-Seppanenauthor=B.+Adinolfiauthor=P.+Nieriauthor=C.+Maneraauthor=O.+Keinanenauthor=A.+Posoauthor=T.+J.+Nevalainenauthor=T.+Parkkari&title=Synthesis%2C+in+vitro+and+in+vivo+evaluation+of+1%2C3%2C5-triazines+as+cannabinoid+CB2+receptor+agonists&doi=10.1016%2Fj.ejps.2014.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists</span></div><div class="casAuthors">Yrjola, Sari; Sarparanta, Mirkka; Airaksinen, Anu J.; Hytti, Maria; Kauppinen, Anu; Pasonen-Seppanen, Sanna; Adinolfi, Barbara; Nieri, Paola; Manera, Clementina; Keinanen, Outi; Poso, Antti; Nevalainen, Tapio J.; Parkkari, Teija</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-96</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The cannabinoid receptors type 2 (CBR2) are attractive therapeutic targets of the endocannabinoid signaling system (ECS) as they are not displaying the undesired psychotropic and cardiovascular side-effects seen with cannabinoid receptor type 1 (CB1R) agonists.  In continuation of our previous work on 2,4,6-trisubstituted 1,3,5-triazines as potent CB2 agonists, we synthesized an addnl. series of more polar analogs (1-10), which were found to possess high CB2R agonist activity with enhanced water soly.  The most potent compd. in the series was N-(adamantan-1-yl)-4-ethoxy-6-(4-(2-fluoroethyl)piperazin-1-yl)-1,3,5-triazin-2-amine (9) with EC50 value of 0.60 nM.  To further evaluate the biol. effects of the compds., the selected compds. were tested in vitro against four different cell lines.  A human retinal pigment epithelial cell line (ARPE-19) was used to evaluate the cytotoxicity of the compds. whereas an androgen-sensitive human prostate adenocarcinoma cell line (LNCaP), a Jurkat leukemia cell line and a C8161 melanoma cell line were used to assess the antiproliferative activity of the compds.  The most interesting results were obtained for N-(adamantan-1-yl)-4-ethoxy-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-amine (6), which induced cell viability decrease in prostate and leukemia cell lines, and diminished proliferation of C8161 melanoma cells.  The results could be reversed in leukemia cells with the selective CB2R antagonist AM630, whereas in prostate cells the AM630 induced a significant cell viability decrease with a mechanism probably unlinked to CB2 cannabinoid receptor.  The antiproliferative effect of 6 on the melanoma cells seemed not to be mediated via the CB1R or CB2R.  No cytotoxicity was detected against ARPE-19 cell line at concns. of 1 and 10 μM for compd. 6.  However, at 30 μM concn. the compd. 6 decreased the cell viability.  Finally, in order to est. in vivo behavior of these compds., 18F labeled PET ligand, N-cyclopentyl-4-ethoxy-6-(4-(2-fluoro-18-ethyl)piperazin-1-yl)-1,3,5-triazin-2-amine ([18F]5), was synthesized and its biodistribution was detd. in healthy male Sprague-Dawley rats.  As a result, the tracer showed a rapid (<15 min) elimination in urine accompanied by a slower excretion via the hepatobiliary route.  In conclusion, we further demonstrated that 1,3,5-triazine scaffold serves as a suitable template for the design of highly potent CB2R agonists with reasonable water soly. properties.  The compds. may be useful when studying the role of the endocannabinoid system in different diseases.  The triazine scaffold is also a promising candidate for the development of new CB2R PET ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_1aEvtEgaW7Vg90H21EOLACvtfcHk0liC0z-7hBjhxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCnt7bL&md5=8153b8fd95235ae3541e6bf209eef499</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2014.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2014.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DYrj%25C3%25B6l%25C3%25A4%26aufirst%3DS.%26aulast%3DSarparanta%26aufirst%3DM.%26aulast%3DAiraksinen%26aufirst%3DA.%2BJ.%26aulast%3DHytti%26aufirst%3DM.%26aulast%3DKauppinen%26aufirst%3DA.%26aulast%3DPasonen-Seppanen%26aufirst%3DS.%26aulast%3DAdinolfi%26aufirst%3DB.%26aulast%3DNieri%26aufirst%3DP.%26aulast%3DManera%26aufirst%3DC.%26aulast%3DKeinanen%26aufirst%3DO.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DNevalainen%26aufirst%3DT.%2BJ.%26aulast%3DParkkari%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%25201%252C3%252C5-triazines%2520as%2520cannabinoid%2520CB2%2520receptor%2520agonists%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D67%26spage%3D85%26epage%3D96%26doi%3D10.1016%2Fj.ejps.2014.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Slavik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herde, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ametamey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, L.</span><span> </span><span class="NLM_article-title">Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92c</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.ejmech.2015.01.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92c&publication_year=2015&pages=554-564&author=R.+Slavikauthor=A.+M.+Herdeauthor=D.+Bieriauthor=M.+Weberauthor=R.+Schibliauthor=S.+D.+Kramerauthor=S.+M.+Ametameyauthor=L.+Mu&title=Synthesis%2C+radiolabeling+and+evaluation+of+novel+4-oxo-quinoline+derivatives+as+PET+tracers+for+imaging+cannabinoid+type+2+receptor&doi=10.1016%2Fj.ejmech.2015.01.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DSlavik%26aufirst%3DR.%26aulast%3DHerde%26aufirst%3DA.%2BM.%26aulast%3DBieri%26aufirst%3DD.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DKramer%26aufirst%3DS.%2BD.%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DMu%26aufirst%3DL.%26atitle%3DSynthesis%252C%2520radiolabeling%2520and%2520evaluation%2520of%2520novel%25204-oxo-quinoline%2520derivatives%2520as%2520PET%2520tracers%2520for%2520imaging%2520cannabinoid%2520type%25202%2520receptor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92c%26spage%3D554%26epage%3D564%26doi%3D10.1016%2Fj.ejmech.2015.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Slavik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grether, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller Herde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fingerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krämer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ametamey, S. M.</span><span> </span><span class="NLM_article-title">Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4266</span><span class="NLM_x">–</span> <span class="NLM_lpage">4277</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00283</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00283" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVSntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4266-4277&author=R.+Slavikauthor=U.+Gretherauthor=A.+M%C3%BCller+Herdeauthor=L.+Gobbiauthor=J.+Fingerleauthor=C.+Ullmerauthor=S.+D.+Kr%C3%A4merauthor=R.+Schibliauthor=L.+Muauthor=S.+M.+Ametamey&title=Discovery+of+a+high+affinity+and+selective+pyridine+analog+as+a+potential+positron+emission+tomography+imaging+agent+for+cannabinoid+type+2+receptor&doi=10.1021%2Facs.jmedchem.5b00283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a High Affinity and Selective Pyridine Analog as a Potential Positron Emission Tomography Imaging Agent for Cannabinoid Type 2 Receptor</span></div><div class="casAuthors">Slavik, Roger; Grether, Uwe; Muller Herde, Adrienne; Gobbi, Luca; Fingerle, Jurgen; Ullmer, Christoph; Kramer, Stefanie D.; Schibli, Roger; Mu, Linjing; Ametamey, Simon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4266-4277</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our efforts to develop CB2 PET imaging agents, we investigated 2,5,6-substituted pyridines as a novel class of potential CB2 PET ligands.  A total of 21 novel compds. were designed, synthesized, and evaluated for their potency and binding properties toward human and rodent CB1 and CB2.  The most promising ligand 6a was radiolabeled with carbon-11 to yield 16 ([11C]RSR-056).  Specific binding of 16 to CB2-pos. spleen tissue of rats and mice was demonstrated by in vitro autogadiog. and verified in vivo in PET and biodistribution expts.  Furthermore, 16 was evaluated in a lipopolysaccharid (LPS) induced murine model of neuroinflammation.  Brain radioactivity was strikingly higher in the LPS-treated mice than the control mice.  Compd. 16 is a promising radiotracer for imaging CB2 in rodents.  It might serve as a tool for the investigation of CB2 receptor expression levels in healthy tissues and different neuroinflammatory disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWUcSCaQyFerVg90H21EOLACvtfcHk0ljJQW-LGh3A1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVSntr8%253D&md5=ed007d65ae82025274ddc73ec0668220</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00283%26sid%3Dliteratum%253Aachs%26aulast%3DSlavik%26aufirst%3DR.%26aulast%3DGrether%26aufirst%3DU.%26aulast%3DM%25C3%25BCller%2BHerde%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DL.%26aulast%3DFingerle%26aufirst%3DJ.%26aulast%3DUllmer%26aufirst%3DC.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DS.%2BD.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DMu%26aufirst%3DL.%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520high%2520affinity%2520and%2520selective%2520pyridine%2520analog%2520as%2520a%2520potential%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520cannabinoid%2520type%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4266%26epage%3D4277%26doi%3D10.1021%2Facs.jmedchem.5b00283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Dart, M. J.; Carroll, W. A.; Florjancic, A. S.; Frost, J. M.; Gallagher, M. E.; Li, T.; Nelson, D. W.; Patel, M. V.; Peddi, S.; Perez-Medrano, A.</span><span> </span><span class="NLM_article-title">Thiazole compounds as cannabinoid receptor ligands and uses thereof</span>. In WO2007140385 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+J.+Dart&author=W.+A.+Carroll&author=A.+S.+Florjancic&author=J.+M.+Frost&author=M.+E.+Gallagher&author=T.+Li&author=D.+W.+Nelson&author=M.+V.+Patel&author=S.+Peddi&author=A.+Perez-Medrano&title=Thiazole+compounds+as+cannabinoid+receptor+ligands+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDart%26aufirst%3DM.%2BJ.%26atitle%3DThiazole%2520compounds%2520as%2520cannabinoid%2520receptor%2520ligands%2520and%2520uses%2520thereof%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daza, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrison, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Kouhen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wensink, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovcimak, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hradil, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Characterization of a cannabinoid CB<sub>2</sub> receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2<i>Z</i>)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1124/jpet.108.145011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1124%2Fjpet.108.145011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=18931146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFyltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=141-151&author=B.+B.+Yaoauthor=G.+Hsiehauthor=A.+V.+Dazaauthor=Y.+Fanauthor=G.+K.+Graysonauthor=T.+R.+Garrisonauthor=O.+El+Kouhenauthor=B.+A.+Hookerauthor=M.+Paiauthor=E.+J.+Wensinkauthor=A.+K.+Salyersauthor=P.+Chandranauthor=C.+Z.+Zhuauthor=C.+Zhongauthor=K.+Rytherauthor=M.+E.+Gallagherauthor=C.+L.+Chinauthor=A.+E.+Tovcimakauthor=V.+P.+Hradilauthor=G.+B.+Foxauthor=M.+J.+Dartauthor=P.+Honoreauthor=M.+D.+Meyer&title=Characterization+of+a+cannabinoid+CB2+receptor-selective+agonist%2C+A-836339+%5B2%2C2%2C3%2C3-tetramethyl-cyclopropanecarboxylic+acid+%5B3-%282-methoxy-ethyl%29-4%2C5-dimethyl-3H-thiazol-%282Z%29-ylidene%5D-amide%5D%2C+using+in+vitro+pharmacological+assays%2C+in+vivo+pain+models%2C+and+pharmacological+magnetic+resonance+imaging&doi=10.1124%2Fjpet.108.145011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethylcyclopropanecarboxylic acid[3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging</span></div><div class="casAuthors">Yao, Betty B.; Hsieh, Gin; Daza, Anthony V.; Fan, Yihong; Grayson, George K.; Garrison, Tiffany Runyan; El Kouhen, Odile; Hooker, Bradley A.; Pai, Madhavi; Wensink, Erica J.; Salyers, Anita K.; Chandran, Prasant; Zhu, Chang Z.; Zhong, Chengmin; Ryther, Keith; Gallagher, Megan E.; Chin, Chih-Liang; Tovcimak, Ann E.; Hradil, Vincent P.; Fox, Gerard B.; Dart, Michael J.; Honore, Prisca; Meyer, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-151</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Studies demonstrating the antihyperalgesic and antiallodynic effects of cannabinoid CB2 receptor activation have been largely derived from the use of receptor-selective ligands.  Here, we report the identification of A-836339, a potent and selective CB2 agonist as characterized in in vitro pharmacol. assays and in in vivo models of pain and central nervous system (CNS) behavior models.  In radioligand binding assays, A-836339 displays high affinities at CB2 receptors and selectivity over CB1 receptors in both human and rat.  Likewise, A-836339 exhibits high potencies at CB2 and selectivity over CB1 receptors in recombinant fluorescence imaging plate reader and cyclase functional assays.  In addn. A-836339 exhibits a profile devoid of significant affinity at other G-protein-coupled receptors and ion channels.  A-836339 was characterized extensively in various animal pain models.  In the complete Freund's adjuvant model of inflammatory pain, A-836339 exhibits a potent CB2 receptor-mediated antihyperalgesic effect that is independent of CB1 or μ-opioid receptors.  A-836339 has also demonstrated efficacies in the chronic constrain injury (CCI) model of neuropathic pain, skin incision, and capsaicin-induced secondary mech. hyperalgesia models.  Furthermore, no tolerance was developed in the CCI model after subchronic treatment with A-836339 for 5 days.  In assessing CNS effects, A-836339 exhibited a CB1 receptor-mediated decrease of spontaneous locomotor activities at a higher dose, a finding consistent with the CNS activation pattern obsd. by pharmacol. magnetic resonance imaging.  These data demonstrate that A-836339 is a useful tool for use of studying CB2 receptor pharmacol. and for investigation of the role of CB2 receptor modulation for treatment of pain in preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0wl8VQFmZm7Vg90H21EOLACvtfcHk0ljJQW-LGh3A1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFyltA%253D%253D&md5=d0b75d4aaccbf1a8c30ba5c68383a417</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.145011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.145011%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DEl%2BKouhen%26aufirst%3DO.%26aulast%3DHooker%26aufirst%3DB.%2BA.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DWensink%26aufirst%3DE.%2BJ.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DRyther%26aufirst%3DK.%26aulast%3DGallagher%26aufirst%3DM.%2BE.%26aulast%3DChin%26aufirst%3DC.%2BL.%26aulast%3DTovcimak%26aufirst%3DA.%2BE.%26aulast%3DHradil%26aufirst%3DV.%2BP.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DCharacterization%2520of%2520a%2520cannabinoid%2520CB2%2520receptor-selective%2520agonist%252C%2520A-836339%2520%255B2%252C2%252C3%252C3-tetramethyl-cyclopropanecarboxylic%2520acid%2520%255B3-%25282-methoxy-ethyl%2529-4%252C5-dimethyl-3H-thiazol-%25282Z%2529-ylidene%255D-amide%255D%252C%2520using%2520in%2520vitro%2520pharmacological%2520assays%252C%2520in%2520vivo%2520pain%2520models%252C%2520and%2520pharmacological%2520magnetic%2520resonance%2520imaging%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D141%26epage%3D151%26doi%3D10.1124%2Fjpet.108.145011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Friscourt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrni, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boons, G.-J.</span><span> </span><span class="NLM_article-title">A fluorogenic probe for the catalyst-free detection of azide-tagged molecules</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">18809</span><span class="NLM_x">–</span> <span class="NLM_lpage">18815</span><span class="refDoi"> DOI: 10.1021/ja309000s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja309000s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=18809-18815&author=F.+Friscourtauthor=C.+J.+Fahrniauthor=G.-J.+Boons&title=A+fluorogenic+probe+for+the+catalyst-free+detection+of+azide-tagged+molecules&doi=10.1021%2Fja309000s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluorogenic Probe for the Catalyst-Free Detection of Azide-Tagged Molecules</span></div><div class="casAuthors">Friscourt, Frederic; Fahrni, Christoph J.; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18809-18815</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fluorogenic reactions in which non- or weakly fluorescent reagents produce highly fluorescent products can be exploited to detect a broad range of compds. including biomols. and materials.  The authors describe a modified dibenzocyclooctyne (I) that under catalyst-free conditions undergoes fast strain-promoted cycloaddns. with azides to yield strongly fluorescent triazoles.  The cycloaddn. products are >1000-fold brighter compared to the starting cyclooctyne, exhibit large Stokes shift, and can be excited >350 nm, which is required for many applications.  Quantum mech. calcns. indicate that the fluorescence increase upon triazole formation is due to large differences in oscillator strengths of the S0 ↔ S1 transitions in the planar C2v-sym. starting material compared to the symmetry-broken and nonplanar cycloaddn. products.  The new fluorogenic probe was successfully employed for labeling of proteins modified by an azide moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2YAi1WGtmhrVg90H21EOLACvtfcHk0lhfJflaLRUs1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmurrJ&md5=c813b5576f2aac2d64ac6429c118e49e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja309000s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja309000s%26sid%3Dliteratum%253Aachs%26aulast%3DFriscourt%26aufirst%3DF.%26aulast%3DFahrni%26aufirst%3DC.%2BJ.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DA%2520fluorogenic%2520probe%2520for%2520the%2520catalyst-free%2520detection%2520of%2520azide-tagged%2520molecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D18809%26epage%3D18815%26doi%3D10.1021%2Fja309000s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Cui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel <sup>18</sup>F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9283</span><span class="NLM_x">–</span> <span class="NLM_lpage">9296</span><span class="refDoi"> DOI: 10.1021/jm300973k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300973k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9283-9296&author=M.+Cuiauthor=X.+Wangauthor=P.+Yuauthor=J.+Zhangauthor=Z.+Liauthor=X.+Zhangauthor=Y.+Yangauthor=M.+Onoauthor=H.+Jiaauthor=H.+Sajiauthor=B.+Liu&title=Synthesis+and+evaluation+of+novel+18F+labeled+2-pyridinylbenzoxazole+and+2-pyridinylbenzothiazole+derivatives+as+ligands+for+positron+emission+tomography+%28PET%29+imaging+of+%CE%B2-amyloid+plaques&doi=10.1021%2Fjm300973k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm300973k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300973k%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%252018F%2520labeled%25202-pyridinylbenzoxazole%2520and%25202-pyridinylbenzothiazole%2520derivatives%2520as%2520ligands%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520of%2520%25CE%25B2-amyloid%2520plaques%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9283%26epage%3D9296%26doi%3D10.1021%2Fjm300973k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Bonner, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutter, K.</span><span> </span><span class="NLM_article-title">Opening of cyclic acetals by trichloro-, dichloro-, and tribromo-borane</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span><span class="refDoi"> DOI: 10.1039/p19810001807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1039%2Fp19810001807" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1981&pages=1807-1810&author=T.+G.+Bonnerauthor=D.+Lewisauthor=K.+Rutter&title=Opening+of+cyclic+acetals+by+trichloro-%2C+dichloro-%2C+and+tribromo-borane&doi=10.1039%2Fp19810001807"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2Fp19810001807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19810001807%26sid%3Dliteratum%253Aachs%26aulast%3DBonner%26aufirst%3DT.%2BG.%26aulast%3DLewis%26aufirst%3DD.%26aulast%3DRutter%26aufirst%3DK.%26atitle%3DOpening%2520of%2520cyclic%2520acetals%2520by%2520trichloro-%252C%2520dichloro-%252C%2520and%2520tribromo-borane%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1981%26spage%3D1807%26epage%3D1810%26doi%3D10.1039%2Fp19810001807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Albrecht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defoin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarnus, C.</span><span> </span><span class="NLM_article-title">Simple preparation of <i>O</i>-substituted hydroxylamines from alcohols</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1638</span><span class="refDoi"> DOI: 10.1055/s-2006-926440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1055%2Fs-2006-926440" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=1635-1638&author=S.+Albrechtauthor=A.+Defoinauthor=C.+Tarnus&title=Simple+preparation+of+O-substituted+hydroxylamines+from+alcohols&doi=10.1055%2Fs-2006-926440"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-926440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-926440%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3DDefoin%26aufirst%3DA.%26aulast%3DTarnus%26aufirst%3DC.%26atitle%3DSimple%2520preparation%2520of%2520O-substituted%2520hydroxylamines%2520from%2520alcohols%26jtitle%3DSynthesis%26date%3D2006%26volume%3D2006%26spage%3D1635%26epage%3D1638%26doi%3D10.1055%2Fs-2006-926440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Milewska, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gdaniec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poloński, T.</span><span> </span><span class="NLM_article-title">Synthesis, stereochemistry, and chiroptical spectra of cyclopropyl lactones and thionolactones</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3169</span><span class="NLM_x">–</span> <span class="NLM_lpage">3180</span><span class="refDoi"> DOI: 10.1016/0957-4166(96)00419-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2F0957-4166%2896%2900419-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaK28XntlCls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=3169-3180&author=M.+J.+Milewskaauthor=M.+Gdaniecauthor=T.+Polo%C5%84ski&title=Synthesis%2C+stereochemistry%2C+and+chiroptical+spectra+of+cyclopropyl+lactones+and+thionolactones&doi=10.1016%2F0957-4166%2896%2900419-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, stereochemistry, and chiroptical spectra of cyclopropyl lactones and thionolactones</span></div><div class="casAuthors">Milewska, Maria J.; Gdaniec, Maria; Polonski, Tadeusz</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3169-3180</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several optically active substituted 3-oxabicyclo[3.1.0]hexan-2-ones and their thiocarbonyl analogs were synthesized, and their CD spectra are reported.  The n-π* Cotton effect sign is detd. by the helicity of an inherently chiral chromophore formed by the lactone or thiolactone group and the cyclopropyl moiety.  The π-π* Cotton effect of thiocarbonyl compds. shows opposite sign to that obsd. for the lowest energy transition.  The crystal structures of two compds. were solved to establish their mol. geometries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpthQTirXsslLVg90H21EOLACvtfcHk0lhfJflaLRUs1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntlCls7k%253D&md5=757bb27e327168f4adbfcb05e13faf61</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0957-4166%2896%2900419-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0957-4166%252896%252900419-3%26sid%3Dliteratum%253Aachs%26aulast%3DMilewska%26aufirst%3DM.%2BJ.%26aulast%3DGdaniec%26aufirst%3DM.%26aulast%3DPolo%25C5%2584ski%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520stereochemistry%252C%2520and%2520chiroptical%2520spectra%2520of%2520cyclopropyl%2520lactones%2520and%2520thionolactones%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1996%26volume%3D7%26spage%3D3169%26epage%3D3180%26doi%3D10.1016%2F0957-4166%2896%2900419-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Kirihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimosaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, Y.</span><span> </span><span class="NLM_article-title">Chemoselective bromination of active methylene and methyne compounds by potassium bromide, hydrochloric acid and hydrogen peroxide</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">2287</span><span class="NLM_x">–</span> <span class="NLM_lpage">2289</span><span class="refDoi"> DOI: 10.1055/s-2006-948207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1055%2Fs-2006-948207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=2287-2289&author=M.+Kiriharaauthor=S.+Ogawaauthor=T.+Noguchiauthor=K.+Okuboauthor=Y.+Monmaauthor=I.+Shimizuauthor=R.+Shimosakiauthor=A.+Hatanoauthor=Y.+Hirai&title=Chemoselective+bromination+of+active+methylene+and+methyne+compounds+by+potassium+bromide%2C+hydrochloric+acid+and+hydrogen+peroxide&doi=10.1055%2Fs-2006-948207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-948207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-948207%26sid%3Dliteratum%253Aachs%26aulast%3DKirihara%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DOkubo%26aufirst%3DK.%26aulast%3DMonma%26aufirst%3DY.%26aulast%3DShimizu%26aufirst%3DI.%26aulast%3DShimosaki%26aufirst%3DR.%26aulast%3DHatano%26aufirst%3DA.%26aulast%3DHirai%26aufirst%3DY.%26atitle%3DChemoselective%2520bromination%2520of%2520active%2520methylene%2520and%2520methyne%2520compounds%2520by%2520potassium%2520bromide%252C%2520hydrochloric%2520acid%2520and%2520hydrogen%2520peroxide%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26spage%3D2287%26epage%3D2289%26doi%3D10.1055%2Fs-2006-948207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Lynn, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herkenham, M.</span><span> </span><span class="NLM_article-title">Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1623</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=8138973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaK2cXis1WhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1994&pages=1612-1623&author=A.+B.+Lynnauthor=M.+Herkenham&title=Localization+of+cannabinoid+receptors+and+nonsaturable+high-density+cannabinoid+binding+sites+in+peripheral+tissues+of+the+rat%3A+implications+for+receptor-mediated+immune+modulation+by+cannabinoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids</span></div><div class="casAuthors">Lynn, Allison B.; Herkenham, Miles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1612-23</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">[3H]CP-55,940, a high-affinity cannabinoid receptor ligand, was used for in vitro binding and autoradiog. in peripheral tissues in the rat.  Specific cannabinoid receptor binding was restricted to components of the immune system, i.e., spleen, lymph nodes and Peyer's patches.  Displacement studies showed that this binding is identical (similar Kd and structure-activity profile) to that in brain.  Cannabinoid receptors in the immune system are confined to B lymphocyte-enriched areas, i.e., the marginal zone of the spleen, cortex of the lymph nodes and nodular corona of Peyer's patches.  Specific binding is absent in T lymphocyte-enriched areas, such as the thymus and periarteriolar lymphatic sheaths of the spleen.  Certain macrophage-enriched areas, i.e., liver and lung, lack specific binding.  Thus, the single peripheral cell type that may contain cannabinoid receptors is the B lymphocyte.  Numerous sites have dense binding that could not be displaced by excess unlabeled drug.  These nonspecific sites were found in the liver, adrenal glands and sebaceous glands, which are high in fat content, and in the heart, pancreas, components of the male and female reproductive systems and the epithelium of the esophagus.  Thus, the highly lipophilic nature of cannabinoids does not appear to be the sole determinant of nonspecific binding.  The data suggest that cannabinoids may exert specific receptor-mediated actins on the immune system of rats.  Perhaps, also at high concns., cannabinoids exert membrane effects at sites where they are sequestered nonspecifically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAtF8Av-r9C7Vg90H21EOLACvtfcHk0liJ9SIczPy2PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1WhsLs%253D&md5=fce7591d2f7c47a3c3ebf22d67d4730a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynn%26aufirst%3DA.%2BB.%26aulast%3DHerkenham%26aufirst%3DM.%26atitle%3DLocalization%2520of%2520cannabinoid%2520receptors%2520and%2520nonsaturable%2520high-density%2520cannabinoid%2520binding%2520sites%2520in%2520peripheral%2520tissues%2520of%2520the%2520rat%253A%2520implications%2520for%2520receptor-mediated%2520immune%2520modulation%2520by%2520cannabinoids%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D268%26spage%3D1612%26epage%3D1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breese, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, F. T.</span><span> </span><span class="NLM_article-title">Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span><span class="refDoi"> DOI: 10.1002/glia.20467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1002%2Fglia.20467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=17203472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FmtFSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=453-462&author=L.+Qinauthor=X.+Wuauthor=M.+L.+Blockauthor=Y.+Liuauthor=G.+R.+Breeseauthor=J.-S.+Hongauthor=D.+J.+Knappauthor=F.+T.+Crews&title=Systemic+LPS+causes+chronic+neuroinflammation+and+progressive+neurodegeneration&doi=10.1002%2Fglia.20467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration</span></div><div class="casAuthors">Qin Liya; Wu Xuefei; Block Michelle L; Liu Yuxin; Breese George R; Hong Jau-Shyong; Knapp Darin J; Crews Fulton T</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">453-62</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">Inflammation is implicated in the progressive nature of neurodegenerative diseases, such as Parkinson's disease, but the mechanisms are poorly understood.  A single systemic lipopolysaccharide (LPS, 5 mg/kg, i.p.) or tumor necrosis factor alpha (TNFalpha, 0.25 mg/kg, i.p.) injection was administered in adult wild-type mice and in mice lacking TNFalpha receptors (TNF R1/R2(-/-)) to discern the mechanisms of inflammation transfer from the periphery to the brain and the neurodegenerative consequences.  Systemic LPS administration resulted in rapid brain TNFalpha increase that remained elevated for 10 months, while peripheral TNFalpha (serum and liver) had subsided by 9 h (serum) and 1 week (liver).  Systemic TNFalpha and LPS administration activated microglia and increased expression of brain pro-inflammatory factors (i.e., TNFalpha, MCP-1, IL-1beta, and NF-kappaB p65) in wild-type mice, but not in TNF R1/R2(-/-) mice.  Further, LPS reduced the number of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra (SN) by 23% at 7-months post-treatment, which progressed to 47% at 10 months.  Together, these data demonstrate that through TNFalpha, peripheral inflammation in adult animals can: (1) activate brain microglia to produce chronically elevated pro-inflammatory factors; (2) induce delayed and progressive loss of DA neurons in the SN.  These findings provide valuable insight into the potential pathogenesis and self-propelling nature of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBzJ80ULUdypPlX7E30qdzfW6udTcc2ebiURwd9I0YGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FmtFSitw%253D%253D&md5=b999219adcacd99866c13df7a55280d1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fglia.20467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20467%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DBlock%26aufirst%3DM.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DBreese%26aufirst%3DG.%2BR.%26aulast%3DHong%26aufirst%3DJ.-S.%26aulast%3DKnapp%26aufirst%3DD.%2BJ.%26aulast%3DCrews%26aufirst%3DF.%2BT.%26atitle%3DSystemic%2520LPS%2520causes%2520chronic%2520neuroinflammation%2520and%2520progressive%2520neurodegeneration%26jtitle%3DGlia%26date%3D2007%26volume%3D55%26spage%3D453%26epage%3D462%26doi%3D10.1002%2Fglia.20467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Rühl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Günther, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krautscheid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span> </span><span class="NLM_article-title">Cannabinoid receptor type 2 (CB<sub>2</sub>)-selective <i>N</i>-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation</span> <span class="citation_source-journal">Org. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1186/2191-2858-2-32</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1186%2F2191-2858-2-32" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=23067874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FltlKqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=32-32&author=T.+R%C3%BChlauthor=W.+Deuther-Conradauthor=S.+Fischerauthor=R.+G%C3%BCntherauthor=L.+Hennigauthor=H.+Krautscheidauthor=P.+Brust&title=Cannabinoid+receptor+type+2+%28CB2%29-selective+N-aryl-oxadiazolyl-propionamides%3A+synthesis%2C+radiolabelling%2C+molecular+modelling+and+biological+evaluation&doi=10.1186%2F2191-2858-2-32"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation</span></div><div class="casAuthors">Ruhl Thomas; Deuther-Conrad Winnie; Fischer Steffen; Gunther Robert; Hennig Lothar; Krautscheid Harald; Brust Peter</div><div class="citationInfo"><span class="NLM_cas:title">Organic and medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The endocannabinoid system is involved in many physiological and pathological processes.  Two receptors (cannabinoid receptor type 1 (CB1) and type 2 (CB2)) are known so far.  Many unwanted psychotic side effects of inhibitors of this system can be addressed to the interaction with CB1.  While CB1 is one of the most abundant neuroreceptors, CB2 is expressed in the brain only at very low levels.  Thus, highly potent and selective compounds for CB2 are desired.  N-aryl-((hetero)aromatic)-oxadiazolyl-propionamides represent a promising class of such selective ligands for the human CB2.  Here, a library of various derivatives is studied for suitable routes for labelling with 18F.  Such 18F-labelled compounds can then be employed as CB2-selective radiotracers for molecular imaging studies employing positron emission tomography (PET).  RESULTS:  By varying the N-arylamide substructure, we explored the binding pocket of the human CB2 receptor and identified 9-ethyl-9H-carbazole amide as the group with optimal size.  Radioligand replacement experiments revealed that the modification of the (hetero)aromatic moiety in 3-position of the 1,2,4-oxadiazoles shows only moderate impact on affinity to CB2 but high impact on selectivity towards CB2 with respect to CB1.  Further, we could show by autoradiography studies that the most promising compounds bind selectively on CB2 receptors in mouse spleen tissue.  Molecular docking studies based on a novel three-dimensional structural model of the human CB2 receptor in its activated form indicate that the compounds bind with the N-arylamide substructure in the binding pocket. 18F labelling at the (hetero)aromatic moiety at the opposite site of the compounds via radiochemistry was carried out.  CONCLUSIONS:  The synthesized CB2-selective compounds have high affinity towards CB2 and good selectivity against CB1.  The introduction of labelling groups at the (hetero)aromatic moiety shows only moderate impact on CB2 affinity, indicating the introduction of potential labelling groups at this position as a promising approach to develop CB2-selective ligands suitable for molecular imaging with PET.  The high affinity for human CB2 and selectivity against human CB1 of the herein presented compounds renders them as suitable candidates for molecular imaging studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRK42tUugHa_j0O18WR3iAofW6udTcc2eZydYNklu3zV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FltlKqtA%253D%253D&md5=872d48bce8e40490a41ffaec4a3ea4d0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1186%2F2191-2858-2-32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2191-2858-2-32%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BChl%26aufirst%3DT.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DG%25C3%25BCnther%26aufirst%3DR.%26aulast%3DHennig%26aufirst%3DL.%26aulast%3DKrautscheid%26aufirst%3DH.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DCannabinoid%2520receptor%2520type%25202%2520%2528CB2%2529-selective%2520N-aryl-oxadiazolyl-propionamides%253A%2520synthesis%252C%2520radiolabelling%252C%2520molecular%2520modelling%2520and%2520biological%2520evaluation%26jtitle%3DOrg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D2%26spage%3D32%26epage%3D32%26doi%3D10.1186%2F2191-2858-2-32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, B. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaquero, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span> </span><span class="NLM_article-title">Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1891</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1891-1900&author=Y.+Wangauthor=J.+Seidelauthor=B.+M.+W.+Tsuiauthor=J.+J.+Vaqueroauthor=M.+G.+Pomper&title=Performance+evaluation+of+the+GE+healthcare+eXplore+VISTA+dual-ring+small-animal+PET+scanner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSeidel%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DB.%2BM.%2BW.%26aulast%3DVaquero%26aufirst%3DJ.%2BJ.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26atitle%3DPerformance%2520evaluation%2520of%2520the%2520GE%2520healthcare%2520eXplore%2520VISTA%2520dual-ring%2520small-animal%2520PET%2520scanner%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26spage%3D1891%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lu Hou, Jian Rong, Ahmed Haider, Daisuke Ogasawara, Cassis Varlow, Michael A. Schafroth, Linjing Mu, Jiefeng Gan, Hao Xu, Christopher J. Fowler, Ming-Rong Zhang, Neil Vasdev, Simon Ametamey, Benjamin F. Cravatt, Lu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 123-149. <a href="https://doi.org/10.1021/acs.jmedchem.0c01459" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01459%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositron%252BEmission%252BTomography%252BImaging%252Bof%252Bthe%252BEndocannabinoid%252BSystem%25253A%252BOpportunities%252Band%252BChallenges%252Bin%252BRadiotracer%252BDevelopment%26aulast%3DHou%26aufirst%3DLu%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D21082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D123%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ahmed Haider, Luca Gobbi, Julian Kretz, Christoph Ullmer, Andreas Brink, Michael Honer, Thomas J. Woltering, Dieter Muri, Hans Iding, Markus Bürkler, Martin Binder, Christian Bartelmus, Irene Knuesel, Pal Pacher, Adrienne Müller Herde, Francesco Spinelli, Hazem Ahmed, Kenneth Atz, Claudia Keller, Markus Weber, Roger Schibli, Linjing Mu, Uwe Grether, <span class="NLM_string-name hlFld-ContribAuthor">Simon M. Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10287-10306. <a href="https://doi.org/10.1021/acs.jmedchem.0c00778" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00778</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00778%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BPreclinical%252BDevelopment%252Bof%252Ba%252B2%25252C5%25252C6-Trisubstituted%252BFluorinated%252BPyridine%252BDerivative%252Bas%252Ba%252BRadioligand%252Bfor%252Bthe%252BPositron%252BEmission%252BTomography%252BImaging%252Bof%252BCannabinoid%252BType%252B2%252BReceptors%26aulast%3DHaider%26aufirst%3DAhmed%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07052020%26date%3D01092020%26date%3D11082020%26volume%3D63%26issue%3D18%26spage%3D10287%26epage%3D10306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ahmed Haider, Julian Kretz, Luca Gobbi, Hazem Ahmed, Kenneth Atz, Markus Bürkler, Christian Bartelmus, Jürgen Fingerle, Wolfgang Guba, Christoph Ullmer, Michael Honer, Irene Knuesel, Markus Weber, Andreas Brink, Adrienne Müller Herde, Claudia Keller, Roger Schibli, Linjing Mu, Uwe Grether, <span class="NLM_string-name hlFld-ContribAuthor">Simon M. Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11165-11181. <a href="https://doi.org/10.1021/acs.jmedchem.9b01280" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01280%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Bof%252BPyridine-Based%252BLigands%252Band%252BIdentification%252Bof%252Ba%252BFluorinated%252BDerivative%252Bfor%252BPositron%252BEmission%252BTomography%252BImaging%252Bof%252BCannabinoid%252BType%252B2%252BReceptors%26aulast%3DHaider%26aufirst%3DAhmed%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05082019%26date%3D05122019%26date%3D21112019%26volume%3D62%26issue%3D24%26spage%3D11165%26epage%3D11181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabien  Caillé</span>, <span class="hlFld-ContribAuthor ">Fanny  Cacheux</span>, <span class="hlFld-ContribAuthor ">Marie-Anne  Peyronneau</span>, <span class="hlFld-ContribAuthor ">Benoît  Jego</span>, <span class="hlFld-ContribAuthor ">Emilie  Jaumain</span>, <span class="hlFld-ContribAuthor ">Géraldine  Pottier</span>, <span class="hlFld-ContribAuthor ">Christoph  Ullmer</span>, <span class="hlFld-ContribAuthor ">Uwe  Grether</span>, <span class="hlFld-ContribAuthor ">Alexandra  Winkeler</span>, <span class="hlFld-ContribAuthor ">Frédéric  Dollé</span>, <span class="hlFld-ContribAuthor ">Annelaure  Damont</span>, and <span class="hlFld-ContribAuthor ">Bertrand  Kuhnast</span>  . </span><span class="cited-content_cbyCitation_article-title">From Structure–Activity Relationships on Thiazole Derivatives to the In Vivo Evaluation of a New Radiotracer for Cannabinoid Subtype 2 PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (11)
                                     , 4064-4078. <a href="https://doi.org/10.1021/acs.molpharmaceut.7b00746" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.7b00746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.7b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.7b00746%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DFrom%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bon%252BThiazole%252BDerivatives%252Bto%252Bthe%252BIn%252BVivo%252BEvaluation%252Bof%252Ba%252BNew%252BRadiotracer%252Bfor%252BCannabinoid%252BSubtype%252B2%252BPET%252BImaging%26aulast%3DCaill%25C3%25A9%26aufirst%3DFabien%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D29082017%26date%3D02102017%26date%3D21092017%26date%3D18102017%26date%3D06112017%26date%3D02102017%26volume%3D14%26issue%3D11%26spage%3D4064%26epage%3D4078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rareş-Petru  Moldovan</span>, <span class="hlFld-ContribAuthor ">Kristin  Hausmann</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, and <span class="hlFld-ContribAuthor ">Peter  Brust</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Highly Affine and Selective Fluorinated Cannabinoid Type 2 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (5)
                                     , 566-571. <a href="https://doi.org/10.1021/acsmedchemlett.7b00129" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00129%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252BHighly%252BAffine%252Band%252BSelective%252BFluorinated%252BCannabinoid%252BType%252B2%252BReceptor%252BLigands%26aulast%3DMoldovan%26aufirst%3DRare%25C5%259F-Petru%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23032017%26date%3D28042017%26date%3D03052017%26date%3D11052017%26date%3D28042017%26volume%3D8%26issue%3D5%26spage%3D566%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mayar W.  Aly</span>, <span class="hlFld-ContribAuthor ">Friedrich-Alexander  Ludwig</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>, <span class="hlFld-ContribAuthor ">Ashraf H.  Abadi</span>, <span class="hlFld-ContribAuthor ">Rareş-Petru  Moldovan</span>, <span class="hlFld-ContribAuthor ">Noha A.  Osman</span>. </span><span class="cited-content_cbyCitation_article-title">Development of fluorinated and methoxylated benzothiazole derivatives as highly potent and selective cannabinoid CB2 receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105191. <a href="https://doi.org/10.1016/j.bioorg.2021.105191" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105191%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bfluorinated%252Band%252Bmethoxylated%252Bbenzothiazole%252Bderivatives%252Bas%252Bhighly%252Bpotent%252Band%252Bselective%252Bcannabinoid%252BCB2%252Breceptor%252Bligands%26aulast%3DAly%26aufirst%3DMayar%2BW.%26date%3D2021%26volume%3D114%26spage%3D105191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Teodoro</span>, <span class="hlFld-ContribAuthor ">Daniel  Gündel</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Lea  Ueberham</span>, <span class="hlFld-ContribAuthor ">Magali  Toussaint</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>, <span class="hlFld-ContribAuthor ">Rareş-Petru  Moldovan</span>. </span><span class="cited-content_cbyCitation_article-title">Development of [18F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (15)
                                     , 8051. <a href="https://doi.org/10.3390/ijms22158051" title="DOI URL">https://doi.org/10.3390/ijms22158051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22158051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22158051%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDevelopment%252Bof%252B%25255B18F%25255DLU14%252Bfor%252BPET%252BImaging%252Bof%252BCannabinoid%252BReceptor%252BType%252B2%252Bin%252Bthe%252BBrain%26aulast%3DTeodoro%26aufirst%3DRodrigo%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D15%26spage%3D8051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chungsik  Kim</span>, <span class="hlFld-ContribAuthor ">Mintesinot  Kassu</span>, <span class="hlFld-ContribAuthor ">Kenneth P.  Smith</span>, <span class="hlFld-ContribAuthor ">James E.  Kirby</span>, <span class="hlFld-ContribAuthor ">Roman  Manetsch</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazole‐Thiazole Core‐Containing Analogs Exhibit Adjunctive Activity with Meropenem against Carbapenem‐Resistant
              Enterobacteriaceae
              (CRE). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>59 </em><a href="https://doi.org/10.1002/cmdc.202100321" title="DOI URL">https://doi.org/10.1002/cmdc.202100321</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100321%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPyrazole%2525E2%252580%252590Thiazole%252BCore%2525E2%252580%252590Containing%252BAnalogs%252BExhibit%252BAdjunctive%252BActivity%252Bwith%252BMeropenem%252Bagainst%252BCarbapenem%2525E2%252580%252590Resistant%252BEnterobacteriaceae%252B%252528CRE%252529%26aulast%3DKim%26aufirst%3DChungsik%26date%3D2021%26date%3D2021%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ishtiaq  Ahmed</span>, <span class="hlFld-ContribAuthor ">Saif Ur  Rehman</span>, <span class="hlFld-ContribAuthor ">Shiva  Shahmohamadnejad</span>, <span class="hlFld-ContribAuthor ">Muhammad Anjum  Zia</span>, <span class="hlFld-ContribAuthor ">Muhammad  Ahmad</span>, <span class="hlFld-ContribAuthor ">Muhammad Muzammal  Saeed</span>, <span class="hlFld-ContribAuthor ">Zain  Akram</span>, <span class="hlFld-ContribAuthor ">Hafiz M. N.  Iqbal</span>, <span class="hlFld-ContribAuthor ">Qingyou  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3389. <a href="https://doi.org/10.3390/molecules26113389" title="DOI URL">https://doi.org/10.3390/molecules26113389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113389%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTherapeutic%252BAttributes%252Bof%252BEndocannabinoid%252BSystem%252Bagainst%252BNeuro-Inflammatory%252BAutoimmune%252BDisorders%26aulast%3DAhmed%26aufirst%3DIshtiaq%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garth E.  Terry</span>, <span class="hlFld-ContribAuthor ">Vanessa  Raymont</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Horti</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of the Endocannabinoid System. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 319-426. <a href="https://doi.org/10.1007/978-3-030-53176-8_12" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_12%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252BImaging%252Bof%252Bthe%252BEndocannabinoid%252BSystem%26aulast%3DTerry%26aufirst%3DGarth%2BE.%26date%3D2021%26date%3D2020%26spage%3D319%26epage%3D426%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annunziata  D'Elia</span>, <span class="hlFld-ContribAuthor ">Sara  Schiavi</span>, <span class="hlFld-ContribAuthor ">Andrea  Soluri</span>, <span class="hlFld-ContribAuthor ">Roberto  Massari</span>, <span class="hlFld-ContribAuthor ">Alessandro  Soluri</span>, <span class="hlFld-ContribAuthor ">Viviana  Trezza</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Behavioral Neuroscience</span><span> <strong>2020,</strong> <em>14 </em><a href="https://doi.org/10.3389/fnbeh.2020.596509" title="DOI URL">https://doi.org/10.3389/fnbeh.2020.596509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnbeh.2020.596509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnbeh.2020.596509%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Behavioral%2520Neuroscience%26atitle%3DRole%252Bof%252BNuclear%252BImaging%252Bto%252BUnderstand%252Bthe%252BNeural%252BSubstrates%252Bof%252BBrain%252BDisorders%252Bin%252BLaboratory%252BAnimals%25253A%252BCurrent%252BStatus%252Band%252BFuture%252BProspects%26aulast%3DD%2527Elia%26aufirst%3DAnnunziata%26date%3D2020%26date%3D2020%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duo  Xu</span>, <span class="hlFld-ContribAuthor ">Chenyu  Peng</span>, <span class="hlFld-ContribAuthor ">Fei  Gao</span>, <span class="hlFld-ContribAuthor ">Zhide  Guo</span>, <span class="hlFld-ContribAuthor ">Rongqiang  Zhuang</span>, <span class="hlFld-ContribAuthor ">Xinhui  Su</span>, <span class="hlFld-ContribAuthor ">Xianzhong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Radioiodinated estradiol dimer for estrogen receptor targeted breast cancer imaging. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>96 </em>
                                    (6)
                                     , 1332-1340. <a href="https://doi.org/10.1111/cbdd.13754" title="DOI URL">https://doi.org/10.1111/cbdd.13754</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13754%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DRadioiodinated%252Bestradiol%252Bdimer%252Bfor%252Bestrogen%252Breceptor%252Btargeted%252Bbreast%252Bcancer%252Bimaging%26aulast%3DXu%26aufirst%3DDuo%26date%3D2020%26date%3D2020%26volume%3D96%26issue%3D6%26spage%3D1332%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giada  Cipollina</span>, <span class="hlFld-ContribAuthor ">Arash  Davari Serej</span>, <span class="hlFld-ContribAuthor ">Gianluca  Di Nolfi</span>, <span class="hlFld-ContribAuthor ">Andrea  Gazzano</span>, <span class="hlFld-ContribAuthor ">Andrea  Marsala</span>, <span class="hlFld-ContribAuthor ">Mauro G.  Spatafora</span>, <span class="hlFld-ContribAuthor ">Marco  Peviani</span>. </span><span class="cited-content_cbyCitation_article-title">Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 7923. <a href="https://doi.org/10.3390/ijms21217923" title="DOI URL">https://doi.org/10.3390/ijms21217923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21217923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21217923%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DHeterogeneity%252Bof%252BNeuroinflammatory%252BResponses%252Bin%252BAmyotrophic%252BLateral%252BSclerosis%25253A%252BA%252BChallenge%252Bor%252Ban%252BOpportunity%25253F%26aulast%3DCipollina%26aufirst%3DGiada%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D7923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filippo  Basagni</span>, <span class="hlFld-ContribAuthor ">Michela  Rosini</span>, <span class="hlFld-ContribAuthor ">Michael  Decker</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (15)
                                     , 1374-1389. <a href="https://doi.org/10.1002/cmdc.202000298" title="DOI URL">https://doi.org/10.1002/cmdc.202000298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000298%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DFunctionalized%252BCannabinoid%252BSubtype%252B2%252BReceptor%252BLigands%25253A%252BFluorescent%25252C%252BPET%25252C%252BPhotochromic%252Band%252BCovalent%252BMolecular%252BProbes%26aulast%3DBasagni%26aufirst%3DFilippo%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D15%26spage%3D1374%26epage%3D1389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed H.E.  Hassan</span>, <span class="hlFld-ContribAuthor ">Kyung Tae  Park</span>, <span class="hlFld-ContribAuthor ">Hye Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Hyo Jong  Lee</span>, <span class="hlFld-ContribAuthor ">Yeong Ho  Kwon</span>, <span class="hlFld-ContribAuthor ">Ji Young  Hwang</span>, <span class="hlFld-ContribAuthor ">Choon-Gon  Jang</span>, <span class="hlFld-ContribAuthor ">Jin Hwa  Chung</span>, <span class="hlFld-ContribAuthor ">Ki Duk  Park</span>, <span class="hlFld-ContribAuthor ">Sang Joo  Lee</span>, <span class="hlFld-ContribAuthor ">Seung Jun  Oh</span>, <span class="hlFld-ContribAuthor ">Yong Sup  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated CRA13 analogues: Synthesis, in vitro evaluation, radiosynthesis, in silico and in vivo PET study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103834. <a href="https://doi.org/10.1016/j.bioorg.2020.103834" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103834%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DFluorinated%252BCRA13%252Banalogues%25253A%252BSynthesis%25252C%252Bin%252Bvitro%252Bevaluation%25252C%252Bradiosynthesis%25252C%252Bin%252Bsilico%252Band%252Bin%252Bvivo%252BPET%252Bstudy%26aulast%3DHassan%26aufirst%3DAhmed%2BH.E.%26date%3D2020%26volume%3D99%26spage%3D103834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan  Wong</span>, <span class="hlFld-ContribAuthor ">Zhihai  Ke</span>, <span class="hlFld-ContribAuthor ">Ying-Yeung  Yeung</span>. </span><span class="cited-content_cbyCitation_article-title">Lipophilic indole mediated chemoselective α-monobromination of 1,3-dicarbonyl compounds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (16)
                                     , 151772. <a href="https://doi.org/10.1016/j.tetlet.2020.151772" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151772%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DLipophilic%252Bindole%252Bmediated%252Bchemoselective%252B%2525CE%2525B1-monobromination%252Bof%252B1%25252C3-dicarbonyl%252Bcompounds%26aulast%3DWong%26aufirst%3DJonathan%26date%3D2020%26volume%3D61%26issue%3D16%26spage%3D151772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamara  Berdyyeva</span>, <span class="hlFld-ContribAuthor ">Chunfang  Xia</span>, <span class="hlFld-ContribAuthor ">Natalie  Taylor</span>, <span class="hlFld-ContribAuthor ">Yingbo  He</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Chaofeng  Huang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hartmuth  Kolb</span>, <span class="hlFld-ContribAuthor ">Michael  Letavic</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Anna Katrin  Szardenings</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2019,</strong> <em>21 </em>
                                    (5)
                                     , 871-878. <a href="https://doi.org/10.1007/s11307-018-01313-2" title="DOI URL">https://doi.org/10.1007/s11307-018-01313-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-018-01313-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-018-01313-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DPET%252BImaging%252Bof%252Bthe%252BP2X7%252BIon%252BChannel%252Bwith%252Ba%252BNovel%252BTracer%252B%25255B18F%25255DJNJ-64413739%252Bin%252Ba%252BRat%252BModel%252Bof%252BNeuroinflammation%26aulast%3DBerdyyeva%26aufirst%3DTamara%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D5%26spage%3D871%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bala  Attili</span>, <span class="hlFld-ContribAuthor ">Sofie  Celen</span>, <span class="hlFld-ContribAuthor ">Muneer  Ahamed</span>, <span class="hlFld-ContribAuthor ">Michel  Koole</span>, <span class="hlFld-ContribAuthor ">Chris Van Den  Haute</span>, <span class="hlFld-ContribAuthor ">Wim  Vanduffel</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical evaluation of [
              18
              F]MA3: a CB
              2
              receptor agonist radiotracer for PET. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2019,</strong> <em>176 </em>
                                    (10)
                                     , 1481-1491. <a href="https://doi.org/10.1111/bph.14564" title="DOI URL">https://doi.org/10.1111/bph.14564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14564%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DPreclinical%252Bevaluation%252Bof%252B%25255B%252B18%252BF%25255DMA3%25253A%252Ba%252BCB%252B2%252Breceptor%252Bagonist%252Bradiotracer%252Bfor%252BPET%26aulast%3DAttili%26aufirst%3DBala%26date%3D2019%26date%3D2019%26volume%3D176%26issue%3D10%26spage%3D1481%26epage%3D1491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruiqing  Ni</span>, <span class="hlFld-ContribAuthor ">Linjing  Mu</span>, <span class="hlFld-ContribAuthor ">Simon  Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2019,</strong> <em>40 </em>
                                    (3)
                                     , 351-357. <a href="https://doi.org/10.1038/s41401-018-0035-5" title="DOI URL">https://doi.org/10.1038/s41401-018-0035-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-018-0035-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-018-0035-5%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DPositron%252Bemission%252Btomography%252Bof%252Btype%252B2%252Bcannabinoid%252Breceptors%252Bfor%252Bdetecting%252Binflammation%252Bin%252Bthe%252Bcentral%252Bnervous%252Bsystem%26aulast%3DNi%26aufirst%3DRuiqing%26date%3D2019%26date%3D2018%26volume%3D40%26issue%3D3%26spage%3D351%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bieneke  Janssen</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>. </span><span class="cited-content_cbyCitation_article-title">Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 371-399. <a href="https://doi.org/10.1016/bs.pmbts.2019.04.005" title="DOI URL">https://doi.org/10.1016/bs.pmbts.2019.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmbts.2019.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmbts.2019.04.005%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252Bbrain%252BPET%252Bimaging%252Bagents%25253A%252BStrategies%252Bfor%252Bimaging%252Bneuroinflammation%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DJanssen%26aufirst%3DBieneke%26date%3D2019%26spage%3D371%26epage%3D399%26pub%3DElsevier%26atitle%3DBrain%252BImaging%26date%3D2019%26volume%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Mugnaini</span>, <span class="hlFld-ContribAuthor ">Alessandro  Rabbito</span>, <span class="hlFld-ContribAuthor ">Antonella  Brizzi</span>, <span class="hlFld-ContribAuthor ">Nastasja  Palombi</span>, <span class="hlFld-ContribAuthor ">Stefania  Petrosino</span>, <span class="hlFld-ContribAuthor ">Roberta  Verde</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Di Marzo</span>, <span class="hlFld-ContribAuthor ">Alessia  Ligresti</span>, <span class="hlFld-ContribAuthor ">Federico  Corelli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>161 </em>, 239-251. <a href="https://doi.org/10.1016/j.ejmech.2018.09.070" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.070%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnovel%252B2-%2525281-adamantanylcarboxamido%252529thiophene%252Bderivatives.%252BSelective%252Bcannabinoid%252Btype%252B2%252B%252528CB2%252529%252Breceptor%252Bagonists%252Bas%252Bpotential%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Bskin%252Binflammatory%252Bdisease%26aulast%3DMugnaini%26aufirst%3DClaudia%26date%3D2019%26volume%3D161%26spage%3D239%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">João  Franco Machado</span>, <span class="hlFld-ContribAuthor ">Rúben  Silva</span>, <span class="hlFld-ContribAuthor ">Rita  Melo</span>, <span class="hlFld-ContribAuthor ">João  G. Correia</span>. </span><span class="cited-content_cbyCitation_article-title">Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (1)
                                     , 49. <a href="https://doi.org/10.3390/molecules24010049" title="DOI URL">https://doi.org/10.3390/molecules24010049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24010049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24010049%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DLess%252BExploited%252BGPCRs%252Bin%252BPrecision%252BMedicine%25253A%252BTargets%252Bfor%252BMolecular%252BImaging%252Band%252BTheranostics%26aulast%3DFranco%2BMachado%26aufirst%3DJo%25C3%25A3o%26date%3D2019%26date%3D2018%26volume%3D24%26issue%3D1%26spage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irwan Iskandar  Roslan</span>, <span class="hlFld-ContribAuthor ">Kian-Hong  Ng</span>, <span class="hlFld-ContribAuthor ">Mohammed Ashraf  Gondal</span>, <span class="hlFld-ContribAuthor ">Chanbasha  Basheer</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Dastageer</span>, <span class="hlFld-ContribAuthor ">Stephan  Jaenicke</span>, <span class="hlFld-ContribAuthor ">Gaik-Khuan  Chuah</span>. </span><span class="cited-content_cbyCitation_article-title">Visible Light-Mediated Coupling of Thioureas and 1,3-Dicarbonyls: Towards a Leaving Group-Free Synthesis of Aminothiazoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (8)
                                     , 1584-1589. <a href="https://doi.org/10.1002/adsc.201701565" title="DOI URL">https://doi.org/10.1002/adsc.201701565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201701565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201701565%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DVisible%252BLight-Mediated%252BCoupling%252Bof%252BThioureas%252Band%252B1%25252C3-Dicarbonyls%25253A%252BTowards%252Ba%252BLeaving%252BGroup-Free%252BSynthesis%252Bof%252BAminothiazoles%26aulast%3DRoslan%26aufirst%3DIrwan%2BIskandar%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D8%26spage%3D1584%26epage%3D1589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Spinelli</span>, <span class="hlFld-ContribAuthor ">Linjing  Mu</span>, <span class="hlFld-ContribAuthor ">Simon M.  Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 299-308. <a href="https://doi.org/10.1002/jlcr.3579" title="DOI URL">https://doi.org/10.1002/jlcr.3579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3579%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DRadioligands%252Bfor%252Bpositron%252Bemission%252Btomography%252Bimaging%252Bof%252Bcannabinoid%252Btype%252B2%252Breceptor%26aulast%3DSpinelli%26aufirst%3DFrancesco%26date%3D2018%26date%3D2017%26volume%3D61%26issue%3D3%26spage%3D299%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bieneke  Janssen</span>, <span class="hlFld-ContribAuthor ">Danielle  Vugts</span>, <span class="hlFld-ContribAuthor ">Albert  Windhorst</span>, <span class="hlFld-ContribAuthor ">Robert  Mach</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of Microglial Activation—Beyond Targeting TSPO. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (3)
                                     , 607. <a href="https://doi.org/10.3390/molecules23030607" title="DOI URL">https://doi.org/10.3390/molecules23030607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23030607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23030607%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPET%252BImaging%252Bof%252BMicroglial%252BActivation%2525E2%252580%252594Beyond%252BTargeting%252BTSPO%26aulast%3DJanssen%26aufirst%3DBieneke%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Haider</span>, <span class="hlFld-ContribAuthor ">Francesco  Spinelli</span>, <span class="hlFld-ContribAuthor ">Adrienne Müller  Herde</span>, <span class="hlFld-ContribAuthor ">Boshuai  Mu</span>, <span class="hlFld-ContribAuthor ">Claudia  Keller</span>, <span class="hlFld-ContribAuthor ">Markus  Margelisch</span>, <span class="hlFld-ContribAuthor ">Markus  Weber</span>, <span class="hlFld-ContribAuthor ">Roger  Schibli</span>, <span class="hlFld-ContribAuthor ">Linjing  Mu</span>, <span class="hlFld-ContribAuthor ">Simon M.  Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>145 </em>, 746-759. <a href="https://doi.org/10.1016/j.ejmech.2017.12.097" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.097%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvaluation%252Bof%252B4-oxo-quinoline-based%252BCB2%252BPET%252Bradioligands%252Bin%252BR6%25252F2%252Bchorea%252Bhuntington%252Bmouse%252Bmodel%252Band%252Bhuman%252BALS%252Bspinal%252Bcord%252Btissue%26aulast%3DHaider%26aufirst%3DAhmed%26date%3D2018%26volume%3D145%26spage%3D746%26epage%3D759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominik  Heimann</span>, <span class="hlFld-ContribAuthor ">Frederik  Börgel</span>, <span class="hlFld-ContribAuthor ">Henk  de Vries</span>, <span class="hlFld-ContribAuthor ">Marius  Patberg</span>, <span class="hlFld-ContribAuthor ">Eliot  Jan-Smith</span>, <span class="hlFld-ContribAuthor ">Bastian  Frehland</span>, <span class="hlFld-ContribAuthor ">Dirk  Schepmann</span>, <span class="hlFld-ContribAuthor ">Laura H.  Heitman</span>, <span class="hlFld-ContribAuthor ">Bernhard  Wünsch</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB2) ligand designed for PET studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>146 </em>, 409-422. <a href="https://doi.org/10.1016/j.ejmech.2018.01.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Bthe%252Bmetabolic%252Bstability%252Bof%252Ba%252Bfluorinated%252Bcannabinoid%252Breceptor%252Bsubtype%252B2%252B%252528CB2%252529%252Bligand%252Bdesigned%252Bfor%252BPET%252Bstudies%26aulast%3DHeimann%26aufirst%3DDominik%26date%3D2018%26volume%3D146%26spage%3D409%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin J.  Fisher</span>, <span class="hlFld-ContribAuthor ">Lindsay  McMurray</span>, <span class="hlFld-ContribAuthor ">Shuiyu  Lu</span>, <span class="hlFld-ContribAuthor ">Cheryl L.  Morse</span>, <span class="hlFld-ContribAuthor ">Jeih-San  Liow</span>, <span class="hlFld-ContribAuthor ">Sami S.  Zoghbi</span>, <span class="hlFld-ContribAuthor ">Aneta  Kowalski</span>, <span class="hlFld-ContribAuthor ">George L.  Tye</span>, <span class="hlFld-ContribAuthor ">Robert B.  Innis</span>, <span class="hlFld-ContribAuthor ">Franklin I.  Aigbirhio</span>, <span class="hlFld-ContribAuthor ">Victor W.  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">[
              Carboxyl
              -
              11
              C]Labelling of Four High-Affinity cPLA2α Inhibitors and Their Evaluation as Radioligands in Mice by Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (2)
                                     , 138-146. <a href="https://doi.org/10.1002/cmdc.201700697" title="DOI URL">https://doi.org/10.1002/cmdc.201700697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700697%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3D%25255B%252BCarboxyl%252B-%252B11%252BC%25255DLabelling%252Bof%252BFour%252BHigh-Affinity%252BcPLA2%2525CE%2525B1%252BInhibitors%252Band%252BTheir%252BEvaluation%252Bas%252BRadioligands%252Bin%252BMice%252Bby%252BPositron%252BEmission%252BTomography%26aulast%3DFisher%26aufirst%3DMartin%2BJ.%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D2%26spage%3D138%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christin  Schifani</span>, <span class="hlFld-ContribAuthor ">Sina  Hafizi</span>, <span class="hlFld-ContribAuthor ">Tania  Da Silva</span>, <span class="hlFld-ContribAuthor ">Jeremy Joseph  Watts</span>, <span class="hlFld-ContribAuthor ">M. Saad  Khan</span>, <span class="hlFld-ContribAuthor ">Romina  Mizrahi</span>. </span><span class="cited-content_cbyCitation_article-title">Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies. </span><span class="cited-content_cbyCitation_journal-name">International Review of Psychiatry</span><span> <strong>2017,</strong> <em>29 </em>
                                    (6)
                                     , 555-566. <a href="https://doi.org/10.1080/09540261.2017.1396205" title="DOI URL">https://doi.org/10.1080/09540261.2017.1396205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/09540261.2017.1396205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F09540261.2017.1396205%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Review%2520of%2520Psychiatry%26atitle%3DUsing%252Bmolecular%252Bimaging%252Bto%252Bunderstand%252Bearly%252Bschizophrenia-related%252Bpsychosis%252Bneurochemistry%25253A%252Ba%252Breview%252Bof%252Bhuman%252Bstudies%26aulast%3DSchifani%26aufirst%3DChristin%26date%3D2017%26date%3D2017%26volume%3D29%26issue%3D6%26spage%3D555%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Need</span>, <span class="hlFld-ContribAuthor ">Nancy  Kant</span>, <span class="hlFld-ContribAuthor ">Cynthia  Jesudason</span>, <span class="hlFld-ContribAuthor ">Vanessa  Barth</span>. </span><span class="cited-content_cbyCitation_article-title">Approaches for the discovery of novel positron emission tomography radiotracers for brain imaging. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Imaging</span><span> <strong>2017,</strong> <em>5 </em>
                                    (3)
                                     , 265-274. <a href="https://doi.org/10.1007/s40336-017-0221-3" title="DOI URL">https://doi.org/10.1007/s40336-017-0221-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40336-017-0221-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40336-017-0221-3%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Imaging%26atitle%3DApproaches%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bpositron%252Bemission%252Btomography%252Bradiotracers%252Bfor%252Bbrain%252Bimaging%26aulast%3DNeed%26aufirst%3DAnne%26date%3D2017%26date%3D2017%26volume%3D5%26issue%3D3%26spage%3D265%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muneer  Ahamed</span>, <span class="hlFld-ContribAuthor ">Daisy  van Veghel</span>, <span class="hlFld-ContribAuthor ">Christoph  Ullmer</span>, <span class="hlFld-ContribAuthor ">Koen  Van Laere</span>, <span class="hlFld-ContribAuthor ">Alfons  Verbruggen</span>, <span class="hlFld-ContribAuthor ">Guy M.  Bormans</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2016,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnins.2016.00431" title="DOI URL">https://doi.org/10.3389/fnins.2016.00431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2016.00431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2016.00431%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DSynthesis%25252C%252BBiodistribution%252Band%252BIn%252Bvitro%252BEvaluation%252Bof%252BBrain%252BPermeable%252BHigh%252BAffinity%252BType%252B2%252BCannabinoid%252BReceptor%252BAgonists%252B%25255B11C%25255DMA2%252Band%252B%25255B18F%25255DMA3%26aulast%3DAhamed%26aufirst%3DMuneer%26date%3D2016%26date%3D2016%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative radiolabeled CB<sub>2</sub> ligands.<a onclick="showRef(event, 'ref42 ref44 ref47 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref42 ref44 ref47 ref49 ref50">(42, 44, 47, 49, 50)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead compound <b>1</b><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and proposed fluoro-derivatization. For details on the Alk(ox)yl, see Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Lead Compound <b>1</b> and <i>N</i>-Alkyl Derivatives <b>17</b>–<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) RX, neat, 90 °C, 16 h; (b) 2,2,3,3-tetramethylcyclopropane-1-carboxylic acid, BOP, Et<sub>3</sub>N, DCM, rt, 24 h, 30–50% over two steps;<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (c) NaH, alkyl bromide, DMF, 0 °C to rt, 80–85%; BOP = (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Reagents <b>34</b>, <b>35</b>, <b>37</b>, and <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TsCl, KOH, DCM, 0 °C, 3 h, quantitative;<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (b) TBAF, THF, rt, 16 h, 42%; (c) MsCl, Et<sub>3</sub>N, DCM, 0 °C to rt, 1 h, quantitative;<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> (d) BBr<sub>3</sub>, LiAlH<sub>4</sub>, DCM, 0 °C to rt, 1 h, 90%.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the hydrophilic derivatives <b>44</b> and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KMnO<sub>4</sub>, Na<sub>2</sub>SO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 4 h, 30%;<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (b) <b>2</b>, BOP, Et<sub>3</sub>N, DCM, rt, 24 h, 42%; (c) LiAlH<sub>4</sub>, THF, rt, 4 h, quantitative; (d) NaH, MeI, DMF, 0 °C to rt, 4 h, 95%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of compounds <b>50</b> and <b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KBr, H<sub>2</sub>O<sub>2</sub>, 1 h, quantitative;<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> (b) thiourea, EtOH, reflux, 1 h, quantitative; (c) (i) 2-bromoethyl methyl ether, 95 °C, 16 h, (ii) 2,2,3,3-tetramethylcyclopropane-1-carboxylic acid, BOP, Et<sub>3</sub>N, DCM, rt, 24 h, 36% over two steps; (d) MeLi, −78 °C, 30 min, 72%; (e) NaH, MeI, overnight, rt, 79%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Precursor for Radiolabeling <b>53</b> and Radiosynthesis of [<sup>18</sup>F]<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 2,2,3,3-Tetramethylcyclopropane-1-carboxylic acid, BOP, Et<sub>3</sub>N, DCM, rt, 24 h, 18%; (b) NaH, Br(CH<sub>2</sub>)<sub>4</sub>Br, DMF, rt, overnight, 56%; (c) [<sup>18</sup>F]F–K2.2.2., CH<sub>3</sub>CN, 80 °C.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Scheme of the synthesis module Tracer Lab FX-FN for the automated radiosynthesis of [<sup>18</sup>F]<b>29</b>. (1) Chromafix 30 PS-HCO<sub>3</sub><sup>–</sup>, (2) K<sub>2</sub>CO<sub>3</sub> (1.78 mg in 0.4 mL H<sub>2</sub>O), (3) K2.2.2. (11.2 mg in 1 mL of CH<sub>3</sub>CN), (4) 3.5 mg <b>53</b> in 1 mL of CH<sub>3</sub>CN, (5) 3 mL of H<sub>2</sub>O/CH<sub>3</sub>CN (1:1), (6) reactor, (7) Reprosil-Pur C18-AQ (65% CH<sub>3</sub>CN/20 mM NH<sub>4</sub>OAc; flow rate of 4.2 mL/min), (8) 40 mL of H<sub>2</sub>O, (9) 2 mL of H<sub>2</sub>O, (10) 1.25 mL of EtOH, (11) Sep Pak C18 light cartridge, (12) product in 0.9% NaCl containing 10% EtOH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Representative semipreparative radio-HPLC profile of [<sup>18</sup>F]<b>29</b> (conditions: Reprosil-Pur 120 C18-AQ (5 μm, 250 × 10 mm), 65% CH<sub>3</sub>CN/20 mM NH<sub>4</sub>OAc aq., 4.2 mL/min); (B) analytical UV- and radio-HPLC chromatogram of [<sup>18</sup>F]<b>29</b> spiked with corresponding reference compound <b>29</b> (conditions: Reprosil-Pur C18-AQ (5 μm, 250 × 4.6 mm), 70% CH<sub>3</sub>CN/20 mM NH<sub>4</sub>OAc aq., 1 mL/min) (solid line, γ-trace; gray line, UV-trace).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. [<sup>18</sup>F]<b>29</b> selectively binds to CB<sub>2</sub> receptors in vitro. (A) Rat spleen autoradiograms of [<sup>18</sup>F]<b>29</b> without and with coincubation of the radioligand with 1 μM of CB<sub>2</sub>-specific <b>54</b>, CB<sub>1</sub>-specific <b>55</b>, CB<sub>1</sub>/CB<sub>2</sub>-specific <b>56</b>, and <b>29</b>. (B) Evaluation of the specific binding and displacement of [<sup>18</sup>F]<b>29</b> on sections of rat spleen determined without and with coincubation of the radioligand with CB<sub>2</sub>-specific <b>54</b> at 10 nM and 1 μM, CB<sub>1</sub>-specific <b>55</b> at 10 nM and 1 μM, CB<sub>1</sub>/CB<sub>2</sub>-specific <b>56</b> at 1 μM, and <b>29</b> at 1 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo metabolism of [<sup>18</sup>F]<b>29</b> at 30 min p.i. (A) Plasma samples [extraction with MeOH/H<sub>2</sub>O (9:1); 94% extraction yield] and (B) brain homogenates [extraction with MeOH/H<sub>2</sub>O (9:1); 93% extraction yield]. HPLC conditions: Reprosil-Pur C18-AQ (250 × 4.6 mm; 5 μm); Gradient mode (10–90% CH<sub>3</sub>CN/20 mM NH<sub>4</sub>OAc aq.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Whole-body pharmacokinetics of [<sup>18</sup>F]<b>29</b>. (A) Small animal PET/MR-derived TACs in healthy female CD-1 mice (<i>n</i> = 3). (B) (left) Summed whole body PET image (0–60 min p.i.); (middle) T1-weighted whole body MR image; (right) fused PET/MR images of one representative animal.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Spleen uptake of [<sup>18</sup>F]<b>29</b>. (A) TAC of the spleen showing mean SUV (<i>n</i> = 3) and standard deviation. (B) Detailed view of the abdominal region (left: PET; middle: T1-weighted MR; right: PET/MR fusion) with main organs highlighted by arrows. (C) Spleen uptake under baseline and preblocking conditions (3 mg/kg of <b>1</b>, i.p. at 15 min before tracer). Activity uptake at 10 min p.i. of [<sup>18</sup>F]<b>29</b> is signifcantly reduced by preblocking (<i>p</i> < 0.05, students <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/medium/jm-2016-00554x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0009.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. PET whole brain uptake of [<sup>18</sup>F]<b>29</b> in LPS-treated (red) and control (green) mice. (A) Comparison of [<sup>18</sup>F]<b>29</b> baseline uptake in LPS-treated and control mice. There was a statistically significant difference between the LPS-treated and control animals (<i>p</i> < 0.05, nonparametric Mann–Whitney test (one tailed) of the area-under-curve); data are the mean SUV ± SD (<i>n</i> = 3). (insert) Representative images of LPS and control mice (0–35 min). (B) Whole brain uptake of [<sup>18</sup>F]<b>29</b> in the LPS-treated mice is reduced with injection of CB<sub>2</sub> agonist <b>1</b> (solution in 50% aq DMSO, i.p.) to nearly the same level as that in control mice injected with vehicle. Data are the averaged (10–30 min) SUV ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00554/20160901/images/large/jm-2016-00554x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00554&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gaoni, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span> </span><span class="NLM_article-title">Isolation, structure, and partial synthesis of an active constituent of Hashish</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1646</span><span class="NLM_x">–</span> <span class="NLM_lpage">1647</span><span class="refDoi"> DOI: 10.1021/ja01062a046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01062a046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaF2cXkt1GhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1964&pages=1646-1647&author=Y.+Gaoniauthor=R.+Mechoulam&title=Isolation%2C+structure%2C+and+partial+synthesis+of+an+active+constituent+of+Hashish&doi=10.1021%2Fja01062a046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hashish. III. Isolation, structure, and partial synthesis of an active constituent of hashish</span></div><div class="casAuthors">Gaoni, Y.; Mechoulam, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1646-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">cf. CA 60, 6876d.  Chromatography of a hexane ext. of hashish on florisil gave cannabinol (I) and Δ1-3,4-trans-tetrahydrocannabinol (II).  S dehydrogenation of II gave I.  Cannabidiol (III) heated 2 hrs. in alc. contg. 0.05% HCl gave I and unchanged III.  I, II, and III were compared by their nuclear magnetic resonance spectra.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgTMczY36d7bVg90H21EOLACvtfcHk0liZgJaVg3W8mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXkt1GhtLs%253D&md5=da595d192eb0484e6e66971b49b41eb1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fja01062a046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01062a046%26sid%3Dliteratum%253Aachs%26aulast%3DGaoni%26aufirst%3DY.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DIsolation%252C%2520structure%252C%2520and%2520partial%2520synthesis%2520of%2520an%2520active%2520constituent%2520of%2520Hashish%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1964%26volume%3D86%26spage%3D1646%26epage%3D1647%26doi%3D10.1021%2Fja01062a046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shvo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashish, I.</span><span> </span><span class="NLM_article-title">The structure of cannabidiol</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span><span class="refDoi"> DOI: 10.1016/0040-4020(63)85022-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2F0040-4020%2863%2985022-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1963&pages=2073-2078&author=R.+Mechoulamauthor=Y.+Shvoauthor=I.+Hashish&title=The+structure+of+cannabidiol&doi=10.1016%2F0040-4020%2863%2985022-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0040-4020%2863%2985022-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4020%252863%252985022-X%26sid%3Dliteratum%253Aachs%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DShvo%26aufirst%3DY.%26aulast%3DHashish%26aufirst%3DI.%26atitle%3DThe%2520structure%2520of%2520cannabidiol%26jtitle%3DTetrahedron%26date%3D1963%26volume%3D19%26spage%3D2073%26epage%3D2078%26doi%3D10.1016%2F0040-4020%2863%2985022-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">McPartland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">Are cannabidiol and Δ(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span><span class="refDoi"> DOI: 10.1111/bph.12944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1111%2Fbph.12944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25257544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1GisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=737-753&author=J.+M.+McPartlandauthor=M.+Duncanauthor=V.+Di+Marzoauthor=R.+G.+Pertwee&title=Are+cannabidiol+and+%CE%94%289%29-tetrahydrocannabivarin+negative+modulators+of+the+endocannabinoid+system%3F+A+systematic+review&doi=10.1111%2Fbph.12944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review</span></div><div class="casAuthors">McPartland, John M.; Duncan, Marnie; Di Marzo, Vincenzo; Pertwee, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-753</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Based upon evidence that the therapeutic properties of Cannabis prepns. are not solely dependent upon the presence of Δ9-tetrahydrocannabinol (THC), pharmacol. studies have been recently carried out with other plant cannabinoids (phytocannabinoids), particularly cannabidiol (CBD) and Δ9-tetrahydrocannabivarin (THCV).  Results from some of these studies have fostered the view that CBD and THCV modulate the effects of THC via direct blockade of cannabinoid CB1 receptors, thus behaving like first-generation CB1 receptor inverse agonists, such as rimonabant.  Here, we review in vitro and ex vivo mechanistic studies of CBD and THCV, and synthesize data from these studies in a meta-anal.  Synthesized data regarding mechanisms are then used to interpret results from recent pre-clin. animal studies and clin. trials.  The evidence indicates that CBD and THCV are not rimonabant-like in their action and thus appear very unlikely to produce unwanted CNS effects.  They exhibit markedly disparate pharmacol. profiles particularly at CB1 receptors: CBD is a very low-affinity CB1 ligand that can nevertheless affect CB1 receptor activity in vivo in an indirect manner, while THCV is a high-affinity CB1 receptor ligand and potent antagonist in vitro and yet only occasionally produces effects in vivo resulting from CB1 receptor antagonism.  THCV has also high affinity for CB2 receptors and signals as a partial agonist, differing from both CBD and rimonabant.  These cannabinoids illustrate how in vitro mechanistic studies do not always predict in vivo pharmacol. and underlie the necessity of testing compds. in vivo before drawing any conclusion on their functional activity at a given target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_W6xdFBwCQbVg90H21EOLACvtfcHk0ljlv1ggnI_PHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1GisQ%253D%253D&md5=ca76db42227dadff65ef93b30a723625</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fbph.12944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12944%26sid%3Dliteratum%253Aachs%26aulast%3DMcPartland%26aufirst%3DJ.%2BM.%26aulast%3DDuncan%26aufirst%3DM.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DAre%2520cannabidiol%2520and%2520%25CE%2594%25289%2529-tetrahydrocannabivarin%2520negative%2520modulators%2520of%2520the%2520endocannabinoid%2520system%253F%2520A%2520systematic%2520review%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D737%26epage%3D753%26doi%3D10.1111%2Fbph.12944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Svizenska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubovy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulcova, A.</span><span> </span><span class="NLM_article-title">Cannabinoid receptors 1 and 2 (CB<sub>1</sub> and CB<sub>2</sub>), their distribution, ligands and functional involvement in nervous system structures-a short review</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1016/j.pbb.2008.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.pbb.2008.05.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=501-511&author=I.+Svizenskaauthor=P.+Dubovyauthor=A.+Sulcova&title=Cannabinoid+receptors+1+and+2+%28CB1+and+CB2%29%2C+their+distribution%2C+ligands+and+functional+involvement+in+nervous+system+structures-a+short+review&doi=10.1016%2Fj.pbb.2008.05.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2008.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2008.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DSvizenska%26aufirst%3DI.%26aulast%3DDubovy%26aufirst%3DP.%26aulast%3DSulcova%26aufirst%3DA.%26atitle%3DCannabinoid%2520receptors%25201%2520and%25202%2520%2528CB1%2520and%2520CB2%2529%252C%2520their%2520distribution%252C%2520ligands%2520and%2520functional%2520involvement%2520in%2520nervous%2520system%2520structures-a%2520short%2520review%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2008%26volume%3D90%26spage%3D501%26epage%3D511%26doi%3D10.1016%2Fj.pbb.2008.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Panagis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlachou, S.</span><span> </span><span class="NLM_article-title">Cannabinoid regulation of brain reward processing with n emphasis on the role of CB<sub>1</sub> receptors: a step back into the future</span> <span class="citation_source-journal">Front. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span><span class="refDoi"> DOI: 10.3389/fpsyt.2014.00092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.3389%2Ffpsyt.2014.00092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24478729" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1-20&author=G.+Panagisauthor=B.+Mackeyauthor=S.+Vlachou&title=Cannabinoid+regulation+of+brain+reward+processing+with+n+emphasis+on+the+role+of+CB1+receptors%3A+a+step+back+into+the+future&doi=10.3389%2Ffpsyt.2014.00092"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2014.00092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2014.00092%26sid%3Dliteratum%253Aachs%26aulast%3DPanagis%26aufirst%3DG.%26aulast%3DMackey%26aufirst%3DB.%26aulast%3DVlachou%26aufirst%3DS.%26atitle%3DCannabinoid%2520regulation%2520of%2520brain%2520reward%2520processing%2520with%2520n%2520emphasis%2520on%2520the%2520role%2520of%2520CB1%2520receptors%253A%2520a%2520step%2520back%2520into%2520the%2520future%26jtitle%3DFront.%2520Psychiatry%26date%3D2014%26volume%3D5%26spage%3D1%26epage%3D20%26doi%3D10.3389%2Ffpsyt.2014.00092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Console-Bram, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abood, M. E.</span><span> </span><span class="NLM_article-title">Cannabinoid receptors: nomenclature and pharmacological principles</span> <span class="citation_source-journal">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1016/j.pnpbp.2012.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.pnpbp.2012.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=22421596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC38vmvFOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=4-15&author=L.+Console-Bramauthor=J.+Marcuauthor=M.+E.+Abood&title=Cannabinoid+receptors%3A+nomenclature+and+pharmacological+principles&doi=10.1016%2Fj.pnpbp.2012.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors: nomenclature and pharmacological principles</span></div><div class="casAuthors">Console-Bram Linda; Marcu Jahan; Abood Mary E</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neuro-psychopharmacology & biological psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The CB1 and CB2 cannabinoid receptors are members of the G protein-coupled receptor (GPCR) family that are pharmacologically well defined.  However, the discovery of additional sites of action for endocannabinoids as well as synthetic cannabinoid compounds suggests the existence of additional cannabinoid receptors.  Here we review this evidence, as well as the current nomenclature for classifying a target as a cannabinoid receptor.  Basic pharmacological definitions, principles and experimental conditions are discussed in order to place in context the mechanisms underlying cannabinoid receptor activation.  Constitutive (agonist-independent) activity is observed with the overexpression of many GPCRs, including cannabinoid receptors.  Allosteric modulators can alter the pharmacological responses of cannabinoid receptors.  The complex molecular architecture of each of the cannabinoid receptors allows for a single receptor to recognize multiple classes of compounds and produce an array of distinct downstream effects.  Natural polymorphisms and alternative splice variants may also contribute to their pharmacological diversity.  As our knowledge of the distinct differences grows, we may be able to target select receptor conformations and their corresponding pharmacological responses.  Importantly, the basic biology of the endocannabinoid system will continue to be revealed by ongoing investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNFfefR2I-qrjnyZkbE8yXfW6udTcc2ea514zPmNiqZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vmvFOktg%253D%253D&md5=8bc96ed2bc737597f4d985ef786ecaf4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2012.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2012.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DConsole-Bram%26aufirst%3DL.%26aulast%3DMarcu%26aufirst%3DJ.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DCannabinoid%2520receptors%253A%2520nomenclature%2520and%2520pharmacological%2520principles%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2012%26volume%3D38%26spage%3D4%26epage%3D15%26doi%3D10.1016%2Fj.pnpbp.2012.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Matsuda, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lolait, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownstein, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonner, T. I.</span><span> </span><span class="NLM_article-title">Structure of a cannabinoid receptor and functional expression of the cloned cDNA</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1038/346561a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1038%2F346561a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=2165569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1990&pages=561-564&author=L.+A.+Matsudaauthor=S.+J.+Lolaitauthor=M.+J.+Brownsteinauthor=A.+C.+Youngauthor=T.+I.+Bonner&title=Structure+of+a+cannabinoid+receptor+and+functional+expression+of+the+cloned+cDNA&doi=10.1038%2F346561a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a cannabinoid receptor and functional expression of the cloned cDNA</span></div><div class="casAuthors">Matsuda, Lisa A.; Lolait, Stephen J.; Brownstein, Michael J.; Young, Alice C.; Bonner, Tom I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6284</span>),
    <span class="NLM_cas:pages">561-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner.  CNS depression and analgesia are well documented effects of the cannabinoids, but the mechanisms responsible for the cannabinoid-induced effects are not known.  The hydrophobic nature of these substances has suggested that cannabinoids resemble anesthetic agents in their action and nonspecifically disrupt cellular membranes.  Recent evidence has supported a mechanism involving a G-protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner.  Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids.  This study reported the cloning and expression of a cDNA that encodes a G-protein-coupled receptor with all of these properties.  Its mRNA is found in cell lines and regions of the brain that have cannabinoid receptors.  This protein may be involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrydatT83mLVg90H21EOLACvtfcHk0lhYhPc3JlGQ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1Ghu7w%253D&md5=a99aeb39544d87392cee18b82a08003d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F346561a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F346561a0%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DL.%2BA.%26aulast%3DLolait%26aufirst%3DS.%2BJ.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DYoung%26aufirst%3DA.%2BC.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26atitle%3DStructure%2520of%2520a%2520cannabinoid%2520receptor%2520and%2520functional%2520expression%2520of%2520the%2520cloned%2520cDNA%26jtitle%3DNature%26date%3D1990%26volume%3D346%26spage%3D561%26epage%3D564%26doi%3D10.1038%2F346561a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Shaar, M.</span><span> </span><span class="NLM_article-title">Molecular characterization of a peripheral receptor for cannabinoids</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1038/365061a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1038%2F365061a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=7689702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1993&pages=61-65&author=S.+Munroauthor=K.+L.+Thomasauthor=M.+Abu-Shaar&title=Molecular+characterization+of+a+peripheral+receptor+for+cannabinoids&doi=10.1038%2F365061a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of a peripheral receptor for cannabinoids</span></div><div class="casAuthors">Munro, Sean; Thomas, Kerrie L.; Abu-Shaar, Muna</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">6441</span>),
    <span class="NLM_cas:pages">61-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The major active ingredient of marijuana, Δ9-tetrahydrocannabinol (Δ-THC), has been used as a psychoactive agent for thousands of years.  Marijuana, and Δ9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting.  The clin. application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochem. bases of their action.  Progress stemmed initially from the synthesis of potent derivs. of Δ9-THC4,5, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids.  This receptor is expressed in the brain but not in the periphery, except for a low level in testes.  It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins.  Here the authors report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHsq4vy1XH17Vg90H21EOLACvtfcHk0lhYhPc3JlGQ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWiurk%253D&md5=476435b57bd0f24483e2f24b813cc32f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F365061a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F365061a0%26sid%3Dliteratum%253Aachs%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DK.%2BL.%26aulast%3DAbu-Shaar%26aufirst%3DM.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520peripheral%2520receptor%2520for%2520cannabinoids%26jtitle%3DNature%26date%3D1993%26volume%3D365%26spage%3D61%26epage%3D65%26doi%3D10.1038%2F365061a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Brown, A. J.</span><span> </span><span class="NLM_article-title">Novel cannabinoid receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0707481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1038%2Fsj.bjp.0707481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=17906678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ejt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2007&pages=567-575&author=A.+J.+Brown&title=Novel+cannabinoid+receptors&doi=10.1038%2Fsj.bjp.0707481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Novel cannabinoid receptors</span></div><div class="casAuthors">Brown, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">567-575</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cannabinoids have numerous physiol. effects.  In the years since the mol. identification of the G protein-coupled receptors CB1 and CB2, the ion channel TRPV1, and their corresponding endogenous ligand systems, many cannabinoid-evoked actions have been shown conclusively to be mediated by one of these specific receptor targets.  However, there remain several examples where these classical cannabinoid receptors do not explain obsd. pharmacol.  Studies using mice genetically deleted for the known receptors have confirmed the existence of addnl. targets, which have come to be known collectively as non-CB1/CB2 receptors.  Despite intense research efforts, the mol. identity of these non-CB1/CB2 receptors remains for the most part unclear.  Two orphan G protein-coupled receptors have recently been implicated as novel cannabinoid receptors; these are GPR119, which has been proposed as a receptor for oleoylethanolamide, and GPR55 which has been proposed as a receptor activated by multiple different cannabinoid ligands.  This review presents an introduction to non-CB1/CB2 pharmacol., summarize information on GPR55 and GPR119 currently available, and consider their phylogenetic origin and what aspects of non-CB1/CB2 pharmacol., if any, they help explain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo0rVSQgej9rVg90H21EOLACvtfcHk0lhhQR1B1vWf7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ejt7%252FN&md5=87a88f7e93d44d1575cf1f42bd30841b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707481%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26atitle%3DNovel%2520cannabinoid%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D152%26spage%3D567%26epage%3D575%26doi%3D10.1038%2Fsj.bjp.0707481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiley, C. R.</span><span> </span><span class="NLM_article-title">In silico patent searching reveals a new cannabinoid receptor</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1016/j.tips.2005.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.tips.2005.11.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1-4&author=D.+Bakerauthor=G.+Pryceauthor=W.+L.+Daviesauthor=C.+R.+Hiley&title=In+silico+patent+searching+reveals+a+new+cannabinoid+receptor&doi=10.1016%2Fj.tips.2005.11.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DPryce%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DW.%2BL.%26aulast%3DHiley%26aufirst%3DC.%2BR.%26atitle%3DIn%2520silico%2520patent%2520searching%2520reveals%2520a%2520new%2520cannabinoid%2520receptor%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D1%26epage%3D4%26doi%3D10.1016%2Fj.tips.2005.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babbs, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doel, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasamison, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang-Christensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span><span class="refDoi"> DOI: 10.1016/j.cmet.2006.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.cmet.2006.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=16517404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=167-175&author=H.+A.+Overtonauthor=A.+J.+Babbsauthor=S.+M.+Doelauthor=M.+C.+Fyfeauthor=L.+S.+Gardnerauthor=G.+Griffinauthor=H.+C.+Jacksonauthor=M.+J.+Procterauthor=C.+M.+Rasamisonauthor=M.+Tang-Christensenauthor=P.+S.+Widdowsonauthor=G.+M.+Williamsauthor=C.+Reynet&title=Deorphanization+of+a+G+protein-coupled+receptor+for+oleoylethanolamide+and+its+use+in+the+discovery+of+small-molecule+hypophagic+agents&doi=10.1016%2Fj.cmet.2006.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span></div><div class="casAuthors">Overton, Hilary A.; Babbs, Adam J.; Doel, Sheila M.; Fyfe, Matthew C. T.; Gardner, Lisa S.; Griffin, Graeme; Jackson, Helen C.; Procter, Martin J.; Rasamison, Chrystelle M.; Tang-Christensen, Mads; Widdowson, Peter S.; Williams, Geoffery M.; Reynet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The endogenous lipid signaling agent oleoylethanolamide (OEA) has recently been described as a peripherally acting agent that reduces food intake and body wt. gain in rat feeding models.  This paper presents evidence that OEA is an endogenous ligand of the orphan receptor GPR119, a G protein-coupled receptor (GPCR) expressed predominantly in the human and rodent pancreas and gastrointestinal tract and also in rodent brain, suggesting that the reported effects of OEA on food intake may be mediated, at least in part, via the GPR119 receptor.  Furthermore, we have used the recombinant receptor to discover novel selective small-mol. GPR119 agonists, typified by PSN632408, which suppress food intake in rats and reduce body wt. gain and white adipose tissue deposition upon subchronic oral administration to high-fat-fed rats.  GPR119 therefore represents a novel and attractive potential target for the therapy of obesity and related metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8xt3VqDV07Vg90H21EOLACvtfcHk0lhhQR1B1vWf7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D&md5=85c2756aa0809be0069ea515e2a1574d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DBabbs%26aufirst%3DA.%2BJ.%26aulast%3DDoel%26aufirst%3DS.%2BM.%26aulast%3DFyfe%26aufirst%3DM.%2BC.%26aulast%3DGardner%26aufirst%3DL.%2BS.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DH.%2BC.%26aulast%3DProcter%26aufirst%3DM.%2BJ.%26aulast%3DRasamison%26aufirst%3DC.%2BM.%26aulast%3DTang-Christensen%26aufirst%3DM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DWilliams%26aufirst%3DG.%2BM.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DDeorphanization%2520of%2520a%2520G%2520protein-coupled%2520receptor%2520for%2520oleoylethanolamide%2520and%2520its%2520use%2520in%2520the%2520discovery%2520of%2520small-molecule%2520hypophagic%2520agents%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D167%26epage%3D175%26doi%3D10.1016%2Fj.cmet.2006.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Vemuri, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of cannabinoids</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span><span class="refDoi"> DOI: 10.1002/cpt.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1002%2Fcpt.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25801236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFKrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=553-558&author=V.+K.+Vemuriauthor=A.+Makriyannis&title=Medicinal+chemistry+of+cannabinoids&doi=10.1002%2Fcpt.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of cannabinoids</span></div><div class="casAuthors">Vemuri, V. Kiran; Makriyannis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-558</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The endocannabinoid system comprises the two well characterized Gi/o-protein coupled receptors (cannabinoid receptor 1 (CB1) and CB2), their endogenous lipid ligands, and the enzymes involved in their biosynthesis and biotransformation.  Drug discovery efforts relating to the endocannabinoid system have been focused mainly on the two cannabinoid receptors and the two endocannabinoid deactivating enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGL).  This review provides an overview of cannabinergic agents used in drug research and those being explored clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUhg1K1g6d67Vg90H21EOLACvtfcHk0ljdedFuVooExw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFKrsbc%253D&md5=89e98ec89810137591045fa3ee57c701</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fcpt.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt.115%26sid%3Dliteratum%253Aachs%26aulast%3DVemuri%26aufirst%3DV.%2BK.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DMedicinal%2520chemistry%2520of%2520cannabinoids%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2015%26volume%3D97%26spage%3D553%26epage%3D558%26doi%3D10.1002%2Fcpt.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Roche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, D. P.</span><span> </span><span class="NLM_article-title">Brain CB<sub>2</sub> receptors: implications for neuropsychiatric disorders</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2517</span><span class="NLM_x">–</span> <span class="NLM_lpage">2553</span><span class="refDoi"> DOI: 10.3390/ph3082517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.3390%2Fph3082517" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=2517-2553&author=M.+Rocheauthor=D.+P.+Finn&title=Brain+CB2+receptors%3A+implications+for+neuropsychiatric+disorders&doi=10.3390%2Fph3082517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3390%2Fph3082517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3082517%26sid%3Dliteratum%253Aachs%26aulast%3DRoche%26aufirst%3DM.%26aulast%3DFinn%26aufirst%3DD.%2BP.%26atitle%3DBrain%2520CB2%2520receptors%253A%2520implications%2520for%2520neuropsychiatric%2520disorders%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26spage%3D2517%26epage%3D2553%26doi%3D10.3390%2Fph3082517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Horti, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span> </span><span class="NLM_article-title">Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB<sub>1</sub>) in human brain</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3363</span><span class="NLM_x">–</span> <span class="NLM_lpage">3383</span><span class="refDoi"> DOI: 10.2174/138161208786549380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.2174%2F138161208786549380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=19075713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtV2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3363-3383&author=A.+G.+Hortiauthor=K.+Van+Laere&title=Development+of+radioligands+for+in+vivo+imaging+of+type+1+cannabinoid+receptors+%28CB1%29+in+human+brain&doi=10.2174%2F138161208786549380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain</span></div><div class="casAuthors">Horti, Andrew G.; Van Laere, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3363-3383</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cerebral cannabinoid receptor (CB1) and cannabinoid drugs constitute a vibrant field in modern medicine and pharmacol.  However, the physiol. and pharmacol. roles played by the cannabinoid receptor in the central nervous system are still not fully understood.  Positron-emission tomog. (PET) is the most advanced technique for non-invasive research of cerebral receptors.  Quant. PET imaging of CB1 in animal and human brains has been limited by drawbacks of the available CB1 radioligands that manifested low specific binding, high non-specific binding and/or low brain uptake.  The latest research revealed three CB1 PET radioligands ([11C]JHU75528, [18F]MK9470 and [11C]MePPEP) with improved imaging properties.  These compds. are now being employed for the quant. evaluation of CB1 in human subjects with PET.  Mol. imaging of the CB1 receptor with these radioligands has now become possible and their application in healthy humans and in patients is underway.  Despite the substantial progress in development of CB1 PET radioligands even the latest radioligands manifest certain disadvantages.  Current research efforts on the development of CB1 radioligands with higher binding potential, greater brain uptake and more optimal brain kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMybxdwa52k7Vg90H21EOLACvtfcHk0ljdedFuVooExw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtV2quw%253D%253D&md5=27771b15f344d8e628ec984cbe3da791</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F138161208786549380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208786549380%26sid%3Dliteratum%253Aachs%26aulast%3DHorti%26aufirst%3DA.%2BG.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26atitle%3DDevelopment%2520of%2520radioligands%2520for%2520in%2520vivo%2520imaging%2520of%2520type%25201%2520cannabinoid%2520receptors%2520%2528CB1%2529%2520in%2520human%2520brain%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D3363%26epage%3D3383%26doi%3D10.2174%2F138161208786549380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guevara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ming, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grachev, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascella, N.</span><span> </span><span class="NLM_article-title">Quantification of cerebral cannabinoid receptors subtype 1 (CB<sub>1</sub>) in healthy subjects and schizophrenia by the novel PET radioligand [<sup>11</sup>C]OMAR</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1505</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2010.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.neuroimage.2010.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=20406692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVGnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=1505-1513&author=D.+F.+Wongauthor=H.+Kuwabaraauthor=A.+G.+Hortiauthor=V.+Raymontauthor=J.+Brasicauthor=M.+Guevaraauthor=W.+Yeauthor=R.+F.+Dannalsauthor=H.+T.+Ravertauthor=A.+Nandiauthor=A.+Rahmimauthor=J.+E.+Mingauthor=I.+Grachevauthor=C.+Royauthor=N.+Cascella&title=Quantification+of+cerebral+cannabinoid+receptors+subtype+1+%28CB1%29+in+healthy+subjects+and+schizophrenia+by+the+novel+PET+radioligand+%5B11C%5DOMAR&doi=10.1016%2Fj.neuroimage.2010.04.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR</span></div><div class="casAuthors">Wong, Dean F.; Kuwabara, Hiroto; Horti, Andrew G.; Raymont, Vanessa; Brasic, James; Guevara, Maria; Ye, Weiguo; Dannals, Robert F.; Ravert, Hayden T.; Nandi, Ayon; Rahmim, Arman; Ming, Jeffrey E.; Grachev, Igor; Roy, Christine; Cascella, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1505-1513</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Several studies have examd. the link between the cannabinoid CB1 receptor and several neuropsychiatric illnesses, including schizophrenia.  As such, there is a need for in vivo imaging tracers so that the relationship between CB1 and schizophrenia (SZ) can be further studied.  In this paper, we present our first human studies in both healthy control patients and patients with schizophrenia using the novel PET tracer, [11C]OMAR (JHU75528), we have shown its utility as a tracer for imaging human CB1 receptors and to investigate normal aging and the differences in the cannabinoid system of healthy controls vs. patients with schizophrenia.  A total of ten healthy controls and nine patients with schizophrenia were included and studied with high specific activity [11C]OMAR.  The CB1 binding (expressed as the distribution vol.; VT) was highest in the globus pallidus and the cortex in both controls and patients with schizophrenia.  Controls showed a correlation with the known distribution of CB1 and decline of [11C]OMAR binding with age, most significantly in the globus pallidus.  Overall, we obsd. elevated mean binding in patients with schizophrenia across all regions studied, and this increase was statistically significant in the pons (p < 0.05), by the Students t-test.  When we ran a regression of the control subjects VT values with age and then compared the patient data to 95% prediction limits of the linear regression, three patients fell completely outside for the globus pallidus, and in all other regions there were at least 1-3 patients outside of the prediction intervals.  There was no statistically significant correlations between PET measures and the individual Brief Psychiatry Rating Score (BPRS) subscores (r = 0.49), but there was a significant correlation between VT and the ratio of the BPRS psychosis to withdrawal score in the frontal lobe (r = 0.60), and middle and posterior cingulate regions (r = 0.71 and r = 0.79 resp.).  In conclusion, we found that [11C]OMAR can image human CB1 receptors in normal aging and schizophrenia.  In addn., our initial data in subjects with schizophrenia seem to suggest an assocn. of elevated binding specific brain regions and symptoms of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOEH2Wkw4jW7Vg90H21EOLACvtfcHk0ljdedFuVooExw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVGnt70%253D&md5=6f7bf8d2410075a00b7f7f1969106823</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2010.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2010.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DKuwabara%26aufirst%3DH.%26aulast%3DHorti%26aufirst%3DA.%2BG.%26aulast%3DRaymont%26aufirst%3DV.%26aulast%3DBrasic%26aufirst%3DJ.%26aulast%3DGuevara%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DNandi%26aufirst%3DA.%26aulast%3DRahmim%26aufirst%3DA.%26aulast%3DMing%26aufirst%3DJ.%2BE.%26aulast%3DGrachev%26aufirst%3DI.%26aulast%3DRoy%26aufirst%3DC.%26aulast%3DCascella%26aufirst%3DN.%26atitle%3DQuantification%2520of%2520cerebral%2520cannabinoid%2520receptors%2520subtype%25201%2520%2528CB1%2529%2520in%2520healthy%2520subjects%2520and%2520schizophrenia%2520by%2520the%2520novel%2520PET%2520radioligand%2520%255B11C%255DOMAR%26jtitle%3DNeuroImage%26date%3D2010%26volume%3D52%26spage%3D1505%26epage%3D1513%26doi%3D10.1016%2Fj.neuroimage.2010.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Onaivi, E. S.</span><span> </span><span class="NLM_article-title">Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB<sub>2</sub> receptors in the brain</span> <span class="citation_source-journal">Neuropsychobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.1159/000100778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1159%2F000100778" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=231-246&author=E.+S.+Onaivi&title=Neuropsychobiological+evidence+for+the+functional+presence+and+expression+of+cannabinoid+CB2+receptors+in+the+brain&doi=10.1159%2F000100778"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1159%2F000100778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000100778%26sid%3Dliteratum%253Aachs%26aulast%3DOnaivi%26aufirst%3DE.%2BS.%26atitle%3DNeuropsychobiological%2520evidence%2520for%2520the%2520functional%2520presence%2520and%2520expression%2520of%2520cannabinoid%2520CB2%2520receptors%2520in%2520the%2520brain%26jtitle%3DNeuropsychobiology%26date%3D2006%26volume%3D54%26spage%3D231%26epage%3D246%26doi%3D10.1159%2F000100778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Van Sickle, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouihate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittman, Q. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharkey, K. A.</span><span> </span><span class="NLM_article-title">Identification and functional characterization of brainstem cannabinoid CB<sub>2</sub> receptors</span> <span class="citation_source-journal">Science (Washington, DC, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1126/science.1115740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1126%2Fscience.1115740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=16224028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2hurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=329-332&author=M.+D.+Van+Sickleauthor=M.+Duncanauthor=P.+J.+Kingsleyauthor=A.+Mouihateauthor=P.+Urbaniauthor=K.+Mackieauthor=N.+Stellaauthor=A.+Makriyannisauthor=D.+Piomelliauthor=J.+S.+Davisonauthor=L.+J.+Marnettauthor=V.+Di+Marzoauthor=Q.+J.+Pittmanauthor=K.+D.+Patelauthor=K.+A.+Sharkey&title=Identification+and+functional+characterization+of+brainstem+cannabinoid+CB2+receptors&doi=10.1126%2Fscience.1115740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and functional characterization of brainstem cannabinoid CB2 receptors</span></div><div class="casAuthors">Van Sickle, Marja D.; Duncan, Marnie; Kingsley, Philip J.; Mouihate, Abdeslam; Urbani, Paolo; Mackie, Ken; Stella, Nephi; Makriyannis, Alexandros; Piomelli, Daniele; Davison, Joseph S.; Marnett, Lawrence J.; Di Marzo, Vincenzo; Pittman, Quentin J.; Patel, Kamala D.; Sharkey, Keith A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">5746</span>),
    <span class="NLM_cas:pages">329-332</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The presence and function of CB2 receptors in central nervous system (CNS) neurons are controversial.  The authors report the expression of CB2 receptor mRNA and protein localization on brainstem neurons.  These functional CB2 receptors in the brainstem were activated by a CB2 receptor agonist, 2-arachidonoylglycerol, and by elevated endogenous levels of endocannabinoids, which also act at CB1 receptors.  CB2 receptors represent an alternative site of action of endocannabinoids that opens the possibility of nonpsychotropic therapeutic interventions using enhanced endocannabinoid levels in localized brain areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWgg6LDIT0bVg90H21EOLACvtfcHk0lh7ePTsx9r7Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2hurvL&md5=ab457ab0bd1b8e30ea927a1e61366323</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.1115740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1115740%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BSickle%26aufirst%3DM.%2BD.%26aulast%3DDuncan%26aufirst%3DM.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DMouihate%26aufirst%3DA.%26aulast%3DUrbani%26aufirst%3DP.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DStella%26aufirst%3DN.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DDavison%26aufirst%3DJ.%2BS.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPittman%26aufirst%3DQ.%2BJ.%26aulast%3DPatel%26aufirst%3DK.%2BD.%26aulast%3DSharkey%26aufirst%3DK.%2BA.%26atitle%3DIdentification%2520and%2520functional%2520characterization%2520of%2520brainstem%2520cannabinoid%2520CB2%2520receptors%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2005%26volume%3D310%26spage%3D329%26epage%3D332%26doi%3D10.1126%2Fscience.1115740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ashton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. F.</span><span> </span><span class="NLM_article-title">Expression of the cannabinoid CB<sub>2</sub> receptor in the rat cerebellum: an immunohistochemical study</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span><span class="refDoi"> DOI: 10.1016/j.neulet.2005.11.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.neulet.2005.11.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2006&pages=113-116&author=J.+C.+Ashtonauthor=D.+Fribergauthor=C.+L.+Darlingtonauthor=P.+F.+Smith&title=Expression+of+the+cannabinoid+CB2+receptor+in+the+rat+cerebellum%3A+an+immunohistochemical+study&doi=10.1016%2Fj.neulet.2005.11.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2005.11.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2005.11.038%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DJ.%2BC.%26aulast%3DFriberg%26aufirst%3DD.%26aulast%3DDarlington%26aufirst%3DC.%2BL.%26aulast%3DSmith%26aufirst%3DP.%2BF.%26atitle%3DExpression%2520of%2520the%2520cannabinoid%2520CB2%2520receptor%2520in%2520the%2520rat%2520cerebellum%253A%2520an%2520immunohistochemical%2520study%26jtitle%3DNeurosci.%2520Lett.%26date%3D2006%26volume%3D396%26spage%3D113%26epage%3D116%26doi%3D10.1016%2Fj.neulet.2005.11.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Sheng, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabral, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokensgard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, P. K.</span><span> </span><span class="NLM_article-title">Synthetic cannabinoid WIN55,212–2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1002/glia.20108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1002%2Fglia.20108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=211-219&author=W.+S.+Shengauthor=S.+Huauthor=X.+Minauthor=G.+A.+Cabralauthor=J.+R.+Lokensgardauthor=P.+K.+Peterson&title=Synthetic+cannabinoid+WIN55%2C212%E2%80%932+inhibits+generation+of+inflammatory+mediators+by+IL-1beta-stimulated+human+astrocytes&doi=10.1002%2Fglia.20108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fglia.20108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20108%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DW.%2BS.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DMin%26aufirst%3DX.%26aulast%3DCabral%26aufirst%3DG.%2BA.%26aulast%3DLokensgard%26aufirst%3DJ.%2BR.%26aulast%3DPeterson%26aufirst%3DP.%2BK.%26atitle%3DSynthetic%2520cannabinoid%2520WIN55%252C212%25E2%2580%25932%2520inhibits%2520generation%2520of%2520inflammatory%2520mediators%2520by%2520IL-1beta-stimulated%2520human%2520astrocytes%26jtitle%3DGlia%26date%3D2005%26volume%3D49%26spage%3D211%26epage%3D219%26doi%3D10.1002%2Fglia.20108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Golech, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shohami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spatz, M.</span><span> </span><span class="NLM_article-title">Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1016/j.molbrainres.2004.08.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.molbrainres.2004.08.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=15548432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSktr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2004&pages=87-92&author=S.+A.+Golechauthor=R.+M.+McCarronauthor=Y.+Chenauthor=J.+Bembryauthor=F.+Lenzauthor=R.+Mechoulamauthor=E.+Shohamiauthor=M.+Spatz&title=Human+brain+endothelium%3A+coexpression+and+function+of+vanilloid+and+endocannabinoid+receptors&doi=10.1016%2Fj.molbrainres.2004.08.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors</span></div><div class="casAuthors">Golech, Susanne Andrea; McCarron, Richard M.; Chen, Ye; Bembry, Joliet; Lenz, Frederick; Mechoulam, Raphael; Shohami, Esther; Spatz, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The arachidonic acid deriv., 2-arachidonoyl-glycerol (2-AG), was initially isolated from gut and brain; it is also produced and released from blood and vascular cells.  Many of the 2-AG-induced cellular responses (i.e., neuromodulation, cytoprotection and vasodilation) are mediated by cannabinoid receptors CB1 and CB2.  The findings presented here demonstrate the expression of CB1, CB2 and TRPV1 receptors on cerebromicrovascular endothelial cells (HBEC).  The expression of TRPV1, CB1 and CB2 receptor mRNA and proteins were demonstrated by RT-PCR and polyclonal antibodies, resp.  The endocannabinoid 2-AG, and other related compds. [anandamide (ANA), methanandamide (m-ANA), N-(4-hydroxyphenyl-arachidonyl-ethanolamide) (AM404) and capsaicin] dose-dependently stimulated Ca2+ influx in HBEC.  The selective TRPV1 receptor antagonist (capsazepine), CB1 receptor antagonist (SR141716A) and CB2 receptor antagonist (SR144528) inhibited these responses.  The effects of capsaicin, a specific agonist for TRPV1 receptors, were inhibited by capsazepine, but only weakly by CB1 or CB2 receptor antagonists.  2-AG also induced phosphorylation of vasodilator-stimulated phosphoprotein (VASP); this response was mediated by VR1 receptors.  These studies clearly indicate that 2-AG and other related compds. may function as agonists on VR1 receptors, as well as CB1 and CB2 receptors, and implicated these factors in various HBEC functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxdzokfZjGN7Vg90H21EOLACvtfcHk0ljkBooYHH6gWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSktr3F&md5=88cc9f723c71a8af745f9128015302c1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.molbrainres.2004.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbrainres.2004.08.025%26sid%3Dliteratum%253Aachs%26aulast%3DGolech%26aufirst%3DS.%2BA.%26aulast%3DMcCarron%26aufirst%3DR.%2BM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DBembry%26aufirst%3DJ.%26aulast%3DLenz%26aufirst%3DF.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DSpatz%26aufirst%3DM.%26atitle%3DHuman%2520brain%2520endothelium%253A%2520coexpression%2520and%2520function%2520of%2520vanilloid%2520and%2520endocannabinoid%2520receptors%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D2004%26volume%3D132%26spage%3D87%26epage%3D92%26doi%3D10.1016%2Fj.molbrainres.2004.08.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrier, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">Cannabinoid CB<sub>2</sub> receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer’s disease brains</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">11136</span><span class="NLM_x">–</span> <span class="NLM_lpage">11141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=14657172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=11136-11141&author=C.+Benitoauthor=E.+Nunezauthor=R.+M.+Tolonauthor=E.+J.+Carrierauthor=A.+Rabanoauthor=C.+J.+Hillardauthor=J.+Romero&title=Cannabinoid+CB2+receptors+and+fatty+acid+amide+hydrolase+are+selectively+overexpressed+in+neuritic+plaque-associated+glia+in+Alzheimer%E2%80%99s+disease+brains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains</span></div><div class="casAuthors">Benito, Cristina; Nunez, Estefania; Tolon, Rosa M.; Carrier, Erica J.; Rabano, Alberto; Hillard, Cecilia J.; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11136-11141</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The endocannabinoid system is still poorly understood.  Recently, the basic elements that constitute it, i.e., membrane receptors, endogenous ligands, and mechanisms for termination of the signaling process, have been partially characterized.  There is a considerable lack of information, however, concerning the distribution, concn., and function of those components in the human body, particularly during pathol. events.  We have studied the status of some of the components of the endocannabinoid system, fatty acid amide hydrolase and cannabinoid CB1 and CB2 receptors, in postmortem brains from patients with Alzheimer's disease.  Using specific polyclonal antibodies, we have performed immunohistochem. anal. in hippocampus and entorhinal cortex sections from brains of Alzheimer's disease patients.  Our results show that both fatty acid amide hydrolase and cannabinoid CB2 receptors are abundantly and selectively expressed in neuritic plaque-assocd. astrocytes and microglia, resp., whereas the expression of CB1 receptors remains unchanged.  In addn., the hydrolase activity seems to be elevated in the plaques and surrounding areas.  Thus, some elements of the endocannabinoid system may be postulated as possible modulators of the inflammatory response assocd. with this neurodegenerative process and as possible targets for new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8Gm8V3n8jrVg90H21EOLACvtfcHk0ljkBooYHH6gWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtbw%253D&md5=c324980efac10a672fc425ef376694f1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DNunez%26aufirst%3DE.%26aulast%3DTolon%26aufirst%3DR.%2BM.%26aulast%3DCarrier%26aufirst%3DE.%2BJ.%26aulast%3DRabano%26aufirst%3DA.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB2%2520receptors%2520and%2520fatty%2520acid%2520amide%2520hydrolase%2520are%2520selectively%2520overexpressed%2520in%2520neuritic%2520plaque-associated%2520glia%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26spage%3D11136%26epage%3D11141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemente, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Docagne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guaza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2396</span><span class="NLM_x">–</span> <span class="NLM_lpage">2402</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4814-06.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1523%2FJNEUROSCI.4814-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=17329437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVymsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=2396-2402&author=C.+Benitoauthor=J.+P.+Romeroauthor=R.+M.+Tolonauthor=D.+Clementeauthor=F.+Docagneauthor=C.+J.+Hillardauthor=C.+Guazaauthor=J.+Romero&title=Cannabinoid+CB1+and+CB2+receptors+and+fatty+acid+amide+hydrolase+are+specific+markers+of+plaque+cell+subtypes+in+human+multiple+sclerosis&doi=10.1523%2FJNEUROSCI.4814-06.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis</span></div><div class="casAuthors">Benito, Cristina; Romero, Juan Pablo; Tolon, Rosa Maria; Clemente, Diego; Docagne, Fabian; Hillard, Cecilia J.; Guaza, Camen; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2396-2402</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Increasing evidence supports the idea of a beneficial effect of cannabinoid compds. for the treatment of multiple sclerosis (MS).  However, most exptl. data come from animal models of MS.  We investigated the status of cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase (FAAH) enzyme in brain tissue samples obtained from MS patients.  Areas of demyelination were identified and classified as active, chronic, and inactive plaques.  CB1 and CB2 receptors and FAAH densities and cellular sites of expression were examd. using immunohistochem. and immunofluorescence.  In MS samples, cannabinoid CB1 receptors were expressed by cortical neurons, oligodendrocytes, and also oligodendrocyte precursor cells, demonstrated using double immunofluorescence with antibodies against the CB1 receptor with antibodies against type 2 microtubule-assocd. protein, myelin basic protein, and the platelet-derived growth factor receptor-α, resp.  CB1 receptors were also present in macrophages and infiltrated T-lymphocytes.  Conversely, CB2 receptors were present in T-lymphocytes, astrocytes, and perivascular and reactive microglia (major histocompatibility complex class-II pos.) in MS plaques.  Specifically, CB2-pos. microglial cells were evenly distributed within active plaques but were located in the periphery of chronic active plaques.  FAAH expression was restricted to neurons and hypertrophic astrocytes.  As seen for other neuroinflammatory conditions, selective glial expression of cannabinoid CB1 and CB2 receptors and FAAH enzyme is induced in MS, thus supporting a role for the endocannabinoid system in the pathogenesis and/or evolution of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohbJVv49pGA7Vg90H21EOLACvtfcHk0ljkBooYHH6gWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVymsLY%253D&md5=597beaa5d37154540dd56bd58b2034bc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4814-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4814-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%2BP.%26aulast%3DTolon%26aufirst%3DR.%2BM.%26aulast%3DClemente%26aufirst%3DD.%26aulast%3DDocagne%26aufirst%3DF.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DCannabinoid%2520CB1%2520and%2520CB2%2520receptors%2520and%2520fatty%2520acid%2520amide%2520hydrolase%2520are%2520specific%2520markers%2520of%2520plaque%2520cell%2520subtypes%2520in%2520human%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D2396%26epage%3D2402%26doi%3D10.1523%2FJNEUROSCI.4814-06.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Yiangou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banati, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shaughnessy, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessell, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span> </span><span class="NLM_article-title">Cannabinoid receptor CB<sub>2</sub> expression in activated microglia of multiple sclerosis and amyotrophic lateral sclerosis spinal cord</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1226</span><span class="NLM_x">–</span> <span class="NLM_lpage">1226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2004&pages=1226-1226&author=Y.+Yiangouauthor=P.+Facerauthor=R.+B.+Banatiauthor=C.+T.+O%E2%80%99Shaughnessyauthor=I.+P.+Chessellauthor=P.+Anand&title=Cannabinoid+receptor+CB2+expression+in+activated+microglia+of+multiple+sclerosis+and+amyotrophic+lateral+sclerosis+spinal+cord"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYiangou%26aufirst%3DY.%26aulast%3DFacer%26aufirst%3DP.%26aulast%3DBanati%26aufirst%3DR.%2BB.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DC.%2BT.%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DAnand%26aufirst%3DP.%26atitle%3DCannabinoid%2520receptor%2520CB2%2520expression%2520in%2520activated%2520microglia%2520of%2520multiple%2520sclerosis%2520and%2520amyotrophic%2520lateral%2520sclerosis%2520spinal%2520cord%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2004%26volume%3D75%26spage%3D1226%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nunez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">Glial expression of cannabinoid CB<sub>2</sub> receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down’s syndrome</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2007.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.neuroscience.2007.10.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2008&pages=104-110&author=E.+Nunezauthor=C.+Benitoauthor=R.+M.+Tolonauthor=C.+J.+Hillardauthor=W.+S.+Griffinauthor=J.+Romero&title=Glial+expression+of+cannabinoid+CB2+receptors+and+fatty+acid+amide+hydrolase+are+beta+amyloid-linked+events+in+Down%E2%80%99s+syndrome&doi=10.1016%2Fj.neuroscience.2007.10.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2007.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2007.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DNunez%26aufirst%3DE.%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DTolon%26aufirst%3DR.%2BM.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DGriffin%26aufirst%3DW.%2BS.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DGlial%2520expression%2520of%2520cannabinoid%2520CB2%2520receptors%2520and%2520fatty%2520acid%2520amide%2520hydrolase%2520are%2520beta%2520amyloid-linked%2520events%2520in%2520Down%25E2%2580%2599s%2520syndrome%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D151%26spage%3D104%26epage%3D110%26doi%3D10.1016%2Fj.neuroscience.2007.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Palazuelos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguado, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pazos, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagredo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azcoitia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Ruiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galve-Roperh, I.</span><span> </span><span class="NLM_article-title">Microglial CB<sub>2</sub> cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">3152</span><span class="NLM_x">–</span> <span class="NLM_lpage">3164</span><span class="refDoi"> DOI: 10.1093/brain/awp239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1093%2Fbrain%2Fawp239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=19805493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BD1MjhvFWhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2009&pages=3152-3164&author=J.+Palazuelosauthor=T.+Aguadoauthor=M.+R.+Pazosauthor=B.+Julienauthor=C.+Carrascoauthor=E.+Reselauthor=O.+Sagredoauthor=C.+Benitoauthor=J.+Romeroauthor=I.+Azcoitiaauthor=J.+Fernandez-Ruizauthor=M.+Guzmanauthor=I.+Galve-Roperh&title=Microglial+CB2+cannabinoid+receptors+are+neuroprotective+in+Huntington%E2%80%99s+disease+excitotoxicity&doi=10.1093%2Fbrain%2Fawp239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity</span></div><div class="casAuthors">Palazuelos Javier; Aguado Tania; Pazos M Ruth; Julien Boris; Carrasco Carolina; Resel Eva; Sagredo Onintza; Benito Cristina; Romero Julian; Azcoitia Inigo; Fernandez-Ruiz Javier; Guzman Manuel; Galve-Roperh Ismael</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">Pt 11</span>),
    <span class="NLM_cas:pages">3152-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cannabinoid-derived drugs are promising agents for the development of novel neuroprotective strategies.  Activation of neuronal CB(1) cannabinoid receptors attenuates excitotoxic glutamatergic neurotransmission, triggers prosurvival signalling pathways and palliates motor symptoms in animal models of neurodegenerative disorders.  However, in Huntington's disease there is a very early downregulation of CB(1) receptors in striatal neurons that, together with the undesirable psychoactive effects triggered by CB(1) receptor activation, foster the search for alternative pharmacological treatments.  Here, we show that CB(2) cannabinoid receptor expression increases in striatal microglia of Huntington's disease transgenic mouse models and patients.  Genetic ablation of CB(2) receptors in R6/2 mice, that express human mutant huntingtin exon 1, enhanced microglial activation, aggravated disease symptomatology and reduced mice lifespan.  Likewise, induction of striatal excitotoxicity in CB(2) receptor-deficient mice by quinolinic acid administration exacerbated brain oedema, microglial activation, proinflammatory-mediator state and medium-sized spiny neuron degeneration.  Moreover, administration of CB(2) receptor-selective agonists to wild-type mice subjected to excitotoxicity reduced neuroinflammation, brain oedema, striatal neuronal loss and motor symptoms.  Studies on ganciclovir-induced depletion of astroglial proliferation in transgenic mice expressing thymidine kinase under the control of the glial fibrillary acidic protein promoter excluded the participation of proliferating astroglia in CB(2) receptor-mediated actions.  These findings support a pivotal role for CB(2) receptors in attenuating microglial activation and preventing neurodegeneration that may pave the way to new therapeutic strategies for neuroprotection in Huntington's disease as well as in other neurodegenerative disorders with a significant excitotoxic component.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJn0l4kFQOHDDnmmyUf5qOfW6udTcc2ebGUJQzu9G4Jrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjhvFWhsQ%253D%253D&md5=4fbcfbef2441cb9542ea1302bd851f46</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawp239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawp239%26sid%3Dliteratum%253Aachs%26aulast%3DPalazuelos%26aufirst%3DJ.%26aulast%3DAguado%26aufirst%3DT.%26aulast%3DPazos%26aufirst%3DM.%2BR.%26aulast%3DJulien%26aufirst%3DB.%26aulast%3DCarrasco%26aufirst%3DC.%26aulast%3DResel%26aufirst%3DE.%26aulast%3DSagredo%26aufirst%3DO.%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DAzcoitia%26aufirst%3DI.%26aulast%3DFernandez-Ruiz%26aufirst%3DJ.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DGalve-Roperh%26aufirst%3DI.%26atitle%3DMicroglial%2520CB2%2520cannabinoid%2520receptors%2520are%2520neuroprotective%2520in%2520Huntington%25E2%2580%2599s%2520disease%2520excitotoxicity%26jtitle%3DBrain%26date%3D2009%26volume%3D132%26spage%3D3152%26epage%3D3164%26doi%3D10.1093%2Fbrain%2Fawp239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Donat, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodhun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span> </span><span class="NLM_article-title">Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet</span> <span class="citation_source-journal">Acta Neurobiol. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24993629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC2cfptVaqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=197-210&author=C.+K.+Donatauthor=F.+Fischerauthor=B.+Walterauthor=W.+Deuther-Conradauthor=M.+Brodhunauthor=R.+Bauerauthor=P.+Brust&title=Early+increase+of+cannabinoid+receptor+density+after+experimental+traumatic+brain+injury+in+the+newborn+piglet"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet</span></div><div class="casAuthors">Donat Cornelius K; Fischer Felix; Walter Bernd; Deuther-Conrad Winnie; Brodhun Michael; Bauer Reinhard; Brust Peter</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurobiologiae experimentalis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-210</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Paediatric traumatic brain injury (TBI) is a leading cause of death and disability.  Previous studies showed neuroprotection after TBI by (endo)cannabinoid mechanisms, suggesting involvement of cannabinoid receptors (CBR).  We therefore determined CBR densities and expression of the translocator protein 18 kDA (TSPO) in newborn piglets after experimental TBI.  Newborn female piglets were subjected to sham operation (n=6) or fluid-percussion (FP) injury (n=7) under controlled physiological conditions.  After six hours, brains were frozen, sagittally cut and incubated with radioligands for CBR ([3HCP-55,940, [3H]SR141716A) and TSPO ([3H]PK11195), an indicator of gliosis/brain injury.  Early after injury, FP-TBI elicited a significant ICP increase at a temporary reduced cerebral perfusion pressure; however, CBF and CMRO2 remained within physiological range.  At 6 hours post injury, we found a statistically significant increase in binding of the non-selective agonist [3H]CP-55,940 in 15 of the 24 investigated brain regions of injured animals.  By contrast, no significant changes in binding of the CB1R-selective antagonist [3H]SR141716A were observed.  A non-significant trend towards increased binding of [3H]PK11195 was observed, suggesting an incipient microglial activation.  We therefore conclude that in this model and time span after injury, the increase in [3H]CP-55,940 binding reflects changes in CB2R density, while CB1R density is not affected.  The results may provide explanation for the neuroprotective properties of cannabinoid ligands and future therapeutic strategies of TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8Wbh92eIbqsSzjBFCN0BJfW6udTcc2ebGUJQzu9G4Jrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfptVaqtw%253D%253D&md5=9a408ead808ea8d78498a919f6d2352f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonat%26aufirst%3DC.%2BK.%26aulast%3DFischer%26aufirst%3DF.%26aulast%3DWalter%26aufirst%3DB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DBrodhun%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DEarly%2520increase%2520of%2520cannabinoid%2520receptor%2520density%2520after%2520experimental%2520traumatic%2520brain%2520injury%2520in%2520the%2520newborn%2520piglet%26jtitle%3DActa%2520Neurobiol.%2520Exp.%26date%3D2014%26volume%3D74%26spage%3D197%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Páldyová, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bereczki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sántha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borsodi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benyhe, S.</span><span> </span><span class="NLM_article-title">Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation <i>via</i> CB<sub>2</sub> cannabinoid receptors</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1016/j.neuint.2007.06.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.neuint.2007.06.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=17698254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjtL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=321-328&author=E.+P%C3%A1ldyov%C3%A1author=E.+Bereczkiauthor=M.+S%C3%A1nthaauthor=T.+Wengerauthor=A.+Borsodiauthor=S.+Benyhe&title=Noladin+ether%2C+a+putative+endocannabinoid%2C+inhibits+%CE%BC-opioid+receptor+activation+via+CB2+cannabinoid+receptors&doi=10.1016%2Fj.neuint.2007.06.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation via CB2 cannabinoid receptors</span></div><div class="casAuthors">Paldyova, Estera; Bereczki, Erika; Santha, Miklos; Wenger, Tibor; Borsodi, Anna; Benyhe, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">321-328</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the occurrence of possible changes in mRNA expression and the functional activity of opioid receptors after acute in vivo and in vitro treatment with the putative endogenous cannabinoid noladin ether.  While noladin ether (NE) demonstrates agonist activity at CB1 cannabinoid receptors, recent data indicate that NE acts as a full agonist at CB2 cannabinoid receptors too.  Considering the functional interactions between opioids and cannabinoids, it is of interest to examine whether NE affects the opioid system.  To that end, we studied the influence of NE on μ-opioid receptor (MOR) mRNA expression and MOR mediated G-protein signaling.  We used real-time PCR and [35S]GTPγS binding assays to examine the changes of MOR mRNA levels and the capability of the μ-opioid agonist peptide [D-Ala2,N-Me-Phe4,Gly5-ol]enkephalin (DAMGO) in activating regulatory G-proteins via MORs in forebrain membrane fractions of wild-type (w.t., CB1+/+) and CB1 receptor deficient transgenic mice (knockout, CB1-/-).  We found, that the expression of MOR mRNAs significantly decreased both in CB1+/+ and CB1-/- forebrain after a single injection of NE at 1 mg/kg when compared to control.  Consequently, MOR-mediated signaling is attenuated after acute in vivo treatment with NE in both CB1+/+ and CB1-/- mice.  Inhibition on MOR mediated activation is obsd. after in vitro NE administration as well.  Radioligand binding competition studies showed that the noticed effect of NE on MOR signaling is not mediated through MORs.  Both in vivo and in vitro attenuations of NE can be antagonized by the CB2 selective antagonist SR 144528.  Taken together, our data suggest that the NE caused pronounced decrease in the activity of MOR is mediated via CB2 cannabinoid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbO2jGTRGMcLVg90H21EOLACvtfcHk0ljJ8HDExixelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjtL%252FK&md5=7179296aae301f1f1c542385e4ed7c40</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2007.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2007.06.033%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A1ldyov%25C3%25A1%26aufirst%3DE.%26aulast%3DBereczki%26aufirst%3DE.%26aulast%3DS%25C3%25A1ntha%26aufirst%3DM.%26aulast%3DWenger%26aufirst%3DT.%26aulast%3DBorsodi%26aufirst%3DA.%26aulast%3DBenyhe%26aufirst%3DS.%26atitle%3DNoladin%2520ether%252C%2520a%2520putative%2520endocannabinoid%252C%2520inhibits%2520%25CE%25BC-opioid%2520receptor%2520activation%2520via%2520CB2%2520cannabinoid%2520receptors%26jtitle%3DNeurochem.%2520Int.%26date%3D2008%26volume%3D52%26spage%3D321%26epage%3D328%26doi%3D10.1016%2Fj.neuint.2007.06.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Benito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavarria, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillard, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, J.</span><span> </span><span class="NLM_article-title">A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2530</span><span class="NLM_x">–</span> <span class="NLM_lpage">2536</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3923-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1523%2FJNEUROSCI.3923-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=15758162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1ygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=2530-2536&author=C.+Benitoauthor=W.+K.+Kimauthor=I.+Chavarriaauthor=C.+J.+Hillardauthor=K.+Mackieauthor=R.+M.+Tolonauthor=K.+Williamsauthor=J.+Romero&title=A+glial+endogenous+cannabinoid+system+is+upregulated+in+the+brains+of+macaques+with+simian+immunodeficiency+virus-induced+encephalitis&doi=10.1523%2FJNEUROSCI.3923-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis</span></div><div class="casAuthors">Benito, Cristina; Kim, Wong-Ki; Chavarria, Ivan; Hillard, Ceceila J.; Mackie, Ken; Tolon, Rosa M.; Williams, Ken; Romero, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2530-2536</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent evidence supports the notion that the endocannabinoid system may play a crucial role in neuroinflammation.  We explored the changes that some elements of this system exhibit in a macaque model of encephalitis induced by simian immunodeficiency virus.  These results show that profound alterations in the distribution of specific components of the endocannabinoid system occur as a consequence of the viral infection of the brain.  Specifically, expression of cannabinoid receptors of the CB2 subtype was induced in the brains of infected animals, mainly in perivascular macrophages, microglial nodules, and T-lymphocytes, most likely of the CD8 subtype.  In addn., the endogenous cannabinoid-degrading enzyme fatty acid amide hydrolase was overexpressed in perivascular astrocytes as well as in astrocytic processes reaching cellular infiltrates.  Finally, the pattern of CB1 receptor expression was not modified in the brains of infected animals compared with that in control animals.  These results resemble previous data obtained in Alzheimer's disease human tissue samples and suggest that the endocannabinoid system may participate in the development of human immunodeficiency virus-induced encephalitis, because activation of CB2 receptors expressed by immune cells is likely to reduce their antiviral response and thus could favor the CNS entry of infected monocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXNr4cW4QrirVg90H21EOLACvtfcHk0ljJ8HDExixelQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1ygs74%253D&md5=12762f8109130916e997eb06db6fa166</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3923-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3923-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DW.%2BK.%26aulast%3DChavarria%26aufirst%3DI.%26aulast%3DHillard%26aufirst%3DC.%2BJ.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DTolon%26aufirst%3DR.%2BM.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DRomero%26aufirst%3DJ.%26atitle%3DA%2520glial%2520endogenous%2520cannabinoid%2520system%2520is%2520upregulated%2520in%2520the%2520brains%2520of%2520macaques%2520with%2520simian%2520immunodeficiency%2520virus-induced%2520encephalitis%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D2530%26epage%3D2536%26doi%3D10.1523%2FJNEUROSCI.3923-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chakravarti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganju, R. K.</span><span> </span><span class="NLM_article-title">Cannabinoids as therapeutic agents in cancer: current status and future implications</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5852</span><span class="NLM_x">–</span> <span class="NLM_lpage">5872</span><span class="refDoi"> DOI: 10.18632/oncotarget.2233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.18632%2Foncotarget.2233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25115386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Fht1SgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=5852-5872&author=B.+Chakravartiauthor=J.+Raviauthor=R.+K.+Ganju&title=Cannabinoids+as+therapeutic+agents+in+cancer%3A+current+status+and+future+implications&doi=10.18632%2Foncotarget.2233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids as therapeutic agents in cancer: current status and future implications</span></div><div class="casAuthors">Chakravarti Bandana; Ravi Janani; Ganju Ramesh K</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5852-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmacological importance of cannabinoids has been in study for several years.  Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant, (b) endogenous as well as (c) synthetic cannabinoids.  Though cannabinoids are clinically used for anti-palliative effects, recent studies open a promising possibility as anti-cancer agents.  They have been shown to possess anti-proliferative and anti-angiogenic effects in vitro as well as in vivo in different cancer models.  Cannabinoids regulate key cell signaling pathways that are involved in cell survival, invasion, angiogenesis, metastasis, etc.  There is more focus on CB1 and CB2, the two cannabinoid receptors which are activated by most of the cannabinoids.  In this review article, we will focus on a broad range of cannabinoids, their receptor dependent and receptor independent functional roles against various cancer types with respect to growth, metastasis, energy metabolism, immune environment, stemness and future perspectives in exploring new possible therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI4t9ZrFEBIXy-c-E1v-fmfW6udTcc2eZqzMzVt61oALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Fht1SgtA%253D%253D&md5=a7337b09f46c5df725ab7ce07fd5fee5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2233%26sid%3Dliteratum%253Aachs%26aulast%3DChakravarti%26aufirst%3DB.%26aulast%3DRavi%26aufirst%3DJ.%26aulast%3DGanju%26aufirst%3DR.%2BK.%26atitle%3DCannabinoids%2520as%2520therapeutic%2520agents%2520in%2520cancer%253A%2520current%2520status%2520and%2520future%2520implications%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D5852%26epage%3D5872%26doi%3D10.18632%2Foncotarget.2233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ellert-Miklaszewska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciechomska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminska, B.</span><span> </span><span class="NLM_article-title">Cannabinoid signaling in glioma cells</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">986</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span><span class="refDoi"> DOI: 10.1007/978-94-007-4719-7_11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1007%2F978-94-007-4719-7_11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=986&publication_year=2013&pages=209-220&author=A.+Ellert-Miklaszewskaauthor=I.+Ciechomskaauthor=B.+Kaminska&title=Cannabinoid+signaling+in+glioma+cells&doi=10.1007%2F978-94-007-4719-7_11"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2F978-94-007-4719-7_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-94-007-4719-7_11%26sid%3Dliteratum%253Aachs%26aulast%3DEllert-Miklaszewska%26aufirst%3DA.%26aulast%3DCiechomska%26aufirst%3DI.%26aulast%3DKaminska%26aufirst%3DB.%26atitle%3DCannabinoid%2520signaling%2520in%2520glioma%2520cells%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2013%26volume%3D986%26spage%3D209%26epage%3D220%26doi%3D10.1007%2F978-94-007-4719-7_11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Evens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G. M.</span><span> </span><span class="NLM_article-title">Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1543</span><span class="refDoi"> DOI: 10.2174/156802610793176819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.2174%2F156802610793176819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=20583994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ahtr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1527-1543&author=N.+Evensauthor=G.+M.+Bormans&title=Non-invasive+imaging+of+the+type+2+cannabinoid+receptor%2C+focus+on+positron+emission+tomography&doi=10.2174%2F156802610793176819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography</span></div><div class="casAuthors">Evens, Nele; Bormans, Guy M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1527-1543</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The type 2 cannabinoid receptor (CB2R) is a relatively new target for drug development, as the receptor was only discovered in 1993.  The CB2R is mainly expressed in tissues and organs related to the immune system.  However, in pathol. conditions, mostly inflammatory, a strong upregulation has been obsd.  Because of its expression in activated microglia, the type 2 cannabinoid receptor might play an important role in pathologies with a neuroinflammatory component.  Positron emission tomog. provides a sensitive non-invasive imaging technique to study and quantify receptor expression.  In this review, the importance of CB2R imaging, the current status and the future possibilities for the development of CB2R PET radioligands are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq56zuWZZDbYbVg90H21EOLACvtfcHk0lib5c4jE68Leg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ahtr3O&md5=7145b2e47502b702015c9882d9f69389</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F156802610793176819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610793176819%26sid%3Dliteratum%253Aachs%26aulast%3DEvens%26aufirst%3DN.%26aulast%3DBormans%26aufirst%3DG.%2BM.%26atitle%3DNon-invasive%2520imaging%2520of%2520the%2520type%25202%2520cannabinoid%2520receptor%252C%2520focus%2520on%2520positron%2520emission%2520tomography%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D1527%26epage%3D1543%26doi%3D10.2174%2F156802610793176819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ory, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">PET radioligands for in vivo visualization of neuroinflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5897</span><span class="NLM_x">–</span> <span class="NLM_lpage">5913</span><span class="refDoi"> DOI: 10.2174/1381612820666140613120212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.2174%2F1381612820666140613120212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24939192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CntbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=5897-5913&author=D.+Oryauthor=S.+Celenauthor=A.+Verbruggenauthor=G.+Bormans&title=PET+radioligands+for+in+vivo+visualization+of+neuroinflammation&doi=10.2174%2F1381612820666140613120212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PET Radioligands for In Vivo Visualization of Neuroinflammation</span></div><div class="casAuthors">Ory, Dieter; Celen, Sofie; Verbruggen, Alfons; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5897-5913</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neuroinflammation is a well-orchestrated, dynamic, multicellular process playing a major role in neurodegenerative disorders.  The microglia which make up the innate immune system of the central nervous system are key cellular mediators of neuroinflammatory processes.  In normal condition they exert a protective function, providing tissue repair by releasing anti-inflammatory cytokines and neurotrophic factors.  Upon neuronal injury or infection, they become overactivated, thereby releasing neurotoxic substances, amplifying neuroinflammation leading to neurodegeneration.  Positron emission tomog. (PET) provides a sensitive non-invasive imaging technique to study and quantify receptor and enzyme expression.  A radiolabeled tracer for a protein (over)expressed in neuroinflammation and more specifically for the overactivated microglia would be useful as a diagnostic tool in the follow-up of neuroinflammation progression and to study the efficacy of anti-inflammatory therapy over time.  In this manuscript, an overview of potential PET tracer targets upregulated during neuroinflammation is provided together with the current radiotracers used to image these targets.  In addn., lead structures to develop radiotracers for new targets are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXoaVwMntYOLVg90H21EOLACvtfcHk0lib5c4jE68Leg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CntbfI&md5=73f79ddec9f9143b5bbbf9368de54dc7</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140613120212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140613120212%26sid%3Dliteratum%253Aachs%26aulast%3DOry%26aufirst%3DD.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPET%2520radioligands%2520for%2520in%2520vivo%2520visualization%2520of%2520neuroinflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D5897%26epage%3D5913%26doi%3D10.2174%2F1381612820666140613120212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. Q.</span><span> </span><span class="NLM_article-title">Latest advances in novel cannabinoid CB<sub>2</sub> ligands for drug abuse and their therapeutic potential</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.4155/fmc.11.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.4155%2Ffmc.11.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=22300098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGgs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=187-204&author=P.+Yangauthor=L.+Wangauthor=X.+Q.+Xie&title=Latest+advances+in+novel+cannabinoid+CB2+ligands+for+drug+abuse+and+their+therapeutic+potential&doi=10.4155%2Ffmc.11.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Latest advances in novel cannabinoid CB2 ligands for drug abuse and their therapeutic potential</span></div><div class="casAuthors">Yang, Peng; Wang, Lirong; Xie, Xiang-Qun</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-204</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The field of cannabinoid (CB) drug research is experiencing a challenge as the CB1 antagonist Rimonabant, launched in 2006 as an anorectic/anti-obesity drug, was withdrawn from the European market due to the complications of suicide and depression as side effects.  There is interest in developing CB2 drugs without CB1 psychotropic side effects for drug-abuse treatment and therapeutic medication.  The CB1 receptor was discovered predominantly in the brain, whereas the CB2 is mainly expressed in peripheral cells and tissues, and is involved in immune signal transduction.  Conversely, the CB2 receptor was recently detected in the CNS, for example, in the microglial cells and the neurons.  While the CB2 neurons activity remains controversial, the CB2 receptor is an attractive therapeutic target for neuropathic pain, immune system, cancer and osteoporosis without psychoactivity.  This review addresses CB drug abuse and therapeutic potential with a focus on the most recent advances on new CB2 ligands from the literature as well as patents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo8oI_xh-woLVg90H21EOLACvtfcHk0lggLuSr9aI79w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGgs7k%253D&md5=8aad3cf73fc56e4324889a942cd6287d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.179%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DX.%2BQ.%26atitle%3DLatest%2520advances%2520in%2520novel%2520cannabinoid%2520CB2%2520ligands%2520for%2520drug%2520abuse%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D187%26epage%3D204%26doi%3D10.4155%2Ffmc.11.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kohnz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span> </span><span class="NLM_article-title">Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6859</span><span class="NLM_x">–</span> <span class="NLM_lpage">6869</span><span class="refDoi"> DOI: 10.1039/C4CS00047A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1039%2FC4CS00047A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24676249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6859-6869&author=R.+A.+Kohnzauthor=D.+K.+Nomura&title=Chemical+approaches+to+therapeutically+target+the+metabolism+and+signaling+of+the+endocannabinoid+2-AG+and+eicosanoids&doi=10.1039%2FC4CS00047A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids</span></div><div class="casAuthors">Kohnz, Rebecca A.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6859-6869</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid system, most popularly known as the target of the psychoactive component of marijuana, Δ9-tetrahydrocannabinol (THC), is a signaling network that modulates a diverse range of physiol. processes including nociception, behavior, cognitive function, appetite, metab., motor control, memory formation, and inflammation.  While THC and its derivs. have garnered notoriety in the eyes of the public, the endocannabinoid system consists of two endogenous signaling lipids, 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (anandamide), which activate cannabinoid receptors CB1 and CB2 in the nervous system and peripheral tissues.  This review will focus on the recent efforts to chem. manipulate 2-AG signaling through the development of inhibitors of the 2-AG-synthesizing enzyme diacylglycerol lipase (DAGL) or the 2-AG-degrading enzyme monoacylglycerol lipase (MAGL), and assessing the therapeutic potential of DAGL and MAGL inhibitors in pain, inflammation, degenerative diseases, tissue injury, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo061VrnQ7sP7Vg90H21EOLACvtfcHk0lggLuSr9aI79w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mtrjM&md5=930d2e70ae5741c872c870860b61d5a7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC4CS00047A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4CS00047A%26sid%3Dliteratum%253Aachs%26aulast%3DKohnz%26aufirst%3DR.%2BA.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DChemical%2520approaches%2520to%2520therapeutically%2520target%2520the%2520metabolism%2520and%2520signaling%2520of%2520the%2520endocannabinoid%25202-AG%2520and%2520eicosanoids%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6859%26epage%3D6869%26doi%3D10.1039%2FC4CS00047A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Therapeutic utility of cannabinoid receptor type 2 (CB<sub>2</sub>) selective agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8224</span><span class="NLM_x">–</span> <span class="NLM_lpage">8256</span><span class="refDoi"> DOI: 10.1021/jm4005626</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005626" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeru7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8224-8256&author=S.+Hanauthor=J.+Thatteauthor=D.+J.+Buzardauthor=R.+M.+Jones&title=Therapeutic+utility+of+cannabinoid+receptor+type+2+%28CB2%29+selective+agonists&doi=10.1021%2Fjm4005626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists</span></div><div class="casAuthors">Han, Sangdon; Thatte, Jayant; Buzard, Daniel J.; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8224-8256</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The cannabinoid receptor type 2 (CB2) is a class A GPCR that was cloned in 1993 while looking for an alternative receptor that could explain the pharmacol. properties of Δ9-tetrahydrocannabinol.  CB2 was identified among cDNAs based on its similarity in amino acid sequence to the CB1 receptor and helped provide an explanation for the established effects of cannabinoids on the immune system.  In addn. to the immune system, CB2 has widespread tissue expression and has been found in brain, peripheral nervous system, and gastrointestinal tract.  Several "mixed" cannabinoid agonists are currently in clin. use primarily for controlling pain, and it is believed that selective CB2 agonism may afford a superior analgesic agent devoid of the centrally mediated CB1 effects.  Thus, selective CB2 receptor agonists represent high value putative therapeutics for treating pain and other disease states.  In this Perspective, we seek to provide a concise update of progress in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqncpGbOhjA5bVg90H21EOLACvtfcHk0lggLuSr9aI79w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeru7bO&md5=bb532e5c81b475aa04a3311a017c82f1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm4005626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005626%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DTherapeutic%2520utility%2520of%2520cannabinoid%2520receptor%2520type%25202%2520%2528CB2%2529%2520selective%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8224%26epage%3D8256%26doi%3D10.1021%2Fjm4005626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Aso, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, I.</span><span> </span><span class="NLM_article-title">Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.3389/fphar.2014.00037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.3389%2Ffphar.2014.00037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24634659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC2cflslSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=37&author=E.+Asoauthor=I.+Ferrer&title=Cannabinoids+for+treatment+of+Alzheimer%E2%80%99s+disease%3A+moving+toward+the+clinic&doi=10.3389%2Ffphar.2014.00037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic</span></div><div class="casAuthors">Aso Ester; Ferrer Isidre</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">The limited effectiveness of current therapies against Alzheimer's disease (AD) highlights the need for intensifying research efforts devoted to developing new agents for preventing or retarding the disease process.  During the last few years, targeting the endogenous cannabinoid system has emerged as a potential therapeutic approach to treat Alzheimer.  The endocannabinoid system is composed by a number of cannabinoid receptors, including the well-characterized CB1 and CB2 receptors, with their endogenous ligands and the enzymes related to the synthesis and degradation of these endocannabinoid compounds.  Several findings indicate that the activation of both CB1 and CB2 receptors by natural or synthetic agonists, at non-psychoactive doses, have beneficial effects in Alzheimer experimental models by reducing the harmful β-amyloid peptide action and tau phosphorylation, as well as by promoting the brain's intrinsic repair mechanisms.  Moreover, endocannabinoid signaling has been demonstrated to modulate numerous concomitant pathological processes, including neuroinflammation, excitotoxicity, mitochondrial dysfunction, and oxidative stress.  The present paper summarizes the main experimental studies demonstrating the polyvalent properties of cannabinoid compounds for the treatment of AD, which together encourage progress toward a clinical trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCYty_MiAZP50d-O_J5C0AfW6udTcc2eZjkceMp74UK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflslSltg%253D%253D&md5=18ab4f10157b9f6be7cf343ed9c3bde5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00037%26sid%3Dliteratum%253Aachs%26aulast%3DAso%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DI.%26atitle%3DCannabinoids%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520moving%2520toward%2520the%2520clinic%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D37%26doi%3D10.3389%2Ffphar.2014.00037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Varley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edison, P.</span><span> </span><span class="NLM_article-title">Imaging neuroinflammation in Alzheimer’s and other dementias: Recent advances and future directions</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.jalz.2014.08.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.jalz.2014.08.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25443857" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=1-11&author=J.+Varleyauthor=D.+J.+Brooksauthor=P.+Edison&title=Imaging+neuroinflammation+in+Alzheimer%E2%80%99s+and+other+dementias%3A+Recent+advances+and+future+directions&doi=10.1016%2Fj.jalz.2014.08.105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2014.08.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2014.08.105%26sid%3Dliteratum%253Aachs%26aulast%3DVarley%26aufirst%3DJ.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DEdison%26aufirst%3DP.%26atitle%3DImaging%2520neuroinflammation%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520other%2520dementias%253A%2520Recent%2520advances%2520and%2520future%2520directions%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.jalz.2014.08.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Dhopeshwarkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span> </span><span class="NLM_article-title">CB<sub>2</sub> Cannabinoid receptors as a therapeutic target-what does the future hold?</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1124/mol.114.094649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1124%2Fmol.114.094649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25106425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12iu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=430-437&author=A.+Dhopeshwarkarauthor=K.+Mackie&title=CB2+Cannabinoid+receptors+as+a+therapeutic+target-what+does+the+future+hold%3F&doi=10.1124%2Fmol.114.094649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">CB2 cannabinoid receptors as a therapeutic target - what does the future hold?</span></div><div class="casAuthors">Dhopeshwarkar, Amey; Mackie, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">430-437, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The past decades have seen an exponential rise in our understanding of the endocannabinoid system, comprising CB1 and CB2 cannabinoid receptors, endogenous cannabinoids (endocannabinoids), and the enzymes that synthesize and degrade endocannabinoids.  The primary focus of this review is the CB2 receptor.  CB2 receptors have been the subject of considerable attention, primarily due to their promising therapeutic potential for treating various pathologies while avoiding the adverse psychotropic effects that can accompany CB1 receptor-based therapies.  With the appreciation that CB2-selective ligands show marked functional selectivity, there is a renewed opportunity to explore this promising area of research from both a mechanistic as well as a therapeutic perspective.  In this review, we summarize our present knowledge of CB2 receptor signaling, localization, and regulation.  We discuss the availability of genetic tools (and their limitations) to study CB2 receptors and also provide an update on preclin. data on CB2 agonists in pain models.  Finally, we suggest possible reasons for the failure of CB2 ligands in clin. pain trials and offer possible ways to move the field forward in a way that can help reconcile the inconsistencies between preclin. and clin. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtBsnApceQu7Vg90H21EOLACvtfcHk0liPakkYQRoNJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12iu7nN&md5=76d3335b4ef5194f805f67619466739b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.094649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.094649%26sid%3Dliteratum%253Aachs%26aulast%3DDhopeshwarkar%26aufirst%3DA.%26aulast%3DMackie%26aufirst%3DK.%26atitle%3DCB2%2520Cannabinoid%2520receptors%2520as%2520a%2520therapeutic%2520target-what%2520does%2520the%2520future%2520hold%253F%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D430%26epage%3D437%26doi%3D10.1124%2Fmol.114.094649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Slavik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cermak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ametamey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, L.</span><span> </span><span class="NLM_article-title">Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.2533/chimia.2014.208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.2533%2Fchimia.2014.208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=208-210&author=R.+Slavikauthor=D.+Bieriauthor=S.+Cermakauthor=A.+Mullerauthor=S.+D.+Kramerauthor=M.+Weberauthor=R.+Schibliauthor=S.+M.+Ametameyauthor=L.+Mu&title=Development+and+evaluation+of+novel+PET+tracers+for+imaging+cannabinoid+receptor+type+2+in+brain&doi=10.2533%2Fchimia.2014.208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2533%2Fchimia.2014.208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2533%252Fchimia.2014.208%26sid%3Dliteratum%253Aachs%26aulast%3DSlavik%26aufirst%3DR.%26aulast%3DBieri%26aufirst%3DD.%26aulast%3DCermak%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DKramer%26aufirst%3DS.%2BD.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DMu%26aufirst%3DL.%26atitle%3DDevelopment%2520and%2520evaluation%2520of%2520novel%2520PET%2520tracers%2520for%2520imaging%2520cannabinoid%2520receptor%2520type%25202%2520in%2520brain%26jtitle%3DChimia%26date%3D2014%26volume%3D68%26spage%3D208%26epage%3D210%26doi%3D10.2533%2Fchimia.2014.208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Horti, A. G.; Raymont, V.; Terry, G. E.</span><span> </span><span class="NLM_article-title">PET imaging of endocannabinoid system</span>. In  <span class="citation_source-book">PET and SPECT of Neurobiological Systems</span>; <span class="NLM_contrib-group">Dierckx, R. A. J. O.; Otte, A.; de Vries, E. F. J.; van Waarde, A.; Luiten, P. G. M.</span>, Eds.; <span class="NLM_publisher-name">Springer:</span><span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1007%2F978-3-642-42014-6_11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=249-319&author=A.+G.+Horti&author=V.+Raymont&author=G.+E.+Terryauthor=R.+A.+J.+O.+Dierckx&author=A.+Otte&author=E.+F.+J.+de+Vries&author=A.+van+Waarde&author=P.+G.+M.+Luiten&title=PET+and+SPECT+of+Neurobiological+Systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-42014-6_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-42014-6_11%26sid%3Dliteratum%253Aachs%26aulast%3DHorti%26aufirst%3DA.%2BG.%26atitle%3DPET%2520imaging%2520of%2520endocannabinoid%2520system%26btitle%3DPET%2520and%2520SPECT%2520of%2520Neurobiological%2520Systems%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26pub%3DSpringer%253A%26date%3D2014%26spage%3D249%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Casteels, C.; Ahmad, R.; Vandenbulcke, M.; Vandenberghe, W.; Van Laere, K.</span><span> </span><span class="NLM_article-title">Chapter 4 - Cannabinoids and Huntington’s disease</span>. In  <span class="citation_source-book">Cannabinoids in Neurologic and Mental Disease</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2FB978-0-12-417041-4.00004-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=61-97&author=C.+Casteels&author=R.+Ahmad&author=M.+Vandenbulcke&author=W.+Vandenberghe&author=K.+Van+Laere&title=Cannabinoids+in+Neurologic+and+Mental+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417041-4.00004-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-417041-4.00004-7%26sid%3Dliteratum%253Aachs%26aulast%3DCasteels%26aufirst%3DC.%26atitle%3DChapter%25204%2520-%2520Cannabinoids%2520and%2520Huntington%25E2%2580%2599s%2520disease%26btitle%3DCannabinoids%2520in%2520Neurologic%2520and%2520Mental%2520Disease%26pub%3DAcademic%2520Press%26date%3D2015%26spage%3D61%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Horti, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savonenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span> </span><span class="NLM_article-title">Synthesis and biodistribution of [<sup>11</sup>C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB<sub>2</sub>)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5202</span><span class="NLM_x">–</span> <span class="NLM_lpage">5207</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.05.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.bmc.2010.05.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=20554448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3cXoslagurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5202-5207&author=A.+G.+Hortiauthor=Y.+Gaoauthor=H.+T.+Ravertauthor=P.+Finleyauthor=H.+Valentineauthor=D.+F.+Wongauthor=C.+J.+Endresauthor=A.+V.+Savonenkoauthor=R.+F.+Dannals&title=Synthesis+and+biodistribution+of+%5B11C%5DA-836339%2C+a+new+potential+radioligand+for+PET+imaging+of+cannabinoid+type+2+receptors+%28CB2%29&doi=10.1016%2Fj.bmc.2010.05.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2)</span></div><div class="casAuthors">Horti, Andrew G.; Gao, Yongjun; Ravert, Hayden T.; Finley, Paige; Valentine, Heather; Wong, Dean F.; Endres, Christopher J.; Savonenko, Alena V.; Dannals, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5202-5207</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recently, A-836339 [2,2,3,3-tetramethylcyclopropanecarboxylic acid [3-(2-methoxyethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]amide] (1) was reported to be a selective CB2 agonist with high binding affinity.  Here we describe the radiosynthesis of [11C]A-836339 ([11C]1) via its desmethyl precursor as a candidate radioligand for imaging CB2 receptors with positron-emission tomog. (PET).  Whole body and the regional brain distribution of [11C]1 in control CD1 mice demonstrated that this radioligand exhibits specific uptake in the CB2-rich spleen and little specific in vivo binding in the control mouse brain.  However, [11C]1 shows specific cerebral uptake in the lipopolysaccharide (LPS)-induced mouse model of neuroinflammation and in the brain areas with Aβ amyloid plaque deposition in a mouse model of Alzheimer's disease (APPswe/PS1dE9 mice).  These data establish a proof of principle that CB2 receptors binding in the neuroinflammation and related disorders can be measured in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrriR2pw_HawbVg90H21EOLACvtfcHk0lh-e3YBCSapcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXoslagurc%253D&md5=1baba739bf8db92d34ac41f16906482c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.058%26sid%3Dliteratum%253Aachs%26aulast%3DHorti%26aufirst%3DA.%2BG.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DFinley%26aufirst%3DP.%26aulast%3DValentine%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DEndres%26aufirst%3DC.%2BJ.%26aulast%3DSavonenko%26aufirst%3DA.%2BV.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26atitle%3DSynthesis%2520and%2520biodistribution%2520of%2520%255B11C%255DA-836339%252C%2520a%2520new%2520potential%2520radioligand%2520for%2520PET%2520imaging%2520of%2520cannabinoid%2520type%25202%2520receptors%2520%2528CB2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5202%26epage%3D5207%26doi%3D10.1016%2Fj.bmc.2010.05.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Savonenko, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnikova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayyida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiatt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A. G.</span><span> </span><span class="NLM_article-title">Cannabinoid CB<sub>2</sub> receptors in a mouse model of Aβ amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0129618</span><span class="refDoi"> DOI: 10.1371/journal.pone.0129618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1371%2Fjournal.pone.0129618" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0129618&author=A.+V.+Savonenkoauthor=T.+Melnikovaauthor=Y.+Wangauthor=H.+Ravertauthor=Y.+Gaoauthor=J.+Koppelauthor=D.+Leeauthor=O.+Pletnikovaauthor=E.+Choauthor=N.+Sayyidaauthor=A.+Hiattauthor=J.+Troncosoauthor=P.+Daviesauthor=R.+F.+Dannalsauthor=M.+G.+Pomperauthor=A.+G.+Horti&title=Cannabinoid+CB2+receptors+in+a+mouse+model+of+A%CE%B2+amyloidosis%3A+immunohistochemical+analysis+and+suitability+as+a+PET+biomarker+of+neuroinflammation&doi=10.1371%2Fjournal.pone.0129618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0129618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0129618%26sid%3Dliteratum%253Aachs%26aulast%3DSavonenko%26aufirst%3DA.%2BV.%26aulast%3DMelnikova%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRavert%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DKoppel%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DPletnikova%26aufirst%3DO.%26aulast%3DCho%26aufirst%3DE.%26aulast%3DSayyida%26aufirst%3DN.%26aulast%3DHiatt%26aufirst%3DA.%26aulast%3DTroncoso%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DHorti%26aufirst%3DA.%2BG.%26atitle%3DCannabinoid%2520CB2%2520receptors%2520in%2520a%2520mouse%2520model%2520of%2520A%25CE%25B2%2520amyloidosis%253A%2520immunohistochemical%2520analysis%2520and%2520suitability%2520as%2520a%2520PET%2520biomarker%2520of%2520neuroinflammation%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0129618%26doi%3D10.1371%2Fjournal.pone.0129618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Evens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandeputte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coolen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciot, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G. M.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of [<sup>11</sup>C]NE40, a type 2 cannabinoid receptor PET tracer</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2011.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.nucmedbio.2011.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=22154685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Oqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=389-399&author=N.+Evensauthor=C.+Vandeputteauthor=C.+Coolenauthor=P.+Janssenauthor=R.+Sciotauthor=V.+Baekelandtauthor=A.+M.+Verbruggenauthor=Z.+Debyserauthor=K.+Van+Laereauthor=G.+M.+Bormans&title=Preclinical+evaluation+of+%5B11C%5DNE40%2C+a+type+2+cannabinoid+receptor+PET+tracer&doi=10.1016%2Fj.nucmedbio.2011.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer</span></div><div class="casAuthors">Evens, Nele; Vandeputte, Caroline; Coolen, Charlotte; Janssen, Peter; Sciot, Raf; Baekelandt, Veerle; Verbruggen, Alfons M.; Debyser, Zeger; Van Laere, Koen; Bormans, Guy M.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Up-regulation of the type 2 cannabinoid receptor (CB2R) has been reported in (neuro)inflammatory diseases.  In this study, we report the preclin. evaluation of [11C]NE40 as positron emission tomog. (PET) radioligand for visualization of the CB2R.  The selectivity of NE40 for CB2R and its toxicity and mutagenicity were detd.  [11C]NE40 was evaluated by biodistribution and autoradiog. studies in normal rats and a microPET study in normal mice, rats and a rhesus monkey.  Specific in vivo binding of [11C]NE40 to human CB2R (hCB2R) was studied in a rat model with hCB2R overexpression.[11C]NE40 shows specific CB2R binding in the spleen and blood of normal rats and high brain uptake in rhesus monkey.  [11C]NE40 showed specific and reversible binding to hCB2R in vivo in a rat model with local hCB2R overexpression.  [11C]NE40 shows favorable characteristics as radioligand for in vivo visualization of the CB2R and is a promising candidate for hCB2R PET imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJz5-qNs-FbVg90H21EOLACvtfcHk0li4vP6IwpQOLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Oqu7k%253D&md5=be1c9b2ff6196d6f7cbe5f4ab02150bb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2011.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2011.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DEvens%26aufirst%3DN.%26aulast%3DVandeputte%26aufirst%3DC.%26aulast%3DCoolen%26aufirst%3DC.%26aulast%3DJanssen%26aufirst%3DP.%26aulast%3DSciot%26aufirst%3DR.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DVerbruggen%26aufirst%3DA.%2BM.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DBormans%26aufirst%3DG.%2BM.%26atitle%3DPreclinical%2520evaluation%2520of%2520%255B11C%255DNE40%252C%2520a%2520type%25202%2520cannabinoid%2520receptor%2520PET%2520tracer%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2012%26volume%3D39%26spage%3D389%26epage%3D399%26doi%3D10.1016%2Fj.nucmedbio.2011.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span> </span><span class="NLM_article-title">Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [<sup>11</sup>C]NE40 in healthy subjects</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1007/s11307-013-0626-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1007%2Fs11307-013-0626-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=23508466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC3svnsFSlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=384-390&author=R.+Ahmadauthor=M.+Kooleauthor=N.+Evensauthor=K.+Serdonsauthor=A.+Verbruggenauthor=G.+Bormansauthor=K.+Van+Laere&title=Whole-body+biodistribution+and+radiation+dosimetry+of+the+cannabinoid+type+2+receptor+ligand+%5B11C%5DNE40+in+healthy+subjects&doi=10.1007%2Fs11307-013-0626-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects</span></div><div class="casAuthors">Ahmad Rawaha; Koole Michel; Evens Nele; Serdons Kim; Verbruggen Alfons; Bormans Guy; Van Laere Koen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">384-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The type 2 cannabinoid receptor (CB2R) is part of the human endocannabinoid system and is involved in central and peripheral inflammatory processes.  In vivo imaging of the CB2R would allow study of several (neuro)inflammatory disorders.  In this study we have investigated the safety and tolerability of [11C]-NE40, a CB2R positron emission tomography (PET) ligand, in healthy human male subjects and determined its biodistribution and radiation dosimetry.  PROCEDURE:  Six healthy male subjects (age 20-65 years) underwent a dynamic series of nine whole-body PET/CT scans for up to 140 min, after injection of an average bolus of 286 MBq of [11C]-NE40.  Organ absorbed and total effective doses were calculated through OLINDA.  RESULTS:  [11C]-NE40 showed high initial uptake in the spleen and a predominant hepatobiliary excretion.  In the brain, rapid uptake and swift washout were seen.  Organ absorbed doses were largest for the small intestine and liver, with 15.6 and 11.5 μGy/MBq, respectively.  The mean effective dose was 3.64±0.81 μSv/MBq.  There were no changes with aging observed.  No adverse events were encountered.  CONCLUSIONS:  This first-in-man study of [11C]-NE40 showed an expected biodistribution compatible with lymphoid tissue uptake and appropriate fast brain kinetics in the healthy human brain, underscoring the potential of this tracer for further application in central and peripheral inflammation imaging.  The effective dose is within the typical expected range for 11C ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFnNFqZ5cQjxe4jJGKT5N0fW6udTcc2eam4iR8aZqQUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svnsFSlsQ%253D%253D&md5=e0371073d056817582cb62788e4bf19c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs11307-013-0626-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-013-0626-y%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DEvens%26aufirst%3DN.%26aulast%3DSerdons%26aufirst%3DK.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26atitle%3DWhole-body%2520biodistribution%2520and%2520radiation%2520dosimetry%2520of%2520the%2520cannabinoid%2520type%25202%2520receptor%2520ligand%2520%255B11C%255DNE40%2520in%2520healthy%2520subjects%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2013%26volume%3D15%26spage%3D384%26epage%3D390%26doi%3D10.1007%2Fs11307-013-0626-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Postnov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evens, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versijpt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenbulcke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaqub, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span> </span><span class="NLM_article-title">Quantification of [<sup>11</sup>C]NE40, a novel PET radioligand for CB<sub>2</sub> receptor imaging</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=188&author=A.+Postnovauthor=R.+Ahmadauthor=N.+Evensauthor=J.+Versijptauthor=M.+Vandenbulckeauthor=M.+Yaqubauthor=A.+Verbruggenauthor=G.+Bormansauthor=W.+Vandenbergheauthor=K.+Van+Laere&title=Quantification+of+%5B11C%5DNE40%2C+a+novel+PET+radioligand+for+CB2+receptor+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPostnov%26aufirst%3DA.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DEvens%26aufirst%3DN.%26aulast%3DVersijpt%26aufirst%3DJ.%26aulast%3DVandenbulcke%26aufirst%3DM.%26aulast%3DYaqub%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVandenberghe%26aufirst%3DW.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26atitle%3DQuantification%2520of%2520%255B11C%255DNE40%252C%2520a%2520novel%2520PET%2520radioligand%2520for%2520CB2%2520receptor%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Hortala, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oustric, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury-Donat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alagille, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barret, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagnan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, F.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB<sub>2</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.bmcl.2013.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=24291040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVOhs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=283-287&author=L.+Hortalaauthor=J.+Arnaudauthor=P.+Rouxauthor=D.+Oustricauthor=L.+Bouluauthor=F.+Oury-Donatauthor=P.+Avenetauthor=T.+Rooneyauthor=D.+Alagilleauthor=O.+Barretauthor=G.+Tamagnanauthor=F.+Barth&title=Synthesis+and+preliminary+evaluation+of+a+new+fluorine-18+labelled+triazine+derivative+for+PET+imaging+of+cannabinoid+CB2+receptor&doi=10.1016%2Fj.bmcl.2013.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor</span></div><div class="casAuthors">Hortala, Laurent; Arnaud, Joelle; Roux, Pascale; Oustric, Didier; Boulu, Laurent; Oury-Donat, Florence; Avenet, Patrick; Rooney, Thomas; Alagille, David; Barret, Olivier; Tamagnan, Gilles; Barth, Francis</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">283-287</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cannabinoid CB2 PET tracers are considered as a promising alternative to PBR/TSPO tracers for the in-vivo imaging of neuroinflammation.  We describe here the synthesis and characterization of compd. I, a new potent and brain penetrating CB2 ligand based on an original triazine template.  The PET tracer [18F]-dideutero-I (II) was prepd. in a three steps radiosynthesis, and demonstrated significant uptake in rhesus macaque and baboon brain with a max. SUV of about 0.7-0.9 g/mL, followed by a moderate washout over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOttCEg3j-SLVg90H21EOLACvtfcHk0li4vP6IwpQOLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVOhs7zM&md5=280f4f22351c8468b1147c9dac62d766</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DHortala%26aufirst%3DL.%26aulast%3DArnaud%26aufirst%3DJ.%26aulast%3DRoux%26aufirst%3DP.%26aulast%3DOustric%26aufirst%3DD.%26aulast%3DBoulu%26aufirst%3DL.%26aulast%3DOury-Donat%26aufirst%3DF.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DRooney%26aufirst%3DT.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DTamagnan%26aufirst%3DG.%26aulast%3DBarth%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520preliminary%2520evaluation%2520of%2520a%2520new%2520fluorine-18%2520labelled%2520triazine%2520derivative%2520for%2520PET%2520imaging%2520of%2520cannabinoid%2520CB2%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D283%26epage%3D287%26doi%3D10.1016%2Fj.bmcl.2013.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Yrjölä, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarparanta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Airaksinen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hytti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauppinen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasonen-Seppanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adinolfi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keinanen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkari, T.</span><span> </span><span class="NLM_article-title">Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB<sub>2</sub> receptor agonists</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1016/j.ejps.2014.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.ejps.2014.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=25447744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCnt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=85-96&author=S.+Yrj%C3%B6l%C3%A4author=M.+Sarparantaauthor=A.+J.+Airaksinenauthor=M.+Hyttiauthor=A.+Kauppinenauthor=S.+Pasonen-Seppanenauthor=B.+Adinolfiauthor=P.+Nieriauthor=C.+Maneraauthor=O.+Keinanenauthor=A.+Posoauthor=T.+J.+Nevalainenauthor=T.+Parkkari&title=Synthesis%2C+in+vitro+and+in+vivo+evaluation+of+1%2C3%2C5-triazines+as+cannabinoid+CB2+receptor+agonists&doi=10.1016%2Fj.ejps.2014.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists</span></div><div class="casAuthors">Yrjola, Sari; Sarparanta, Mirkka; Airaksinen, Anu J.; Hytti, Maria; Kauppinen, Anu; Pasonen-Seppanen, Sanna; Adinolfi, Barbara; Nieri, Paola; Manera, Clementina; Keinanen, Outi; Poso, Antti; Nevalainen, Tapio J.; Parkkari, Teija</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-96</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The cannabinoid receptors type 2 (CBR2) are attractive therapeutic targets of the endocannabinoid signaling system (ECS) as they are not displaying the undesired psychotropic and cardiovascular side-effects seen with cannabinoid receptor type 1 (CB1R) agonists.  In continuation of our previous work on 2,4,6-trisubstituted 1,3,5-triazines as potent CB2 agonists, we synthesized an addnl. series of more polar analogs (1-10), which were found to possess high CB2R agonist activity with enhanced water soly.  The most potent compd. in the series was N-(adamantan-1-yl)-4-ethoxy-6-(4-(2-fluoroethyl)piperazin-1-yl)-1,3,5-triazin-2-amine (9) with EC50 value of 0.60 nM.  To further evaluate the biol. effects of the compds., the selected compds. were tested in vitro against four different cell lines.  A human retinal pigment epithelial cell line (ARPE-19) was used to evaluate the cytotoxicity of the compds. whereas an androgen-sensitive human prostate adenocarcinoma cell line (LNCaP), a Jurkat leukemia cell line and a C8161 melanoma cell line were used to assess the antiproliferative activity of the compds.  The most interesting results were obtained for N-(adamantan-1-yl)-4-ethoxy-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-amine (6), which induced cell viability decrease in prostate and leukemia cell lines, and diminished proliferation of C8161 melanoma cells.  The results could be reversed in leukemia cells with the selective CB2R antagonist AM630, whereas in prostate cells the AM630 induced a significant cell viability decrease with a mechanism probably unlinked to CB2 cannabinoid receptor.  The antiproliferative effect of 6 on the melanoma cells seemed not to be mediated via the CB1R or CB2R.  No cytotoxicity was detected against ARPE-19 cell line at concns. of 1 and 10 μM for compd. 6.  However, at 30 μM concn. the compd. 6 decreased the cell viability.  Finally, in order to est. in vivo behavior of these compds., 18F labeled PET ligand, N-cyclopentyl-4-ethoxy-6-(4-(2-fluoro-18-ethyl)piperazin-1-yl)-1,3,5-triazin-2-amine ([18F]5), was synthesized and its biodistribution was detd. in healthy male Sprague-Dawley rats.  As a result, the tracer showed a rapid (<15 min) elimination in urine accompanied by a slower excretion via the hepatobiliary route.  In conclusion, we further demonstrated that 1,3,5-triazine scaffold serves as a suitable template for the design of highly potent CB2R agonists with reasonable water soly. properties.  The compds. may be useful when studying the role of the endocannabinoid system in different diseases.  The triazine scaffold is also a promising candidate for the development of new CB2R PET ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_1aEvtEgaW7Vg90H21EOLACvtfcHk0lhWhMn5iWHrFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCnt7bL&md5=8153b8fd95235ae3541e6bf209eef499</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2014.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2014.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DYrj%25C3%25B6l%25C3%25A4%26aufirst%3DS.%26aulast%3DSarparanta%26aufirst%3DM.%26aulast%3DAiraksinen%26aufirst%3DA.%2BJ.%26aulast%3DHytti%26aufirst%3DM.%26aulast%3DKauppinen%26aufirst%3DA.%26aulast%3DPasonen-Seppanen%26aufirst%3DS.%26aulast%3DAdinolfi%26aufirst%3DB.%26aulast%3DNieri%26aufirst%3DP.%26aulast%3DManera%26aufirst%3DC.%26aulast%3DKeinanen%26aufirst%3DO.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DNevalainen%26aufirst%3DT.%2BJ.%26aulast%3DParkkari%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%25201%252C3%252C5-triazines%2520as%2520cannabinoid%2520CB2%2520receptor%2520agonists%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D67%26spage%3D85%26epage%3D96%26doi%3D10.1016%2Fj.ejps.2014.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Slavik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herde, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ametamey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, L.</span><span> </span><span class="NLM_article-title">Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92c</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2Fj.ejmech.2015.01.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92c&publication_year=2015&pages=554-564&author=R.+Slavikauthor=A.+M.+Herdeauthor=D.+Bieriauthor=M.+Weberauthor=R.+Schibliauthor=S.+D.+Kramerauthor=S.+M.+Ametameyauthor=L.+Mu&title=Synthesis%2C+radiolabeling+and+evaluation+of+novel+4-oxo-quinoline+derivatives+as+PET+tracers+for+imaging+cannabinoid+type+2+receptor&doi=10.1016%2Fj.ejmech.2015.01.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DSlavik%26aufirst%3DR.%26aulast%3DHerde%26aufirst%3DA.%2BM.%26aulast%3DBieri%26aufirst%3DD.%26aulast%3DWeber%26aufirst%3DM.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DKramer%26aufirst%3DS.%2BD.%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DMu%26aufirst%3DL.%26atitle%3DSynthesis%252C%2520radiolabeling%2520and%2520evaluation%2520of%2520novel%25204-oxo-quinoline%2520derivatives%2520as%2520PET%2520tracers%2520for%2520imaging%2520cannabinoid%2520type%25202%2520receptor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92c%26spage%3D554%26epage%3D564%26doi%3D10.1016%2Fj.ejmech.2015.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Slavik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grether, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller Herde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fingerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krämer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ametamey, S. M.</span><span> </span><span class="NLM_article-title">Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4266</span><span class="NLM_x">–</span> <span class="NLM_lpage">4277</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00283</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00283" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVSntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4266-4277&author=R.+Slavikauthor=U.+Gretherauthor=A.+M%C3%BCller+Herdeauthor=L.+Gobbiauthor=J.+Fingerleauthor=C.+Ullmerauthor=S.+D.+Kr%C3%A4merauthor=R.+Schibliauthor=L.+Muauthor=S.+M.+Ametamey&title=Discovery+of+a+high+affinity+and+selective+pyridine+analog+as+a+potential+positron+emission+tomography+imaging+agent+for+cannabinoid+type+2+receptor&doi=10.1021%2Facs.jmedchem.5b00283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a High Affinity and Selective Pyridine Analog as a Potential Positron Emission Tomography Imaging Agent for Cannabinoid Type 2 Receptor</span></div><div class="casAuthors">Slavik, Roger; Grether, Uwe; Muller Herde, Adrienne; Gobbi, Luca; Fingerle, Jurgen; Ullmer, Christoph; Kramer, Stefanie D.; Schibli, Roger; Mu, Linjing; Ametamey, Simon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4266-4277</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our efforts to develop CB2 PET imaging agents, we investigated 2,5,6-substituted pyridines as a novel class of potential CB2 PET ligands.  A total of 21 novel compds. were designed, synthesized, and evaluated for their potency and binding properties toward human and rodent CB1 and CB2.  The most promising ligand 6a was radiolabeled with carbon-11 to yield 16 ([11C]RSR-056).  Specific binding of 16 to CB2-pos. spleen tissue of rats and mice was demonstrated by in vitro autogadiog. and verified in vivo in PET and biodistribution expts.  Furthermore, 16 was evaluated in a lipopolysaccharid (LPS) induced murine model of neuroinflammation.  Brain radioactivity was strikingly higher in the LPS-treated mice than the control mice.  Compd. 16 is a promising radiotracer for imaging CB2 in rodents.  It might serve as a tool for the investigation of CB2 receptor expression levels in healthy tissues and different neuroinflammatory disorders in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWUcSCaQyFerVg90H21EOLACvtfcHk0lhWhMn5iWHrFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVSntr8%253D&md5=ed007d65ae82025274ddc73ec0668220</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00283%26sid%3Dliteratum%253Aachs%26aulast%3DSlavik%26aufirst%3DR.%26aulast%3DGrether%26aufirst%3DU.%26aulast%3DM%25C3%25BCller%2BHerde%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DL.%26aulast%3DFingerle%26aufirst%3DJ.%26aulast%3DUllmer%26aufirst%3DC.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DS.%2BD.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DMu%26aufirst%3DL.%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520high%2520affinity%2520and%2520selective%2520pyridine%2520analog%2520as%2520a%2520potential%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520cannabinoid%2520type%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4266%26epage%3D4277%26doi%3D10.1021%2Facs.jmedchem.5b00283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Dart, M. J.; Carroll, W. A.; Florjancic, A. S.; Frost, J. M.; Gallagher, M. E.; Li, T.; Nelson, D. W.; Patel, M. V.; Peddi, S.; Perez-Medrano, A.</span><span> </span><span class="NLM_article-title">Thiazole compounds as cannabinoid receptor ligands and uses thereof</span>. In WO2007140385 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+J.+Dart&author=W.+A.+Carroll&author=A.+S.+Florjancic&author=J.+M.+Frost&author=M.+E.+Gallagher&author=T.+Li&author=D.+W.+Nelson&author=M.+V.+Patel&author=S.+Peddi&author=A.+Perez-Medrano&title=Thiazole+compounds+as+cannabinoid+receptor+ligands+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDart%26aufirst%3DM.%2BJ.%26atitle%3DThiazole%2520compounds%2520as%2520cannabinoid%2520receptor%2520ligands%2520and%2520uses%2520thereof%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Yao, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daza, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrison, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Kouhen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wensink, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryther, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovcimak, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hradil, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span> </span><span class="NLM_article-title">Characterization of a cannabinoid CB<sub>2</sub> receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2<i>Z</i>)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1124/jpet.108.145011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1124%2Fjpet.108.145011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=18931146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFyltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=141-151&author=B.+B.+Yaoauthor=G.+Hsiehauthor=A.+V.+Dazaauthor=Y.+Fanauthor=G.+K.+Graysonauthor=T.+R.+Garrisonauthor=O.+El+Kouhenauthor=B.+A.+Hookerauthor=M.+Paiauthor=E.+J.+Wensinkauthor=A.+K.+Salyersauthor=P.+Chandranauthor=C.+Z.+Zhuauthor=C.+Zhongauthor=K.+Rytherauthor=M.+E.+Gallagherauthor=C.+L.+Chinauthor=A.+E.+Tovcimakauthor=V.+P.+Hradilauthor=G.+B.+Foxauthor=M.+J.+Dartauthor=P.+Honoreauthor=M.+D.+Meyer&title=Characterization+of+a+cannabinoid+CB2+receptor-selective+agonist%2C+A-836339+%5B2%2C2%2C3%2C3-tetramethyl-cyclopropanecarboxylic+acid+%5B3-%282-methoxy-ethyl%29-4%2C5-dimethyl-3H-thiazol-%282Z%29-ylidene%5D-amide%5D%2C+using+in+vitro+pharmacological+assays%2C+in+vivo+pain+models%2C+and+pharmacological+magnetic+resonance+imaging&doi=10.1124%2Fjpet.108.145011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethylcyclopropanecarboxylic acid[3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging</span></div><div class="casAuthors">Yao, Betty B.; Hsieh, Gin; Daza, Anthony V.; Fan, Yihong; Grayson, George K.; Garrison, Tiffany Runyan; El Kouhen, Odile; Hooker, Bradley A.; Pai, Madhavi; Wensink, Erica J.; Salyers, Anita K.; Chandran, Prasant; Zhu, Chang Z.; Zhong, Chengmin; Ryther, Keith; Gallagher, Megan E.; Chin, Chih-Liang; Tovcimak, Ann E.; Hradil, Vincent P.; Fox, Gerard B.; Dart, Michael J.; Honore, Prisca; Meyer, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-151</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Studies demonstrating the antihyperalgesic and antiallodynic effects of cannabinoid CB2 receptor activation have been largely derived from the use of receptor-selective ligands.  Here, we report the identification of A-836339, a potent and selective CB2 agonist as characterized in in vitro pharmacol. assays and in in vivo models of pain and central nervous system (CNS) behavior models.  In radioligand binding assays, A-836339 displays high affinities at CB2 receptors and selectivity over CB1 receptors in both human and rat.  Likewise, A-836339 exhibits high potencies at CB2 and selectivity over CB1 receptors in recombinant fluorescence imaging plate reader and cyclase functional assays.  In addn. A-836339 exhibits a profile devoid of significant affinity at other G-protein-coupled receptors and ion channels.  A-836339 was characterized extensively in various animal pain models.  In the complete Freund's adjuvant model of inflammatory pain, A-836339 exhibits a potent CB2 receptor-mediated antihyperalgesic effect that is independent of CB1 or μ-opioid receptors.  A-836339 has also demonstrated efficacies in the chronic constrain injury (CCI) model of neuropathic pain, skin incision, and capsaicin-induced secondary mech. hyperalgesia models.  Furthermore, no tolerance was developed in the CCI model after subchronic treatment with A-836339 for 5 days.  In assessing CNS effects, A-836339 exhibited a CB1 receptor-mediated decrease of spontaneous locomotor activities at a higher dose, a finding consistent with the CNS activation pattern obsd. by pharmacol. magnetic resonance imaging.  These data demonstrate that A-836339 is a useful tool for use of studying CB2 receptor pharmacol. and for investigation of the role of CB2 receptor modulation for treatment of pain in preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0wl8VQFmZm7Vg90H21EOLACvtfcHk0lgScib-qKS-wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFyltA%253D%253D&md5=d0b75d4aaccbf1a8c30ba5c68383a417</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.145011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.145011%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DB.%2BB.%26aulast%3DHsieh%26aufirst%3DG.%26aulast%3DDaza%26aufirst%3DA.%2BV.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DGrayson%26aufirst%3DG.%2BK.%26aulast%3DGarrison%26aufirst%3DT.%2BR.%26aulast%3DEl%2BKouhen%26aufirst%3DO.%26aulast%3DHooker%26aufirst%3DB.%2BA.%26aulast%3DPai%26aufirst%3DM.%26aulast%3DWensink%26aufirst%3DE.%2BJ.%26aulast%3DSalyers%26aufirst%3DA.%2BK.%26aulast%3DChandran%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DC.%2BZ.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DRyther%26aufirst%3DK.%26aulast%3DGallagher%26aufirst%3DM.%2BE.%26aulast%3DChin%26aufirst%3DC.%2BL.%26aulast%3DTovcimak%26aufirst%3DA.%2BE.%26aulast%3DHradil%26aufirst%3DV.%2BP.%26aulast%3DFox%26aufirst%3DG.%2BB.%26aulast%3DDart%26aufirst%3DM.%2BJ.%26aulast%3DHonore%26aufirst%3DP.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26atitle%3DCharacterization%2520of%2520a%2520cannabinoid%2520CB2%2520receptor-selective%2520agonist%252C%2520A-836339%2520%255B2%252C2%252C3%252C3-tetramethyl-cyclopropanecarboxylic%2520acid%2520%255B3-%25282-methoxy-ethyl%2529-4%252C5-dimethyl-3H-thiazol-%25282Z%2529-ylidene%255D-amide%255D%252C%2520using%2520in%2520vitro%2520pharmacological%2520assays%252C%2520in%2520vivo%2520pain%2520models%252C%2520and%2520pharmacological%2520magnetic%2520resonance%2520imaging%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D141%26epage%3D151%26doi%3D10.1124%2Fjpet.108.145011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Friscourt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrni, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boons, G.-J.</span><span> </span><span class="NLM_article-title">A fluorogenic probe for the catalyst-free detection of azide-tagged molecules</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">18809</span><span class="NLM_x">–</span> <span class="NLM_lpage">18815</span><span class="refDoi"> DOI: 10.1021/ja309000s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja309000s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=18809-18815&author=F.+Friscourtauthor=C.+J.+Fahrniauthor=G.-J.+Boons&title=A+fluorogenic+probe+for+the+catalyst-free+detection+of+azide-tagged+molecules&doi=10.1021%2Fja309000s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluorogenic Probe for the Catalyst-Free Detection of Azide-Tagged Molecules</span></div><div class="casAuthors">Friscourt, Frederic; Fahrni, Christoph J.; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18809-18815</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fluorogenic reactions in which non- or weakly fluorescent reagents produce highly fluorescent products can be exploited to detect a broad range of compds. including biomols. and materials.  The authors describe a modified dibenzocyclooctyne (I) that under catalyst-free conditions undergoes fast strain-promoted cycloaddns. with azides to yield strongly fluorescent triazoles.  The cycloaddn. products are >1000-fold brighter compared to the starting cyclooctyne, exhibit large Stokes shift, and can be excited >350 nm, which is required for many applications.  Quantum mech. calcns. indicate that the fluorescence increase upon triazole formation is due to large differences in oscillator strengths of the S0 ↔ S1 transitions in the planar C2v-sym. starting material compared to the symmetry-broken and nonplanar cycloaddn. products.  The new fluorogenic probe was successfully employed for labeling of proteins modified by an azide moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2YAi1WGtmhrVg90H21EOLACvtfcHk0lgScib-qKS-wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmurrJ&md5=c813b5576f2aac2d64ac6429c118e49e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fja309000s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja309000s%26sid%3Dliteratum%253Aachs%26aulast%3DFriscourt%26aufirst%3DF.%26aulast%3DFahrni%26aufirst%3DC.%2BJ.%26aulast%3DBoons%26aufirst%3DG.-J.%26atitle%3DA%2520fluorogenic%2520probe%2520for%2520the%2520catalyst-free%2520detection%2520of%2520azide-tagged%2520molecules%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D18809%26epage%3D18815%26doi%3D10.1021%2Fja309000s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Cui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel <sup>18</sup>F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9283</span><span class="NLM_x">–</span> <span class="NLM_lpage">9296</span><span class="refDoi"> DOI: 10.1021/jm300973k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300973k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9283-9296&author=M.+Cuiauthor=X.+Wangauthor=P.+Yuauthor=J.+Zhangauthor=Z.+Liauthor=X.+Zhangauthor=Y.+Yangauthor=M.+Onoauthor=H.+Jiaauthor=H.+Sajiauthor=B.+Liu&title=Synthesis+and+evaluation+of+novel+18F+labeled+2-pyridinylbenzoxazole+and+2-pyridinylbenzothiazole+derivatives+as+ligands+for+positron+emission+tomography+%28PET%29+imaging+of+%CE%B2-amyloid+plaques&doi=10.1021%2Fjm300973k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm300973k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300973k%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%252018F%2520labeled%25202-pyridinylbenzoxazole%2520and%25202-pyridinylbenzothiazole%2520derivatives%2520as%2520ligands%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520of%2520%25CE%25B2-amyloid%2520plaques%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9283%26epage%3D9296%26doi%3D10.1021%2Fjm300973k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Bonner, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutter, K.</span><span> </span><span class="NLM_article-title">Opening of cyclic acetals by trichloro-, dichloro-, and tribromo-borane</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1810</span><span class="refDoi"> DOI: 10.1039/p19810001807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1039%2Fp19810001807" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1981&pages=1807-1810&author=T.+G.+Bonnerauthor=D.+Lewisauthor=K.+Rutter&title=Opening+of+cyclic+acetals+by+trichloro-%2C+dichloro-%2C+and+tribromo-borane&doi=10.1039%2Fp19810001807"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1039%2Fp19810001807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19810001807%26sid%3Dliteratum%253Aachs%26aulast%3DBonner%26aufirst%3DT.%2BG.%26aulast%3DLewis%26aufirst%3DD.%26aulast%3DRutter%26aufirst%3DK.%26atitle%3DOpening%2520of%2520cyclic%2520acetals%2520by%2520trichloro-%252C%2520dichloro-%252C%2520and%2520tribromo-borane%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1981%26spage%3D1807%26epage%3D1810%26doi%3D10.1039%2Fp19810001807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Albrecht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defoin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarnus, C.</span><span> </span><span class="NLM_article-title">Simple preparation of <i>O</i>-substituted hydroxylamines from alcohols</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1638</span><span class="refDoi"> DOI: 10.1055/s-2006-926440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1055%2Fs-2006-926440" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=1635-1638&author=S.+Albrechtauthor=A.+Defoinauthor=C.+Tarnus&title=Simple+preparation+of+O-substituted+hydroxylamines+from+alcohols&doi=10.1055%2Fs-2006-926440"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-926440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-926440%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3DDefoin%26aufirst%3DA.%26aulast%3DTarnus%26aufirst%3DC.%26atitle%3DSimple%2520preparation%2520of%2520O-substituted%2520hydroxylamines%2520from%2520alcohols%26jtitle%3DSynthesis%26date%3D2006%26volume%3D2006%26spage%3D1635%26epage%3D1638%26doi%3D10.1055%2Fs-2006-926440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Milewska, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gdaniec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poloński, T.</span><span> </span><span class="NLM_article-title">Synthesis, stereochemistry, and chiroptical spectra of cyclopropyl lactones and thionolactones</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3169</span><span class="NLM_x">–</span> <span class="NLM_lpage">3180</span><span class="refDoi"> DOI: 10.1016/0957-4166(96)00419-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1016%2F0957-4166%2896%2900419-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaK28XntlCls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=3169-3180&author=M.+J.+Milewskaauthor=M.+Gdaniecauthor=T.+Polo%C5%84ski&title=Synthesis%2C+stereochemistry%2C+and+chiroptical+spectra+of+cyclopropyl+lactones+and+thionolactones&doi=10.1016%2F0957-4166%2896%2900419-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, stereochemistry, and chiroptical spectra of cyclopropyl lactones and thionolactones</span></div><div class="casAuthors">Milewska, Maria J.; Gdaniec, Maria; Polonski, Tadeusz</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3169-3180</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several optically active substituted 3-oxabicyclo[3.1.0]hexan-2-ones and their thiocarbonyl analogs were synthesized, and their CD spectra are reported.  The n-π* Cotton effect sign is detd. by the helicity of an inherently chiral chromophore formed by the lactone or thiolactone group and the cyclopropyl moiety.  The π-π* Cotton effect of thiocarbonyl compds. shows opposite sign to that obsd. for the lowest energy transition.  The crystal structures of two compds. were solved to establish their mol. geometries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpthQTirXsslLVg90H21EOLACvtfcHk0liIQuGIgLb_TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntlCls7k%253D&md5=757bb27e327168f4adbfcb05e13faf61</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0957-4166%2896%2900419-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0957-4166%252896%252900419-3%26sid%3Dliteratum%253Aachs%26aulast%3DMilewska%26aufirst%3DM.%2BJ.%26aulast%3DGdaniec%26aufirst%3DM.%26aulast%3DPolo%25C5%2584ski%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520stereochemistry%252C%2520and%2520chiroptical%2520spectra%2520of%2520cyclopropyl%2520lactones%2520and%2520thionolactones%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1996%26volume%3D7%26spage%3D3169%26epage%3D3180%26doi%3D10.1016%2F0957-4166%2896%2900419-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Kirihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimosaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, Y.</span><span> </span><span class="NLM_article-title">Chemoselective bromination of active methylene and methyne compounds by potassium bromide, hydrochloric acid and hydrogen peroxide</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">2287</span><span class="NLM_x">–</span> <span class="NLM_lpage">2289</span><span class="refDoi"> DOI: 10.1055/s-2006-948207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1055%2Fs-2006-948207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=2287-2289&author=M.+Kiriharaauthor=S.+Ogawaauthor=T.+Noguchiauthor=K.+Okuboauthor=Y.+Monmaauthor=I.+Shimizuauthor=R.+Shimosakiauthor=A.+Hatanoauthor=Y.+Hirai&title=Chemoselective+bromination+of+active+methylene+and+methyne+compounds+by+potassium+bromide%2C+hydrochloric+acid+and+hydrogen+peroxide&doi=10.1055%2Fs-2006-948207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-948207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-948207%26sid%3Dliteratum%253Aachs%26aulast%3DKirihara%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DOkubo%26aufirst%3DK.%26aulast%3DMonma%26aufirst%3DY.%26aulast%3DShimizu%26aufirst%3DI.%26aulast%3DShimosaki%26aufirst%3DR.%26aulast%3DHatano%26aufirst%3DA.%26aulast%3DHirai%26aufirst%3DY.%26atitle%3DChemoselective%2520bromination%2520of%2520active%2520methylene%2520and%2520methyne%2520compounds%2520by%2520potassium%2520bromide%252C%2520hydrochloric%2520acid%2520and%2520hydrogen%2520peroxide%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26spage%3D2287%26epage%3D2289%26doi%3D10.1055%2Fs-2006-948207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Lynn, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herkenham, M.</span><span> </span><span class="NLM_article-title">Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1623</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=8138973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A528%3ADyaK2cXis1WhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=1994&pages=1612-1623&author=A.+B.+Lynnauthor=M.+Herkenham&title=Localization+of+cannabinoid+receptors+and+nonsaturable+high-density+cannabinoid+binding+sites+in+peripheral+tissues+of+the+rat%3A+implications+for+receptor-mediated+immune+modulation+by+cannabinoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids</span></div><div class="casAuthors">Lynn, Allison B.; Herkenham, Miles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1612-23</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">[3H]CP-55,940, a high-affinity cannabinoid receptor ligand, was used for in vitro binding and autoradiog. in peripheral tissues in the rat.  Specific cannabinoid receptor binding was restricted to components of the immune system, i.e., spleen, lymph nodes and Peyer's patches.  Displacement studies showed that this binding is identical (similar Kd and structure-activity profile) to that in brain.  Cannabinoid receptors in the immune system are confined to B lymphocyte-enriched areas, i.e., the marginal zone of the spleen, cortex of the lymph nodes and nodular corona of Peyer's patches.  Specific binding is absent in T lymphocyte-enriched areas, such as the thymus and periarteriolar lymphatic sheaths of the spleen.  Certain macrophage-enriched areas, i.e., liver and lung, lack specific binding.  Thus, the single peripheral cell type that may contain cannabinoid receptors is the B lymphocyte.  Numerous sites have dense binding that could not be displaced by excess unlabeled drug.  These nonspecific sites were found in the liver, adrenal glands and sebaceous glands, which are high in fat content, and in the heart, pancreas, components of the male and female reproductive systems and the epithelium of the esophagus.  Thus, the highly lipophilic nature of cannabinoids does not appear to be the sole determinant of nonspecific binding.  The data suggest that cannabinoids may exert specific receptor-mediated actins on the immune system of rats.  Perhaps, also at high concns., cannabinoids exert membrane effects at sites where they are sequestered nonspecifically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAtF8Av-r9C7Vg90H21EOLACvtfcHk0lheaD56oGtQtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1WhsLs%253D&md5=fce7591d2f7c47a3c3ebf22d67d4730a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynn%26aufirst%3DA.%2BB.%26aulast%3DHerkenham%26aufirst%3DM.%26atitle%3DLocalization%2520of%2520cannabinoid%2520receptors%2520and%2520nonsaturable%2520high-density%2520cannabinoid%2520binding%2520sites%2520in%2520peripheral%2520tissues%2520of%2520the%2520rat%253A%2520implications%2520for%2520receptor-mediated%2520immune%2520modulation%2520by%2520cannabinoids%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1994%26volume%3D268%26spage%3D1612%26epage%3D1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breese, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, F. T.</span><span> </span><span class="NLM_article-title">Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span><span class="refDoi"> DOI: 10.1002/glia.20467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1002%2Fglia.20467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=17203472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FmtFSitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=453-462&author=L.+Qinauthor=X.+Wuauthor=M.+L.+Blockauthor=Y.+Liuauthor=G.+R.+Breeseauthor=J.-S.+Hongauthor=D.+J.+Knappauthor=F.+T.+Crews&title=Systemic+LPS+causes+chronic+neuroinflammation+and+progressive+neurodegeneration&doi=10.1002%2Fglia.20467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration</span></div><div class="casAuthors">Qin Liya; Wu Xuefei; Block Michelle L; Liu Yuxin; Breese George R; Hong Jau-Shyong; Knapp Darin J; Crews Fulton T</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">453-62</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">Inflammation is implicated in the progressive nature of neurodegenerative diseases, such as Parkinson's disease, but the mechanisms are poorly understood.  A single systemic lipopolysaccharide (LPS, 5 mg/kg, i.p.) or tumor necrosis factor alpha (TNFalpha, 0.25 mg/kg, i.p.) injection was administered in adult wild-type mice and in mice lacking TNFalpha receptors (TNF R1/R2(-/-)) to discern the mechanisms of inflammation transfer from the periphery to the brain and the neurodegenerative consequences.  Systemic LPS administration resulted in rapid brain TNFalpha increase that remained elevated for 10 months, while peripheral TNFalpha (serum and liver) had subsided by 9 h (serum) and 1 week (liver).  Systemic TNFalpha and LPS administration activated microglia and increased expression of brain pro-inflammatory factors (i.e., TNFalpha, MCP-1, IL-1beta, and NF-kappaB p65) in wild-type mice, but not in TNF R1/R2(-/-) mice.  Further, LPS reduced the number of tyrosine hydroxylase-immunoreactive neurons in the substantia nigra (SN) by 23% at 7-months post-treatment, which progressed to 47% at 10 months.  Together, these data demonstrate that through TNFalpha, peripheral inflammation in adult animals can: (1) activate brain microglia to produce chronically elevated pro-inflammatory factors; (2) induce delayed and progressive loss of DA neurons in the SN.  These findings provide valuable insight into the potential pathogenesis and self-propelling nature of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBzJ80ULUdypPlX7E30qdzfW6udTcc2eagSv2ZXvg4urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FmtFSitw%253D%253D&md5=b999219adcacd99866c13df7a55280d1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fglia.20467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20467%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DBlock%26aufirst%3DM.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DBreese%26aufirst%3DG.%2BR.%26aulast%3DHong%26aufirst%3DJ.-S.%26aulast%3DKnapp%26aufirst%3DD.%2BJ.%26aulast%3DCrews%26aufirst%3DF.%2BT.%26atitle%3DSystemic%2520LPS%2520causes%2520chronic%2520neuroinflammation%2520and%2520progressive%2520neurodegeneration%26jtitle%3DGlia%26date%3D2007%26volume%3D55%26spage%3D453%26epage%3D462%26doi%3D10.1002%2Fglia.20467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Rühl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Günther, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krautscheid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span> </span><span class="NLM_article-title">Cannabinoid receptor type 2 (CB<sub>2</sub>)-selective <i>N</i>-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation</span> <span class="citation_source-journal">Org. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span><span class="refDoi"> DOI: 10.1186/2191-2858-2-32</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=10.1186%2F2191-2858-2-32" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=23067874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FltlKqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=32-32&author=T.+R%C3%BChlauthor=W.+Deuther-Conradauthor=S.+Fischerauthor=R.+G%C3%BCntherauthor=L.+Hennigauthor=H.+Krautscheidauthor=P.+Brust&title=Cannabinoid+receptor+type+2+%28CB2%29-selective+N-aryl-oxadiazolyl-propionamides%3A+synthesis%2C+radiolabelling%2C+molecular+modelling+and+biological+evaluation&doi=10.1186%2F2191-2858-2-32"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation</span></div><div class="casAuthors">Ruhl Thomas; Deuther-Conrad Winnie; Fischer Steffen; Gunther Robert; Hennig Lothar; Krautscheid Harald; Brust Peter</div><div class="citationInfo"><span class="NLM_cas:title">Organic and medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The endocannabinoid system is involved in many physiological and pathological processes.  Two receptors (cannabinoid receptor type 1 (CB1) and type 2 (CB2)) are known so far.  Many unwanted psychotic side effects of inhibitors of this system can be addressed to the interaction with CB1.  While CB1 is one of the most abundant neuroreceptors, CB2 is expressed in the brain only at very low levels.  Thus, highly potent and selective compounds for CB2 are desired.  N-aryl-((hetero)aromatic)-oxadiazolyl-propionamides represent a promising class of such selective ligands for the human CB2.  Here, a library of various derivatives is studied for suitable routes for labelling with 18F.  Such 18F-labelled compounds can then be employed as CB2-selective radiotracers for molecular imaging studies employing positron emission tomography (PET).  RESULTS:  By varying the N-arylamide substructure, we explored the binding pocket of the human CB2 receptor and identified 9-ethyl-9H-carbazole amide as the group with optimal size.  Radioligand replacement experiments revealed that the modification of the (hetero)aromatic moiety in 3-position of the 1,2,4-oxadiazoles shows only moderate impact on affinity to CB2 but high impact on selectivity towards CB2 with respect to CB1.  Further, we could show by autoradiography studies that the most promising compounds bind selectively on CB2 receptors in mouse spleen tissue.  Molecular docking studies based on a novel three-dimensional structural model of the human CB2 receptor in its activated form indicate that the compounds bind with the N-arylamide substructure in the binding pocket. 18F labelling at the (hetero)aromatic moiety at the opposite site of the compounds via radiochemistry was carried out.  CONCLUSIONS:  The synthesized CB2-selective compounds have high affinity towards CB2 and good selectivity against CB1.  The introduction of labelling groups at the (hetero)aromatic moiety shows only moderate impact on CB2 affinity, indicating the introduction of potential labelling groups at this position as a promising approach to develop CB2-selective ligands suitable for molecular imaging with PET.  The high affinity for human CB2 and selectivity against human CB1 of the herein presented compounds renders them as suitable candidates for molecular imaging studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRK42tUugHa_j0O18WR3iAofW6udTcc2eagSv2ZXvg4urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FltlKqtA%253D%253D&md5=872d48bce8e40490a41ffaec4a3ea4d0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1186%2F2191-2858-2-32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2191-2858-2-32%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BChl%26aufirst%3DT.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DG%25C3%25BCnther%26aufirst%3DR.%26aulast%3DHennig%26aufirst%3DL.%26aulast%3DKrautscheid%26aufirst%3DH.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DCannabinoid%2520receptor%2520type%25202%2520%2528CB2%2529-selective%2520N-aryl-oxadiazolyl-propionamides%253A%2520synthesis%252C%2520radiolabelling%252C%2520molecular%2520modelling%2520and%2520biological%2520evaluation%26jtitle%3DOrg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D2%26spage%3D32%26epage%3D32%26doi%3D10.1186%2F2191-2858-2-32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, B. M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaquero, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span> </span><span class="NLM_article-title">Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1891</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=1891-1900&author=Y.+Wangauthor=J.+Seidelauthor=B.+M.+W.+Tsuiauthor=J.+J.+Vaqueroauthor=M.+G.+Pomper&title=Performance+evaluation+of+the+GE+healthcare+eXplore+VISTA+dual-ring+small-animal+PET+scanner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSeidel%26aufirst%3DJ.%26aulast%3DTsui%26aufirst%3DB.%2BM.%2BW.%26aulast%3DVaquero%26aufirst%3DJ.%2BJ.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26atitle%3DPerformance%2520evaluation%2520of%2520the%2520GE%2520healthcare%2520eXplore%2520VISTA%2520dual-ring%2520small-animal%2520PET%2520scanner%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26spage%3D1891%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i53"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00554">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78708"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00554">10.1021/acs.jmedchem.6b00554</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C, COSY 2D, HMBC 2D, and NOESY 2D NMRs of compound <b>44</b>; <sup>1</sup>H NMR of compounds <b>18</b>–<b>21</b>, <b>23</b>–<b>29</b>, <b>44</b>, <b>45</b>, <b>50</b>, and <b>53</b>; and molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00554/suppl_file/jm6b00554_si_001.pdf">PDF</a>)</p></li><li><p class="inline">CB<sub>1</sub> and CB<sub>2</sub><i>K</i><sub>i</sub> values of compounds <b>1</b>, <b>18</b>–<b>21</b>, <b>23</b>–<b>29</b>, <b>44</b>, <b>45</b>, and <b>50</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00554/suppl_file/jm6b00554_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00554/suppl_file/jm6b00554_si_001.pdf">jm6b00554_si_001.pdf (423.11 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00554/suppl_file/jm6b00554_si_002.csv">jm6b00554_si_002.csv (0.88 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00554&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00554%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00554" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990a15482e3dca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
